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Cover illustration: The hardier members of the viridans streptococcal community are able to 
flourish in the presence of auinolones while other oral flora are depressed. Conditioning therapy 
for transplant destroys the bone marrow as phnned but unfortunately also damages the oral 
mucosa which becomes red, raw, swollen and painful. This tissue damage kindles fever, 
C'Teactive protein and interleukin 6 and aL·ws the streptococci to sneak through gaps in the 
mucosal barrier. Those that get caught in the bloodstream arouse considerable anxiety even 
though they are easily subdued by antimicrobial therapy. Meanwhile fever and inflammation 
remain until the oral mucosa begin to heal and the bone marrow has begun to revive. 
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Chapter 1 
Introduction: the oral viridans streptococci 
"Maar ah men nu in toe komende soo danige lieden sal komen te seggen, 
datT meerder Dieren inde Vuijlicheijt die aende tanden inde mont van een 
Mensch sijn, ahT Menschen in een gansch Coninkrijk leven"1 
Antoni van Leeuwenhoeck 
17th September 1683 
'But what if one should tell future generations that there are more animals living in the scum of their teeth 
than there are people in a whole kingdom 

Introduction the oral vindans streptococci 
Introduction 
Oral vindans streptococci are small spherical or ovoid Gram-positive bacteria which are 
amongst the most populous of the commensal flora of the mouth. The organisms are 
referred to as alpha haemolytic streptococci because of the intense green halo that 
surrounds the colonies that grow on sheep blood agar. However the term vindans is 
preferred to distinguish the reaction from the true haemolysis which results when cells 
lyse and haemoglobin is broken down to its colourless components. Streptococci do not 
produce spores nor are they usually motile and they divide only in one plane resulting 
in chains of varying lengths They grow optimally at temperatures of around 37°C and, 
although not obligate anaerobes, they survive better under conditions where the 
concentration of oxygen is significantly lower than atmospheric, such as is found in the 
oral cavity (Hardie &. Marsh, 1978). Vindans streptococci are chemoorganotrophs gaining 
both energy and carbon from organic substrates by means of fermentation and produce 
lactic acid when glucose is freely available in common with other streptococci (Hardie, 
1986a). However, in their natural habitat, the supply of glucose is strictly limited and 
thus formate, acetate and ethanol are produced as well as lactic acid (Marsh &. Martin, 
1984). These acids alter the immediate environment by lowering pH and the redox 
potential (Eh) thereby helping to create a more favourable environment for the non-
sponng anaerobes such as the Fusobactena, Veiltanella, Bacteroides, Eubactena, and other 
Gram-positive cocci which, in their turn, produce carbon dioxide enabling carboxyphilic 
species such as Capnocytophaga to establish themselves, The non-sponng anaerobes also 
lower the Eh further by producing the hydrogen and ammonia required by certain bacteria 
such as Campylobacter and Wolmella, the menadione required by some Bacteroides and 
also the short-chain fatty acids, amino acids and other growth factors essential for the 
obligate anaerobes Borrelia and Treponema (Sanz & Newman, 1988). Thus, the streptococci 
play a pivotal role in creating the complex labyrinth of ecological niches that occur in 
the mouth and are essential for the establishment and maintenance of the normal oral 
commensal flora It is therefore not surprising that the streptococci are a constant feature 
of the human oral flora but their role in creating a climate for others requires them to 
first become established on the oral surfaces. 
Adherence to mucosal and other surfaces 
Vindans streptococci adhere strongly to the surfaces of both epithelial cells and inanimate 
substrates e.g. plastics, glass by mechanisms which are poorly understood but include 
electrostatic and Van Der Waal's forces (Vosbeck & Mett, 1983, Van Loosdrecht, Lyklema, 
Norde δι Zehnder, 1990). Most strains produce fimbriae although those associated with 
Streptococcus sanguis and Streptococcus mitis tend to be short when compared with 
Streptococcus salwarms (Rosan, 1988). There may also be more specific molecular binding 
(Hardie & Marsh, 1978; Vosbeck & Mett, 1983; Van Loosdrecht, Lyklema, Norde & 
Zehnder, 1990). Strep sanguis possesses hpoteichoic acid which may explain its ready 
adherence to cells (Rosan, 1988) However Strep mitis does not produce this substance 
yet is just as firmly adherent as its counterpart lending support to the hypothesis that 
hydrophobic interactions are responsible (Rosan, 1988). 
Oral distribution 
There appears to be significant demarcation among the streptococci mediated, m part, 
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Introduction the oral vindans streptococci 
by bactenocins in different areas of the oral cavity (Hardie &. Marsh, 1978; Marsh &. 
Martin, 1984; Allen, 1985) although the precise localisation of particular strains has had 
to be revised as a result of the considerable changes made to the taxonomy and 
nomenclature (Kihan, Mikkelsen & Hennchsen, 1989). For instance the strain designated 
Strep, sanguis II has been reclassified as Streptococcus oralis since it is shares more 
characteristics with Strep mms than Strep sanguis sensu smcto to which it is more 
distantly related genetically. On the other hand, Streptococcus gordomi was formerly 
classified as Strep sanguis with which it shows close homology (Figure 1). 
S. gordonii 
Figure 1. Genetic relationship of oral 
vindans streptococci 
Redrawn from Kihan, Mikkelsen & 
Hennchsen, 1989, International Journal of 
Systematic Bacteriology 39 471-484 
Strep sanguis is also able to produce various enzymes including IgAl protease (Kihan &. 
Homgren, 1981) while Strep gordonii and Strep mms bind salivary α-amylase (Douglas, 
Pease & Whiley, 1990; Kihan δι Nyvad, 1990). Features which help differentiate the 
various streptococci are shown in Table 1. 
Supragingival plaque is now known to contain all varieties of oral streptococci 
whereas initial dental plaque is associated with Strep sanguis, Strep mttis biovar 1 and 
Strep oralis (Frandsen, Pedrazzoh &. Kihan, 1991). Strep sanguis species and Strep, mitis 
biovar 1 predominate on the buccal mucosa while Strep oralis is found almost exclusively 
in initial dental plaque Strep gordonii is found in small numbers on the mucosa and in 
mature supragingival plaque. The dorsum of the tongue is associated with Strep mitis 
biovar 2 and Strep sativanus the latter being also predominant on the pharyngeal mucosa. 
Streptococcus anginosus predominates in the subgingival plaque IgA protease producing 
strains are primarily located on the initial dental plaque and buccosal mucosa lending 
further support to the idea that these enzymes play an important role in enabling oral 
streptococci to evade local immune defence during the early stage of colonisation 
(Frandsen, Pedrazzoh & Kihan, 1991). 
Biofilm, the natural environment 
Vindans streptococci are among those species which exhibit planktonic growth i.e. 
growth as dissociated units namely as single cells or short chains of up 8 cocci only in 
5 
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broth culture under the exceptional circumstances found in the laboratory. Colony 
formation is the norm although those that form on the surface of agar comprise 1,000-
10,000 times the number that might occur naturally in any one colony. In their normal 
environment streptococci, like most bacteria, grow as a biofilm i.e. a plaque of growth 
in which cells are associated one with another to form a community or consortium 
(Vosbeck «Si Mett, 1983). 
The ability to produce glycocalyx appears to be the sine qua non of adhesion which 
is itself obligatory if bacteria are to form stable communities and therefore colonise 
various ecological niches (Vosbeck & Mett, 1983). Cells growing as biofilm produce 
extracellular polysaccharides e.g. most Strep, sanguis produce dextrans while Strep mms 
does so much less frequently (Brennan &. Durack, 1984). Dextran production is thought 
to permit adhesion to fibrin (Vosbeck &. Mett, 1983) which partly explains the 
predominance of dextran-producing strains m causing endocarditis (Parker &. Ball, 1975). 
These glycocalyx complexes vary from rigid structures e.g. the capsule of Streptococcus 
pneumoniae to the less-organised matrix found among the vindans streptococci e.g. 
Strep, sanguis (Costerton & Irvin, 1981). Loose extracellular material can, however, be 
organised by linking lectins and other proteins including immunoglobulins to form a 
highly organised matrix within which the microbial community can flourish in what 
might otherwise be a hostile environment (Costerton & Irvin, 1981). Glycocalyx also 
appears to function as a sort of exchange-resin which is almost 99% hydrated thus 
surrounding the cells with their own aqueous microenvironment. Any nutrients that are 
dissolved in this water will therefore be readily available. Iron is essential for both 
bacteria and man and the ability to compete successfully in a highly restricted milieu for 
metal ions is an essential characteristic of both the successful coloniser (Costerton, 
Cheng, Geesey, et αϊ., 1987) and the pathogen (Brubaker, 1985). Glycocalyx therefore 
alters the odds in favour of the bacterium (Brown &. Williams, 1985). 
In common with most Gram-positive bacteria, streptococci release degradative 
enzymes into their immediate surroundings (Glenn, 1976). When encased in biofilm, 
the enzymes are less likely to be leached into the aqueous domain and therefore have 
more opportunity to bind and react with their substrates (Costerton, Cheng, Geesey, et 
al., 1987). Finally, biofilm existence affords the bacteria greater protection from adverse 
conditions such as desiccation, poisoning by disinfectants (Costerton &. Marne, 1983) 
and, in some cases, the action of antimicrobial agents is curtailed (Hoyle, Jass &. Costerton, 
1990). Another feature of biofilm existence is that "seeding" occurs (Figure 2). Thus, 
large numbers of bacterial cells disassociate from the primary site, often as large plaques, 
and are able to relocate at distant sites in an aqueous environment (Costerton, Cheng, 
Geesey, et ai, 1987). In the setting of the human host, seeding of streptococci normally 
takes place through the medium of saliva and other oral secretions leading to colonisation 
of the small intestine and lower bowel in up to 30% of normal individuals (Liljemark 
& Bloomquist, 1988). However blood assumes this function once bacteria have moved 
into tissues i.e. translocated. 
Opportunistic pathogen 
Until the early 1980's, the vindans streptococci were only associated with infective 
bacterial endocarditis although other infections were occasionally encountered (Parker 
&. Ball, 1975). Strep, sanguis and Strep, mms account for almost half of the 60% of 
6 
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strains identified (Young, 1987) and translocate from the mouth to the blood stream via 
damage or trauma. The pathogenic potential of viridans streptococci appears to depend 
upon their predominance in the oral cavity particularly around the gingival-tooth junction. 
The distribution of strains involved in endocarditis also reflects the association of 
Strep, sanguis with the gingival crevice and dental plaque rather than any numerical 
predominance since Strep, mitts is actually more widely distributed and present in greater 
numbers (Hardie &. Marsh, 1978). Other virulence factors include the production of 
hydrogen peroxide and ability to survive in tissue (Marsh &. Martin, 1984). The IgA 
proteases may also help strains establish themselves as well as enhance their resistance 
to gingival crevicular fluid which contains immunoglobulins, complement, granulocytes, 
monocytes and lymphocytes (Marsh & Martin, 1984). Huge numbers are not necessary 
to establish infection since bacteraemia involves only 10 - 100 bacteria per ml (Everett 
& Herschmann, 1977). Rather than being pathogens in their own right, the bacteria are 
opportunists which exploit thrombotic vegetations that have already developed on heart 
valves and other blood vessels. These lesions are composed of platelets and fibrin which 
allow the streptococci to adhere and multiply within the relative safety of a biofilm. 
Once established, bacteria escape as 'seedlings' manifested by constant bacteraemia thereby 
initiating a process which ultimately leads to infective endocarditis (Freedman, 1987). 
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Figure 2. Putative growth cycle of streptococci in their natural environment. A single bacterial cell attaches to a 
surface in an aqueous environment (a) then proceeds to divide in two (b), four (c), eight cells (d) and so on (e) until 
a colony is formed (f). Once the consortium of cells has become established, extracellular materials, e.g. dextrans, 
are produced (g) and envelop the community. As the colony becomes older, "seedlings" are released (h) allowing 
the cycle to begin again. 
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Bacteraemia in the neutropenic patient 
Attention was first drawn to neutropenic patients almost a decade ago when a series of 
10 cases of bacteraemia due to vindans streptococci were reported during a period in 
which a total of 72 patients had experienced 120 episodes of fever during neutropenia 
(Cohen, Donnelly, Worsley, et al, 1983). The attack rate for the streptococci was 8 per 
cent which was similar to that for Gram-negative rods but one-quarter of that for the 
coagulase-negative staphylococci. Five patients had clinically apparent ulcers which 
coincided with herpes simplex infection in one instance while a further two complained 
of a sore throat. Seven patients developed fever and bacteraemia within 4-7 days of their 
becoming neutropenic. A penicillin had been given to nine patients after eradication 
had already been achieved yet fever only resolved after the bone marrow had begun to 
recover in seven cases (Cohen et al, previously unpublished data). A variety of different 
cytostatic regimens had been used and the only patient to develop pulmonary infiltrate 
with respiratory distress died in septic shock two days after the onset of bacteraemia. 
Despite extensive post-mortem culture of tissues, including the lung, neither streptococci 
nor indeed any other microbial aetiology was established. 
Seven of the streptococcal isolates were identified as Strep mitis of which six were 
resistant to co-tnmoxazole which all patients had received as prophylaxis. The single 
strain of Strep sanguis was also resistant to this antimicrobial as were the majority of 
streptococcal strains isolated from healthy volunteers and patients in a general surgical 
ward leading the authors to conclude that resistance to this antimicrobial might be 
inherent among the oral streptococci. Since then viridans streptococci have become one 
of the most frequent isolates from blood cultures of febrile, neutropenic patients undergoing 
therapy for leukaemia with Strep mitis being more frequently involved that Strep, sanguis 
(Henslee, Bostrom, Weisdorf, et al., 1984; Mascret, Maraninchi, Gastaut, et al, 1984; 
Kern, Kunle &. Vanek, 1987; Menichetti, DelFavero, Guerciohm, et al., 1987; Sotiropoulos, 
Jackson, Woods, et al., 1989; Classen, Burke, Ford, et al, 1990; Weisman, Scoopo, 
Johnston, Altman &. Quinn, 1990; Burden, Oppenheim, Crowther, et al., 1991; Valteau, 
Hartmann, Brugieres, et al., 1991; Van der Lelie, Van Ketel, Von dem Borne, et al, 1991; 
Awada, Van Der Auwera, Meunier, Daneau & Klastersky, 1992; Devaux, Archimbaud, 
Guyotat, et al., 1992; Elting, Bodey & Keefe, 1992). 
Risk factors for viridans streptococcal bacteraemia 
Prophylaxis 
The rising incidence of bacteraemia due to oral viridans streptococci in neutropenic 
patients has been attributed to the use of selective oral prophylaxis particularly when 
quinolones have been employed for the prevention of infection in neutropenic patients 
(Classen, Burke, Ford, et αϊ., 1990; Warren, Wimpens, Baglin, Constantine &. Marcus, 
1990; Viot &. Klastersky, 1991; Awada, Van Der Auwera, Meunier, Daneau δι Klastersky, 
1992; Elting, Bodey & Keefe, 1992). Bacteraemia is assumed to have been promoted by 
the quinolone (Van der Lelie, Van Ketel, Von dem Borne, et al, 1991) to which the 
organisms are only marginally susceptible (King & Phillips, 1986; Donnelly, Willemse, 
Horrevorts & De Pauw, 1992) especially at the concentrations thought to occur in the 
oral cavity (Ullman, Giebel, Dalhoff & Koeppe, 1986). However, the majority of patients 
reported by Cohen and colleagues had bacteraemia with viridans streptococci following 
8 
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prophylaxis with co-tnmoxazole (Cohen, Donnelly, Worsley, et al, 1983). Natural 
resistance to trimethoprim is assumed to be infrequent although selection occurs following 
prophylaxis with co-tnmoxazole (Cohen, Donnelly, Worsley, et al., 1983) whereas 
quinolones are known to be only marginally active at the tissue levels that follow a 
normal dose of 500 mg namely 2-4 mg/1 (Sanders, Sanders & Goenng, 1987). Therefore 
bacteraemia may simply be easier to detect when a patients has been given a quinolone 
Oromucositis 
Oromucosms has been implicated as a risk factor (Burden, Oppenheim, Crowther, et al., 
1991, McWhmney, Gillespie, Kibbler, Hoffbrand & Prentice, 1991; Elting, Bodey & 
Keefe, 1992) although others have failed to find any association (Valteau, Hartmann, 
Brugieres, et al., 1991; Awada, Van Der Auwera, Meunier, Daneau δι Klastersky, 1992). 
Bacteraemia due to vindans streptococci appears related to the mucosal damage since 
the particular strains involved comprise the normal commensal flora of the oral cavity 
(Russell δι Melville, 1978). Extensive mucosal toxicity of cytarabine is well established 
and includes conjunctivitis, oromucositis and extensive intestinal damage manifest by 
the high incidence of nausea, vomiting and diarrhoea (Peters, Willemze, Colly δι Guiot, 
1987) as well as histologically (Andersson, Luna, Yee, et al, 1989). Oromucositis is also 
associated with anthracychnes especially when given shortly before total body irradiation 
to prepare for allogeneic bone marrow transplantation (Raemaekers, De Witte, 
Schattenberg δι Van Der Leb/, 1989) Moreover, given the natural habitat of the vindans 
streptococci, any disruption of the mucosal integrity might be expected to increase the 
risk of translocation, especially when the selective pressure of prophylaxis has resulted 
in a predominantly resistant bacterial population. Infection due to herpes simplex might 
also predispose to bacteraemia due to vindans streptococci in allogeneic transplant 
recipients since the incidence was reduced from 27% to nil after the introduction of 
acyclovir (Ringden, Heimdahl, Lonnequist, Malmborg δι Wilczek, 1984) However it 
was not clear how many patients actually developed herpes infection and more patients 
were given cyclosporin A rather than methotrexate with a consequent reduction in 
oromucositis (Bostrom δι Weisdorf, 1984). Nevertheless these observations served to 
emphasise the importance of mucosal integrity in the oral cavity as a means of minimising 
bacteraemia 
Colonisation of other body sites 
Significant alteration of the bowel flora by antimicrobials together with toxic damage to 
the mucosal surfaces by cytsotatics may provide the ideal circumstances for colonisation 
by ingested vindans streptococci In patients receiving H2-receptor antagonists e g. 
Cimetidine, ranitidine, the achlorhydnc stomach offers less resistance to ingested bacteria 
which may be passed onwards through the alimentary tract (Dnks, Craven, Celli, et al, 
1987). For instance, the epithelium of the lower oesophagus are damaged in patients 
with acid reflux or dysphagia and inflammation of the oesophagus and this is a common 
site for infection caused by both herpes simplex and Candida albicans (Bodey, Bolivar &. 
Fanstein, 1982; Sarai, 1988). Also, the production of mucous itself is likely to enhance 
microbial multiplication especially as the levels of inhibitory factors normally secreted 
in saliva are often much lower (Raber-Durlacher, Abraham-Inpijn, Van Leeuwen, Lustig 
δι Van Winkclhof, 1989). Thus the adhesion of infected mucous to the lining of the 
oesophagus together with less efficient digestion might assist intestinal colonisation 
9 
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thereby affording a second route for translocation. Given the surface area involved, the 
potential focus is considerably larger than that provided by the oral cavity alone. Any 
extensive colonisation would then increase the possibility of huge numbers of bacteria 
finding their way into the blood stream in a short time and hence disseminating to the 
major organs including the lung. 
Possible virulence factors 
Viridans streptococci do not appear to have any specific virulence factors apart from 
their ability to adhere to tissues cells and other surfaces. Nonetheless, patients suffering 
viridans streptococci bacteraemia tend to have temperatures of 39°C or more at the start 
of empirical antimicrobial therapy implying that the viridans streptococci possess a 
specific pyrogen. However, none has been described (Brennan & Durack, 1984) and 
although the muramyl dipeptide component of Gram- positive cell walls is pyrogenic, it 
is only marginally so relative to endotoxin (Dinarello &. Wolff, 1982). Nevertheless, 
streptococcal bacteraemia might present a sudden challenge to the macrophages that 
survive cytostatic treatment with high numbers of bacterial cells thereby initiating the 
release of endogenous pyrogen and other cytokines resulting in high temperatures. Yet 
patients with Hickman catheters that are colonised with coagulase-negative staphylococci 
rarely have high fevers with rigors despite steady bacteraemia often with high numbers 
of cells of > 1000 cfu/ml (Weightman, Simpson, Speller, Mott &. Oakhill, 1988) suggesting 
that microbial mass alone is of minor importance. The biology of the streptococci therefore 
offers little evidence for virulence factors indicating that clinical manifestations are 
either the result of the host's reaction or a subtle interplay of the host and organism. 
Sepsis, A R D S and the "alpha-strep" syndrome 
The majority of patients with viridans streptococcal bacteraemia have no other 
manifestations of infection other than fever. However, a minority develop a form of 
sepsis syndrome - the so-called "alpha-strep shock syndrome" following bacteraemia 
mainly with Strep, mi'tis (Elting, Bodey &. Keefe, 1992). This is characterised by sudden 
onset with shock, adult respiratory distress, encephalopathy without meningitis and 
palmar desquamation in some cases and is mainly preceded by bacteraemia. Many of 
these features particularly those involving the skin are reminiscent of toxic shock syndrome 
and seem unlikely to be the direct result of viridans streptococci which do not elaborate 
any specific toxins. Additional risk factors to those that predispose to streptococcal 
bacteraemia include bone marrow transplantation, the use of H2-receptor antagonists 
and the presence of gastritis and/or vomiting. The gastro-intestinal disturbance observed 
may well explain why some, but not all, patients develop sepsis since this may represent 
breakdown of mucosal integrity and consequent extension of colonisation with 
streptococci. 
Fulminant sepsis is much less common than adult respiratory distress syndrome 
(ARDS) which can affect up to one in five patients who develop bacteraemia with 
streptococci following treatment with cytarabine (Kern, Kurrle & Vanek, 1987; 
Sotiropoulos, Jackson, Woods, et ed., 1989). Symptoms included fever, coughing, dyspnoea, 
tachypnoea and hypoxaemia (Peters, Willemze, Colly & Guiot, 1987) and capillary 
leakage occurs with a fibrinous exudate affecting both lungs equally resulting in a diffuse 
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appearance on X-ray. ARDS is part of the multiple organ failure or MOF complex, and 
is therefore orchestrated through TNF and other mediators of the inflammatory response. 
Although both ARDS and septic shock can be induced by sepsis alone (Ognibene, 
Martin, Parker, et al., 1986), the so-called "sepsis cascade" does not always require 
microbial involvement (Bone, 1991a). High-dose cytarabine has been shown to induce 
ARDS in one in ten leukaemic patients without there being any evidence of infection 
(Andersson, Luna, Yee, et al., 1989). Moreover, severe intestinal toxicity was observed 
in every fatal case suggesting that toxicity alone was responsible. Therefore, while 
streptococcal bacteraemia might indeed trigger off a sequence of events culminating m 
noncardiogeneic pulmonary oedema whenever there is pre-existing lung damage (Guiot, 
Peters, Van Den Broek, et al, 1989), both complications might also be manifestations 
of the toxicity induced by intensive chemotherapy and have no causal relationship with 
each other. 

Chapter 2 
Hypothesis and outline of investigation 

Hypothesis and outline of investigation 
The picture that emerges is one suggesting a series of coincident events related to 
cytostatic treatment, oral mucositis and prophylaxis. In Chapter 3, the efficacy of 
ciprofloxacin as prophylaxis was investigated in a consecutive series of allogeneic bone 
marrow transplant recipients given conditioning with and without anthracyclines. It was 
therefore possible to assess the applicability of the hypothetical model illustrated in 
Figure 1 where the antimicrobial given for prophylaxis eg ciprofloxacin selects resistant 
viridans streptococci providing the first step towards the development of bacteraemia. 
Cytostatic treatment then results in mucosal damage thereby increasing the likelihood 
of translocation of the residual commensal flora. Since the component organisms are 
resistant to ciprofloxacin, they invade the tissue but only the streptococci are recovered 
from the blood stream since anaerobes do not survive passage through the tissues (Hardie, 
1986b). 
a) 
V ^ * - - Commensal 
flora 
Flora shifts to 
more resistant 
population 
mucosal 
damage 
induced by 
cytostatics 
Figure 1. Model for explaining the development of bacteraemia due to viridans streptococci in patients given 
prophylaxis and radiochemotherapy. The mucosal barrier protects against the many different sorts of microorgan-
isms that make up the normal commensal flora (a). Treatment with a broad-spectrum antibacterial agent, such as 
ciprofloxacin, alters the ecology significantly by suppressing susceptible bacteria and selecting for the more resistant 
species e.g. the viridans streptococci (b) but the mucosal barrier remains intact. Besides causing bone marrow 
suppression, cytostatic treatment severely damages the epithelial cells resulting in disruption of the mucosa (c). The 
viridans streptococci are then able to migrate into the bloodstream and cause bacteraemia (d). 
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In order to address each element of the model proposed, a study was conducted in a 
cohort of allogeneic bone marrow transplant recipients who presented a homogeneous 
group since they followed essentially the same protocol in terms of conditioning, prophy­
laxis and bone marrow treatment All would become profoundly neutropenic and would 
therefore be expected to run the same infective risks. In addition, all were expected to 
develop oromucositis with bacteraemia due to viridans streptococci occurring in two 
thirds of cases. An integrated scheme for laboratory investigations was therefore designed 
and instituted (Table 1) in order to permit the systematic monitoring required for 
investigating each component of the model. 
Table 1. Laboratory programme employed for allogeneic BMT patients 
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The role of oromucositis 
Oromucositis was known to play a key rôle in the development of viridans streptococcal 
bacteraemia but it was not clear whether it was simply mucosal damage per se, in which 
case the W H O scoring system would suffice or whether or not bacteraemia was 
associated with the progression of oromucositis which would require daily scoring of 
oromucositis. A scheme was therefore devised and evaluated prospectively in which any 
lesions, erythema, dysphagia, oedema and pain which affected the oral cavity were 
graded to four levels according to whether or not they were absent or, if present, were 
mild or limited, moderate or more extensive or severe and very extensive (Chapter 4). 
The impact of ciprofloxacin prophylaxis on the oral flora 
It had already been shown that most of the streptococci were resistant to ciprofloxacin 
and it had been assumed that prophylaxis led to selection of strains from among the oral 
flora. An attempt was therefore made to assess quantitatively, the impact of ciprofloxacin 
on the oral flora by testing directly the susceptibility of viridans streptococci in mouth 
wash cultures to ciprofloxacin at concentrations of 0.25-16 mg/1 (Chapter 5). These 
results were then related temporally to the onset of bacteraemia. 
The detection and significance of bacteraemia 
Assuming that bacteraemia resulted from mucosal damage, all patients might have 
similar numbers of bacteria in their blood and the counts might be expected to rise 
proportionally with the degree of mucosal damage. To address this question, we elected 
for a pour-plate designed in collaboration with Mr Herman van Balen (Chapter 6) 
since a quantitative method of detection was necessary. The technique was simple to 
operate, was performed at the ward and did not require working with molten agar. Blood 
was obtained in a special vial containing concentrated medium, was mixed until lysed 
and was then poured onto a partially-dehydrated agar in a standard Petri-dish 
(Figure 2). The plate was left for 30 minutes to allow complete resorption to occur 
resulting in a plate that was indistinguishable from conventional agar. After incubation 
any colonies which had grown could be counted. Blood was obtained for culture 6 and 
2 days before transplant and during each of the first 15 days after transplant to determine 
the relationship between oromucositis and bacteraemia. 
Treatment of fever associated with oromucositis and bacteraemia 
If viridans streptococci played a crucial role in the development of the mucositis 
syndrome, then the organisms should be detectable in every case and treatment with an 
effective agent should bring obvious benefit. Thus we conducted an open intervention 
study in which patients who received idarubicin together with cyclophosphamide and 
total body irradiation were given high-dose clindamycin (900 mg tds IV) together with 
ceftazidime for five days after the onset of fever (Chapter 7). 
The acute phase response to oromucositis and bacteraemia 
Persistent fever was one of the features which characterised the immediate post-
transplant period following bone marrow transplantation. However pyrexia is by no 
means specific for infection and might, in fact, be the result of the inflammation 
Viridans streptococci and allogeneic bone marrow transplant recipients 
Figure 2. The cold pour-plate blood culture technique. The nutrients required for 
culture are concentrated and distributed in 1 ml amounts in a sterile glass tube under 
vacuum while the partially-dehydrated gel is already set in the Petri-dish (a). Blood 
is collected using the Vacutainer system whereby one end of a two-way needle is 
placed into the vein and, when secure, the collecting vial is pushed onto the other end 
of the needle (b). Blood is drawn until vial is full whereupon it is withdrawn and 
mixed gently until lysis is complete (c). The solution is then poured over the entire 
surface of the agar (d) and the plate is gently rotated on a flat surface to ensure an even 
layer (e). The plate is then left undisturbed for 20-30 minutes to allow the fluid to 
completely absorb and the gel to set (f). The plate is then inverted and incubated at 
37°C for 24-48 hours in a reduced oxygen atmosphere containing about 5% carbon 
dioxide. The plate is then examined by illuminating against a bright light (g). Any 
colonies are counted and picked off directly for Gram-stain, primary identification 
and antimicrobial susceptibility testing. 
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associated with oromucositis. We therefore undertook to monitor C-reactive protein as 
a marker for the acute-phase response and interleukin 6 to represent the cytokines 
(Chapter 8). By undertaking formal statistical analysis we hoped to determine whether 
or not there was any difference in the inflammatory response between those who 
developed bacteraemia with vindans streptococci and those who did not. In so doing, we 
might be able to assign clinical significance to bacteraemia and to establish whether or 
not the presence of streptococci in the blood stream represented an infective process or 
was simply a consequence of oromucositis and, as such, merely a sign of severe mucosal 
damage 
Alternatives agents for empirical therapy 
Were the streptococci to play a pathogenic rôle in the febrile, neutropenic patient, 
appropriate empiric therapy would be required. Ceftazidime had been used successfully 
in this role as monotherapy but it is only reliably active against Gram-negative rods 
(Bauernfeind, Schweighart δι Jungwirth, 1989). Although therapy could be supplemented 
by the addition of clindamycin or penicillin, a more attractive alternative would be an 
agent which combined activity against both Gram-negatives and Gram-positive bacteria 
including streptococci. Of the drugs currently under investigation, meropenem appeared 
the ideal choice since besides having the prerequisite in-vitro characteristics (Kayser, 
Morenzoni, Strassle &. Hadorn, 1989; Neu, Novelli &. Chin, 1989), the antibiotic is 
stable to renal ammopeptidases (Harrison, Moss, Featherstone, et ai, 1989) and high 
doses are not associated with CNS toxicity (Donnelly, Horrevorts, Sauerwein &. Depauw, 
1992). An investigation was therefore undertaken in which the activity of meropenem 
was compared in vitro with that of various antibiotics that might be appropriate for 
treating bacteraemia due to vindans streptococci and other relevant organisms. 
Recognising that lists of MIC data are often inaccessible and do not convey a full enough 
impression of the data, box-plots were explored to see whether or not these devices 
might offer an alternative Chapter 9). The data are also presented in their entirety in 
a more conventional manner in Chapter 10. 
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Abstract 
Ciprofloxacin as antibacterial prophykxis 
The efficacy and safety of ciprofloxacin as long-term antibacterial prophylaxis after 
allogeneic bone marrow transplantation were assessed prospectively. Eighty-nine 
recipients of lymphocytedepleted marrow grafts were each given ciprofloxacin orally, 
500 mg twice daily. Fever developed in 71 out of 78 évaluable patients (91%) and was 
accompanied by positive blood cultures in 42 cases ( 59% ). Viridans streptococci, all but 
one with reduced in vitro susceptibility to ciprofloxacin, accounted for 35 episodes of 
bacteraemia. Thirty-three episodes occurred in patient given anthracyclines compared 
with only two episodes in other patients (χ 2 = 5.58: p<0.05). All bacteraemic fevers 
occurred within 11 days post-transplant. Gram-negative sepsis did not occur in any 
patient. Sixteen patients died but none due to a bacterial cause. Allergy to ciprofloxacin 
was registered in three out of 76 assessable cases (4%). 
Introduction 
Infectious complications occurring during the early post-transplant period in bone marrow 
recipients are often due to bacteria that comprise the endogenous flora of the alimentary 
tract (Winston, Ho, Champlin &. Gale, 1984). Co-trimoxazole has been used in the past for 
selective decontamination of the digestive tract (SDD). Adequate tissue levels are achieved 
following oral administration to protect against Pneumocystis carinii. However, compliance 
is usually poor and the drug causes allergy (Verhagen, Stalpers, De Pauw & Haanen, 1987), 
may interfere with marrow engraftment (Bow, Louie, Riben, et al, 1984) and requires 
supplementation with other antibiotics to maintain its efficacy against colonisation with 
enterobacteria and to expand the spectrum of activity to include Pseudomonas aeruginosa 
(Rozenberg-Arska, Dekker & Verhoef, 1983). The recent introduction of broad-spectrum 
4-quinolones, e.g. ciprofloxacin, offers the possibility of using one drug only to achieve 
similar efficacy whilst reducing the incidence of adverse reactions. Ciprofloxacin has 
excellent activity against Gram-negative bacteria, including Ps. aeruginosa and staphylo­
cocci, but streptococci and anaerobes are relatively resistant (Muytjens, Vand Der Ros - Van 
de Repe & Van Veldhuijzen, 1983). 
In order to assess the efficacy and safety of the drug a prospective study was conducted 
in allogeneic bone marrow transplant (BMT) recipients in which ciprofloxacin was given 
as antibacterial prophylaxis. Since there was no possibility of recruiting sufficient patients 
for a randomised trial, the study was open and all consecutive patients were enrolled. Before 
this study was initiated, pipemidic acid had been used as the standard prophylactic agent. 
However, immediately prior to starting the current study one patient died of P. carinii 
infection two weeks after transplant. In order to try to avoid such a complication it was 
decided to administer co-trimoxazole during the week before the start of ciprofloxacin and 
cyclosporin A. 
Patients and methods 
Patient characteristics, transphntation procedure, and antimicrobial regimen 
Patients of 16 years or older who were admitted to receive a HLA-matched allogeneic BMT 
were included in the study provided that they had no known allergy to quinolone antibiotics 
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and that they had given their informed consent. From day +9 prior to the transplant until 
granulocyte recovery they were given acyclovir orally (400 mg) and amphotericin В 
( 1000 mg) four times a day. The following day until one day before transplant, they received 
co-tnmoxazole (960 mg every 8 hours) and Colistin (100 mg every 6 hours) in order to 
decontaminate the gut and to provide prophylaxis against Ρ carinii. A Hickman catheter 
was inserted about one week before BMT and all patients were nursed in single rooms 
supplied with filtered air under positive pressure. Reverse-barrier techniques were used and 
patients were given a low-microbial content diet. Conditioning treatment (De Witte, 
Hoogenhout, De Pauw, et al, 1986) began in all patients with cyclophosphamide (60 mg/ 
kg day) on days -6 and -5 and total body irradiation of 4-5 Gy on days -2 
and Ί . From June 1986, all patients were given anthracyclines (either daunorubicin at 
26 mg/m2 or idarubicin at 7 mg/m2) from days -7 to -2. The day before transplant 500 mg 
ciprofloxacin was given orally twice a day with the intention of continuing until 90 days post-
transplant. Cyclosporin A 2.5 mg/kg/day was given intravenously as immunosuppression 
for four weeks after transplant followed by 2 mg/kg given orally every eight hours for a further 
eight weeks. The dose was then decreased gradually until the drug was discontinued after 
16 weeks. 
Surveillance cultures were obtained on admission and at least weekly thereafter until 
the patient was discharged. These consisted of a 10-ml saline oral washing and gargle, faeces, 
urine and swabs from the nose, axilla and groin. Target organisms included Staphylococcus 
aureus, Ps. aeruginosa, yeasts, enterobactena and other Gram-negative aerobic rods. Anti­
biotic susceptibility tests were performed using the NCCLS disc diffusion method (National 
Committee for Clinical Laboratory Standards, 1988) and a zone of 15 mm or less was 
considered as resistant. Identification of streptococci was performed using the API-Strep 
system (API, France). 
Each episode of fever (axillary temperature of 38" С or more) was investigated by 
repeating these cultures and by obtaining two 10-ml samples of blood via the Hickman 
catheter separated by 30 minutes and 10-ml from a peripheral vein. Ceftazidime was then 
given intravenously (2 g every eight hours). Vancomycin (500 mg six hourly) or teicoplanin 
(200 mg once daily) was given to supplement this regimen if fever persisted for three or more 
days or if a resistant Gram-positive organism was isolated from the blood. Other antibiotics 
were added as necessary. Oral administration of ciprofloxacin was interrupted as long as 
broad spectrum parenteral antibactenals were given and if the patient found difficulty in 
swallowing due to severe mucositis. 
Definitions of types of infection 
Bacteraemia The occurrence of one positive blood culture specimen of Gram-negative organisms 
or Staph aureus or more than one positive for other Gram-positive bacteria 
Fever of unknown This is denned as fever but failure of clinical and microbiological evaluation to 
origin (FUO) delineate an aetiology for the fever 
Bronchopneumonia The occurrence of at least two sputum samples positive for the same organism or 
bronchial washing or lung tissue sample positive for an organism considered to be 
clinically relevant, in the presence of a pulmonary radiographic infiltrate not of a 
known non-infectious cause A non-bactenologically proven lower respiratory tract 
infection is defined as the presence of cough, dyspnoea and/or physical signs of pul­
monary consolidation, and a pulmonary radiographic infiltrate without a known non­
infectious cause, with negative or unobtainable microbiologic samples 
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Statistical analysis 
Ordinal data were analysed using parametric statistics the dispersion about the mean 
being described by the 95% confidence interval. Categorical data were analysed by either 
Fisher's exact test or the χ 2 test. 
Results 
From October 1984 until April 1988, 89 patients were enrolled into the study of which 11 
were excluded from analysis because of protocol violation, having been given concomitantly 
cephalondme orally during the study period Of the 78 assessable patients, 41 were female. 
The mean age was 33.4 years (±4.3 SD). Sixty-two patients had been treated for leukaemia, 
seven for refractory anaemia with excess of blast cells, four for lymphoma, two for multiple 
myeloma, and three for severe aplastic anaemia. 
Compliance for the ciprofloxacin medication was excellent; none of the patients 
refused the drug before the onset of fever. Fever developed in 71 patients (91 %) after a mean 
of 5 9±2.3 days after transplant and was accompanied by positive blood cultures in 42 cases 
(59%). All cultures had been taken before the cessation of ciprofloxacin, vindans strepto­
cocci accounted for 35 episodes of bacteraemia (Strep sanguis 21, Strep mitis five, Strep bovis 
two, and one each of Strep morbillorum, Strep, salwanus and five undifferentiated) The 
remainder were due to coagulase-negative staphylococci (five episodes), one episode of 
Staph aureus plus Peptococcus spp. and one of vindans streptococci plus coagulase-negative 
staphylococci. Of vindans isolates, 16 were resistant to ciprofloxacin and of the remainder 
all but one strain had zones of 21 mm or less indicating reduced susceptibility. Thirty-three 
episodes of bacteraemia due to these streptococci occurred in patient given anthracychnes 
compared with only two episodes m other patients and this difference was significant (χ 2 = 
5 58: p<0.05). Patients given anthracychnes were neutropenic longer than others (22 8±3.3 
days versus 15.1±2.1 days respectively: p<0.01: t-test) and all experienced severe oral 
mucositis In case of fever ciprofloxacin medication was interrupted and ceftazidime was 
given for a mean of 10±7 days; in 28% of the cases the addition of a glycopeptide was 
considered necessary and 14 patients received intravenous antifungal therapy. 
There was no difference between the rate of onset of fever in streptococcal bacteraemia 
(mean 6.3±4 days) and the rate in those whose fever was related to other causes (mean 
7.3+11 days). All bacteraemic fevers occurred within 11 days post-transplant and none 
persisted except for the episode caused by streptococci and coagulase-negative staphylococci 
and one case of Hickman catheter associated bacteraemia; the staphylococci persisted until 
after removal of the catheter. After resumption of the ciprofloxacin prophylaxis no new 
bacteraemias were observed. 
In all cases, ciprofloxacin was successful in maintaining the gut flora free of Gram-
negative bacteria and there was no evidence of yeast overgrowth. One patient showed 
persistent oro-pharyngeal colonisation with Ps aeruginosa and Canada albicans was detected 
repeatedly in the oral washings from three patients. None developed any signs of infection 
and all survived. 
Sixteen patients died but none due to a bacterial cause. The mean time to death was 
18.4±6.8 days. One patient had an infection due to cytomegalovirus which induced marrow 
hypoplasia, one died from graft rejection and two patients died of cardio-pulmonary 
insufficiency. Bronchopneumonia was diagnosed in 12 cases but documented in only four. 
One patient had disseminated infection due to herpes simplex and had clinical evidence of 
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pulmonary mycosis although fungi were not cultured; two patients died from pulmonary 
aspergillosis and one from disseminated candidiasis. In the remaining eight cases no 
causative organism was found, neither during life, nor at autopsy. Eighteen patients (24%) 
developed an erythematous skin eruption after a mean of 30.3± 10 7 days of treatment and 
ciprofloxacin was discontinued in all cases. Afterwards graft versus host disease was 
diagnosed in five cases Of the remaining 13 cases, seven were given the drug at a later date 
as a rechallenge, and a rash again developed in three cases. In six cases no explanation for 
the rash was found. Therefore, allergy to ciprofloxacin developed in three out of 76 assessable 
cases (4%) 
Discussion 
Ciprofloxacin was successful in maintaining the gut flora free of Gram- negative bacteria 
without there being concomitant yeast overgrowth and none of the patients developed 
infection caused by Gram-negative bacteria The drug was well-tolerated except during 
severe mucositis, when most patients stopped taking any form of oral medication, at that 
time fever already had occurred. In spite of the effective suppression of aerobic Gram-
negative bacteria, most patients still became febrile and over half were bacteraemic The 
relatively high number of positive blood cultures may have been associated with the 
consistent cultunng procedure Only Gram-positive cocci were isolated, a finding in 
accordance with the data of Menichettt et al (Menichetti, Fellemi, Bucaneve, et al, 1989), 
the majority being vindans streptococci which were shown to have reduced susceptibility 
to ciprofloxacin These organisms comprise the normal commensal flora of the mouth and 
bacteraemia appeared to correspond with the use of anthracychnes which resulted in severe 
damage to the oral mucosa as well as prolonged neutropenia. Other centres have reported 
similar findings (Cohen, Donnelly, Worsley, et al, 1983; Viscoli, Van Der Auwera & 
Meunier, 1988), but whether vindans streptococci represent true pathogens remains an 
open question. Indeed our evidence suggests (Winters, Moolhuijzen & Donnelly, 1989) that 
bacteraemia due to these bacteria is associated with oral mucositis. Furthermore morbidity 
appeared to be low in this series and, moreover, no patient had died thus far. Bacteraemia 
due to the streptococci may be only a marker of mucosal damage in the majority of bone 
marrow transplant patients since there is neither a difference in terms of the onset of fever 
for bacteraemic and non-bacteraemic patients, nor convincing evidence of a true infection. 
Whatever the meaning of the vindans streptococcal bacteraemias, ciprofloxacin is clearly 
deficient m preventing it, as has been reported previously (Dekker, Rozenberg-Arska & 
Verhoef, 1987; Menichetti, Fellemi, Bucaneve, et al., 1989). 
Prevention of streptococcal bacteraemia may be possible if an oral penicillin is used or 
perhaps a lincosamide. Given that penicillins are effective and assuming that the organism 
has a primary infective role, addition of an oral penicillin or a lincosamide to ciprofloxacin 
during the risk-period, namely within the first 10 days post-transplant, may be of benefit. 
Only patients in whom severe mucosal damage is anticipated as a result of the conditioning 
regimen appear to require such a prophylaxis If, on the other hand, the streptococci are only 
a marker of mucosal damage and the mucositis is mainly chemically induced then 
prophylaxis may not be necessary. Only a prospective study can address these questions. One 
further potential disadvantage of using ciprofloxacin is that quinolones have no activity 
against Ρ carinii but use of twice weekly co-tnmoxazole appears to offer effective 
prophylaxis (Hughes, Kuhn, Chaudhary, et αϊ, 1977) 
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Morever one third of patients developed a skin rash but from the limited data it would 
appear that only about a third of these were related to the drug. Nevertheless as many as one 
in five patients can be expected to react adversely and this is significantly higher than that 
observed in the general population (Ball, 1986) but similar to experience with other drugs 
used in leukaemic patients (Verhagen, Stalpers, De Pauw ¿к Haanen, 1987). Dermatological 
signs and symptoms are important early indications of graft-versus host disease and therefore 
in populations where this occurs frequently, having to exclude a drug as a possible cause is 
an additional burden. Although the aim was to provide prophylaxis for ninety days post-
transplant, the evidence suggests that this is not necessary. It appears to be more appropriate 
to continue until granulocytopenia has subsided for a week. 
In conclusion, ciprofloxacin was effective in maintaining the gut flora of patients 
undergoing allogeneic bone marrow transplantation free of Gram-negative bacteria but not 
in preventing vindans streptococcal bacteraemia. The drug appears to be well tolerated 
except during an episode of severe mucositis during which time all oral medication has to 
be interrupted. Ciprofloxacin seems to be a safe drug; drug-related skin reactions occur in 4% 
of the patients within three weeks of starting treatment. 
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Abstract 
A scheme for scoring mucositis 
A system was developed for scoring oral mucositis in order to investigate its connection 
with fever and bacteraemia due to vindans streptococci. A series of 42 allogeneic bone 
marrow transplant recipients given demethoxydaunonbicin and total body irradiation 
for conditioning therapy were monitored daily for the presence of lesions, erythema, 
oral oedema, pain and dysphagia, each of which was graded numerically at four levels. 
These values were added together to yield a daily mucositis score (DMS) with a scale 
of 0-15. Mucositis developed shortly after transplant and progressed within a few days 
to grade III (WHO grade 3-4) m the majority of patients. Bacteraemia due to vindans 
streptococci was documented in 64% of cases and the organisms were first detected as 
fever developed and mucositis approached its peak. The WHO scheme defined 
mucositis as either absent or grade 3-4 corresponding to a DMS of 4 or 5, whereas a 
grading system based on the most pronounced sign or symptom resulted in three grades 
of seventy which corresponded to a DMS of 4, 5-9 and 10 respectively. However, only 
the DMS permitted monitoring of mucositis through all its stages of development. The 
scheme therefore offers the potential of exploring causal relationships between mucosal 
damage, granulocytopenia, fever and bacteraemia 
Introduction 
Oral mucositis is a frequent and often severe complication following irradiation and 
cystostatic chemotherapy and is assumed to be due primarily to toxicity (Raber-Durlacher, 
Abraham-Inpijn, Van Leeuwen, Lustig δι Van Winkelhof, 1989). Several schemes have 
been devised in order to score mucositis in cancer patients based on the presence of signs 
only, e.g. erythema, lesions,(Van der Schueren, Van den Bogaert &. Kian Ang, 1983) or 
together with symptoms, e.g. pain and difficulties in swallowing (Anonymous, 1977; Miller, 
Hoogstraten, Staquet & Winkler, 1981 ; Hickey, Toth &. Lindquist, 1982 ). Allogeneic bone 
marrow transplant (BMT) recipients who received anthracychnes, cyclophosphamide and 
total body irradiation (TBI) developed a particularly severe episode of mucositis of WHO 
grade 3 or 4 (Raemaekers, De Witte, Schattenberg & Van Der Lely, 1989). The mucosal 
damage might have been the result of synergy between the irradiation and chemotherapy and 
was frequently accompanied by fever which persisted despite broad-spectrum antimicrobial 
therapy. Two-thirds of patients also experienced bacteraemia due to vindans streptococci 
around the same time (De Pauw, Donnelly, DeWitte, Nováková & Schattenberg, 1990, De 
Bel, Gerritsen, De Maaker, Moolenaar 6* Vossen, 1991) which was a remarkably high 
incidence when compared with 14-29% documented for other BMT patients (Villablanca, 
Steiner, Kersey, et al., 1990). This led to speculation that these bacteria might contribute 
significantly to the morbidity associated with mucositis and possibly also have a causal role. 
A reliable means of describing and monitoring mucositis daily was evidently necessary 
if the relationship between streptococcal bacteraemia and mucositis was to be properly 
understood and future strategies for prevention and therapy were to be developed. A scoring 
scheme for mucositis was therefore devised in which readily manifest signs and symptoms 
were graded individually, each at four levels. The values were added together to generate a 
mucositis score which was used to monitor the development, progression and course of 
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mucositis on a daily basis. Mucositis was also graded at four levels to delineate overall 
severity, and classified by the W H O scheme (Anonymous, 1977; Miller, Hoogstraten, 
Staquet & Winkler, 1931). 
Patients and methods 
From December 1987 to January 1990 52 patients received allogeneic BMT. However, only 
42 subjects were selected for this analysis since these patients had received the same 
conditioning regimen with cyclophosphamide 60 mg/kg on days -6 and -5, TBI (900 cGy) 
and demethoxydaunorubicin (total dose of 42 mg/m2: Van Der Lely, De Witte, Raemaekers, 
Schattenberg δι Haanen, 1989). The majority were young, adult males with acute leukaemia 
in complete remission (Table I). O n the day of transplant, the graft was prepared by 
counterflow centrifugation resulting in less than 2% lymphocytes (Schattenberg, De Witte, 
Preijers, et al, 1990). Immunoprophylaxis was achieved using cyclosporin A given as a 
Table 1. Patient demography 
Number 42 
M:F 26:16 
Age (years) 
median 34 
range 14-48 
Underlying disease: 
Acute lymphoblastic leukaemia 16 
Acute non-lymphoblastic leukaemia 11 
Chronic Myeloid leukaemia 5 
Lymphoblastic lymphoma 3 
Myelodysplasie syndrome 3 
Myeloma 2 
Undifferentiated leukaemia 1 
Essential thrombocytosis 1 
continuous intravenous transfusion of 3 mg/kg/day from the day prior to BMT until day +14 
whereupon the dose was reduced to 2 mg/kg/day and maintained at this level until discharge. 
Patients were nursed in single, purpose-built rooms. They each received a low-
microbial content diet and all were given parenteral nutrition the day after transplant which 
continued until normal swallowing was resumed. O n admission oral antimicrobial prophy­
laxis was begun with acyclovir 1.6 g/day, itraconazole 200 or 400 mg/day and amphotericin 
В 4 g/day. The first 27 patients were given co-trimoxazole (2.88 g/day) with Colistin 
(400 mg/day) until the day prior to BMT after which this regimen was replaced by 
ciprofloxacin (1 g/day) in all except one case (De Pauw, Donnelly, DeWitte, Nováková & 
Schattenberg, 1990). The next cohort of patients received ciprofloxacin from the time of 
admission and co-trimoxazolc was given at the same dose twice weekly as prophylaxis against 
Pneumocystis carinii (Hughes, Rivera, Schell, Thornton & Lott, 1987). When patients could 
no longer tolerate oral medication, acyclovir was continued parenterally and patients were 
encouraged to continue taking itraconazole capsules. All other oral drugs were stopped. 
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Each patient had undergone a thorough dental examination as part of the preparation 
for transplant and any remedial care was completed before admission Throughout their 
hospital stay, patients followed the same protocol for mouth care Teeth were cleaned with 
framycetin toothpaste and the brush was replaced daily. Tablets of 2 5 mg Chlorhexidine 
were taken six times during the day for slow dissolution by sucking and patients could also 
rinse their mouths with Chlorhexidine (0.2%) ad libitum The mouth was kept as free as 
possible from loose or necrotic tissue. Vaseline was used to prevent the lips from drying and 
nicomorphine was given at 60-80 mg/day when necessary to manage oral pain. 
During the first 2 weeks after BMT, 10 ml of blood were obtained for culture at the start 
of each day before administration of any antimicrobials. Oral and faecal surveillance cultures 
were taken at least three times weekly but all other microbiological investigations were 
undertaken only as necessary. Haematological and biochemical measurements were per-
formed at least three times weekly. All medications were recorded together with an 
indication of whether or not the patient had complied with a particular drug regimen. 
Mucositis was characterized by the occurrence of lesions, erythema, oral oedema, pain 
and dysphagia. The presence and extent of lesions of any sort was recorded but further 
delineation, e g. by colour, character and type of lesion was not attempted Erythema was 
defined as redness or inflammation of any part of the mouth. Oral oedema was characterized 
by marked distension of the tongue and swelling of the buccal mucosa Difficulty and pain 
upon swallowing was regarded as evidence of dysphagia and was distinguished from the 
sensation of pain not associated with this activity Signs and symptoms were graded 
individually as grade 0 if absent, 1 if mild or few, 2 if moderate or several and 3 if severe or 
extensive. The results were recorded each from onset to resolution using a standard record 
form designed for the purpose A daily mucositis score (DMS) was constructed by the simple 
addition of each of the individual scores and used to determine the days of onset and 
resolution of mucositis. 
The overall severity of mucositis was also determined by the most pronounced 
individual sign or symptom and grade as I, II or III corresponding to mild, moderate or severe. 
Mucositis was also classified according to the W H O scheme which defines grades 1 and 2 by 
the presence of erythema, ulceration and discomfort, grade 3 by the inability to eat solids and 
grade 4 by the use of parenteral nutrition. Since all patients in the current study received 
parenteral nutrition from the day of transplant onwards, the conversion from the oral to the 
parenteral route was assumed equivalent to the use of parenteral nutrition 
The differences between means were tested for significance by the two-sided, unpaired 
student's A scheme for scoring mucositis-test and mean values are presented together with their 
95% confidence intervals. The Box-plot technique was used to describe mucositis scores and 
granulocyte counts (Williamson, Parker & Kendnck, 1989) 
Results 
At the onset of mucositis, pain and dysphagia were present in just over half the case while 
erythema and lesions were recorded in 48% and 38% of cases respectively. Oral oedema was 
observed in only 24% of cases. Twenty-nine patients (69%) presented with two two or more 
signs and symptoms. At the peak period of mucositis a grade of 3 was recorded for erythema 
in 69%, lesions in 50% and oedema in 43% of patients. Four-fifths of patients complained 
of grade 3 dysphagia and pain despite maximal pain control. All patients had at least three 
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signs and symptoms with 83% having all five. On the last day of mucositis almost half the 
patients still complained of dysphagia and lesions were still visible in 44% of patients. Onc-
third had residual erythema, 27% had evidence of oral oedema and 22% experienced some 
oral pain. 
A total of 718 days of mucositis were recorded giving an average of 17 days per patient. 
Dysphagia, lesions, erythema and pain were present on 80%, 79%, 76% and 73% of days 
respectively whereas oedema was present on 57% of days. The WHO scheme failed to classify 
43% of mucositis days and when grading was achieved, 91% were classified as WHO grade 
4- The range of DMS values which corresponded to the WHO scheme indicated a single cut­
off point of 5 above which mucositis was severe and below which it was either low-grade or 
unclassifiable (Figure la). In contrast, the grading system based on the most pronounced sign 
or symptom resulted in an almost equal distribution between each of grades I, II and III 
(Figure lb). A DMS of 4 showed a 91% agreement with grade I mucositis while a DMS of 
10 corresponded to grade III in 85% of cases. DMS values of 5-9 corresponded to grade II 
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Figure 1 (a). The relationship between the 
daily mucositis score and mucositis scored 
by the WHO score The grades of mucositis 
do notcorrcspond to the DMS with 308 days 
being unclassifiable Only 9 days were 
classified at grades 0-2 and 29 days at 
grade 3 Consequently mucositis was either 
severe or absent There was poor 
correspondence ofthisschemewiththe DMS 
and only a single threshold of 4-5 could be 
identified (b) The relationship between the 
daily mucositis score and mucositis graded 
by the most pronounced sign or symptom 
The three grades of seventy were almost 
equally distributed with 286, 217 and 215 
days being graded at I, II and III respectively 
corresponding to scores of 4, 5-9 and 10 
However, the overlap which occurs with 
the DMS scores of 4 and 10 shows clearly 
that concordance is incomplete 
mucositis but resulted in discrepancy rates of 13% and 14% for mis-classifications of grade 
1 and III respectively. However, the overall agreement for this classification was 84% 
compared with only 54% for the WHO scheme. 
The onset and course of mucositis could be defined to some extent by both grading 
systems (Table II). A more precise definition of the peak of mucositis was afforded by the 
DMS since the highest score occurred 2-3 days after mucositis had already been graded as 
severe. Similarly, the DMS had begun to decline before their was improvement in the grade 
and mucositis could be clearly shown to subside gradually as granulocytes began to recover. 
The transition of mucositis in relation to granulocytopenia was clearly demonstrated 
using the DMS (Figure 2). Fever developed in all patients 4.0±0.6 days after transplant and 
was associated with a DMS of 8.6±1.0. Bacteraemia due to vindans streptococci was 
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documented in 27 cases (64%), occurred 4 9±0.7 days after transplant and was associated 
with a DMS of 8.8± 1.0, Coagulase-negative staphylococci were also cultured together with 
streptococci in eight cases These events occurred as mucositis approached its maximum 
severity but before the DMS reached its highest score. Granulocytes recovered to >0 1 χ IO9/ 
114 9±1.5 days after transplant after mucositis had begun to subside and counts reached >0 5 
χ 109/16.5±2.0 days later Acute GVHD developed to grade I or II in 12 cases and grade III 
in one case after granulocytes counts had already begun to recover and was not associated 
with oral complications. 
Table 2. Mucositis and related events 
Onset of mucositis 1.1 ± 0 7 
Onset of highest grade of mucositis 
according to: 
The WHO scheme 4 6 ± 0.7 
The most pronounced sign or symptom 5 6 ± 0.5 
The highest DMS 7.1 ± 0.6 
Start of improvement of mucositis 
according to: 
The WHO scheme 13 0 ±1.2 
The most pronounced sign or symptom 11 2 ± 1.0 
The highest DMS 9 4 ± 0.8 
Resolution of mucositis 16.4 ± 1.5 
Discussion 
Daily monitoring of mucositis was made possible by summation of a 4-level score of five signs 
and symptoms of mucositis to create the daily mucositis score (DMS). The majority of 
patients had either one or two signs or symptoms at the onset of mucositis, all five during the 
peak but only one at its resolution. Oral oedema was present for just over half the period of 
mucositis whereas the other signs and symptoms occurred on most days. The five individual 
signs and symptoms contributed almost equally and consistently which together with their 
appearance at different times gave reasonable assurance of their independence. 
Although the majority of patients were classified as having severe mucositis by both 
grading systems, the severity based on the most pronounced sign or symptom achieved better 
differentiation and correlated more accurately with the DMS than did that of the WHO, 
because each sign and symptom was treated independently. However neither seventy 
scheme allowed for the level of daily monitoring afforded by the DMS Moreover, grading 
for seventy failed both to locate the actual peak of mucositis and the point at which mucositis 
began to subside. The DMS also made possible a more precise description of the relationship 
between mucositis and granulocytopenia as a result of the broader scale of possible values. 
By assigning a more flexible score to any given point in the course of mucositis, it then 
became possible to relate the onset of fever and bacteraemia to a given level of mucositis. 
The addition of anthracychnes has been previously shown to result in more severe 
mucositis than that induced by cyclophosphamide and irradiation (Raemaekers, De Witte, 
35 
Vmdans streptococci and allogeneic bone marrow transplant recipients 
CD 
О Ü 
со 
CO 
·•-» 
со 
О Ü 
:э E 
>» 
ce 
η 
,—^  
_ J 
σΓ 
о 
τ— 
о 
—^ 
О) 
о 
*—-
со 
φ 
υ 
о 
з 
с 
л 
14 
1 ^ 
10 
8 
b 
4 
2 
0 
1 
0.1 
о 0.01 
I 
π ^
1
 -
!, Ί J L ι 
!! J ι 
! I ' 
W 
I 
V о 
У 
с — 
U 
, . . _J J L _ 
14 21 
Days post transplant 
28 
Figure 2. Box-plots of the daily mucositis score and granulocyte counts in relation to the day of transplant. Mucositis 
begins around the day of transplant, becoming progressively more severe until reaching a peak at the same time 
as granulocytes have reached the nadir. As granulocytes begin their recovery, symptoms and signs of mucositis 
begin to dimmish resolving by the end of the third week post-transplant. 
Schattenberg & Van Der Lely, 1989). The oral oedema observed in the current study might 
therefore be a unique feature since Kolbinson and colleagues made no reference to swelling 
of any description despite noting that the tongue, bucea and labia were the most affected by 
mucosal damage induced by more conventional conditioning regimens (Kolbinson, Schubert, 
Fluornoy & Truelove, 1988). In comparison with other BMT recipients, patients included 
in the present study also had several other distinctive features apart from the use of 
anthracyclines. The incidence of acute GVHD was low probably as a result of T-cell 
depletion by counter-flow elutriation and the exclusive use of cyclosporin A for 
immunoprophylaxis. Neither did GVHD appear to be associated with any oral morbidity 
which might have been expected (Kolbinson, Schubert, Fluornoy & Truelove, 1988). There 
was also a total absence of oral infection due to Gram-negative rods, herpes simplex and 
Candida as a result of comprehensive antimicrobial prophylaxis which included itraconazole 
and acyclovir. Other features of oral mucositis such as increased salivary viscosity, 
xerostomia and the sensation of dryness were not included in the daily monitoring, neither 
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was there any attempt to differentiate between the type of lesion nor record their anatomical 
distribution. Thus the scoring system presented here might be relevant for some but not all 
BMT recipients. Nevertheless, the course of mucositis was very similar to that reported by 
Weisdorf and colleagues who employed a much more sophisticated method of 
scoring,(Weisdorf, Bostrom, Raether, et al., 1989) indicating that both approaches were 
measuring the same intensity of mucositis Moreover the system presented here showed that 
mucositis altered its character day by day confirming the need for daily monitoring when 
investigating the morbidity associated with conditioning regimens for BMT. The DMS 
therefore provides a simple and effective means of achieving this which should prove a useful 
additional parameter for both exploring epidemiology and assessing the impact of 
prophylactic and therapeutic regimens designed to ameliorate mucositis. 
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impact of ciprofloxacin on the oral streptococci 
Abstract 
A study was undertaken to determine the impact of ciprofloxacin on the oral flora of 
51 consecutive allogeneic bone marrow recipients. The first 28 patients had received 
ciprofloxacin 1 g/day for a mean of 6.8 days having begun prophylaxis on the day before 
BMT while the next cohort of 23 patients received the same regimen for a mean of 12,1 
days from the time of admission. Before beginning prophylaxis, 27 of 46 patients 
(59%) sampled were already colonised with viridans streptococci resistant to 4 mg/l. 
This proportion rose to 83% of patients sampled by the end of six days treatment. 
Moreover, the proportion of samples yielding streptococci resistant to 16 mg/L or more 
rose from 17% to 63% by the end of prophylaxis. Commensal flora were also 
significantly reduced during prophylaxis leaving only viridans streptococci with a 
small number of coagulase negative staphylococci. Thirty one patients (62% ) became 
bacteraemic with viridans streptococci 4-7 days post transplant after oromucositis had 
become progressively worse and around the onset of fever. Only five of 45 blood 
isolates (11%) were fully susceptible to ciprofloxacin, which corresponded to the rate 
observed for oral samples obtained on the same day. Empirical therapy with ceftazid-
ime with or without clindamycin successfully eradicated the streptococci from blood 
but led to temporary suppression of oral streptococci in 86% of cases until clindamycin 
had been discontinued. Prophylactic ciprofloxacin therefore selects resistant viridans 
streptococci in the oral cavity but does not, of itself, lead to bacteraemia. This only 
ensues once mucosal damage has become severe. 
Introduction 
The rising incidence of bacteraemia due to oral viridans streptococci in neutropenic patients 
has been attributed to the use of selective oral prophylaxis particularly when quinolones 
have been employed for the prevention of infection in neutropenic patients (Classen, Burke, 
Ford, et ai, 1990; Warren, Wimperis, Baglin, Constantine & Marcus, 1990; Viot 6k 
Klastersky, 1991; Awada, Van Der Auwera, Meunier, Daneau & Klastersky, 1992; Elting, 
Bodey & Keefe, 1992). Bacteraemia is assumed to have been promoted by the quinolone 
(Van der Lelie, Van Ketel, Von dem Borne, et ai, 1991) to which the organisms are only 
marginally susceptible (King 6k Phillips, 1986; Donnelly, Willemse, Horrevorts & De Pauw, 
1992) especially at the concentrations thought to occur in the oral cavity (Ullman, Giebel, 
Dalhoff 6k Koeppe, 1986). However, oromucositis has also been implicated as a risk factor 
(Burden, Oppenheim, Crowther, etai, 1991 ; McWhinney, Gillespie, Kibbler, Hoffbrand & 
Prentice, 1991; Valteau, Hartmann, Brugieres, et ai, 1991; Elting, Bodey 6k Keefe, 1992). 
Ciprofloxacin had proved very successful in preventing Gram-negative infection 
among allogeneic bone marrow transplant recipients treated at our hospital (De Pauw, 
Donnelly, DeWitte, Nováková 6k Schattenberg, 1990) but the incidence of bacteraemia due 
to oral viridans streptococci and oromucositis increased significantly after anthracyclines 
had been introduced to intensify the conditioning regimen (Raemaekers, De Witte, 
Schattenberg 6k Van Der Lely, 1989). Hence it appeared that both the selective pressure on 
oral flora introduced by prophylaxis and mucosal damage were required for bacteraemia to 
develop. A series of studies were therefore undertaken to establish the relationship between 
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oral vindans streptococci and those found in the blood (Donnelly et al, unpublished data), 
to monitor oromucobitis (Donnelly, Muus, Schattenberg, et al, 1992) and, the subject of the 
present report, to determine the impact of ciprofloxacin on the oral flora. 
Patients and methods 
Consecutive patients who received an allogeneic BMT from December 1987 to January 1990 
were recruited for the study. They were admitted eight days before transplantation and were 
nursed in single, purpose-built rooms where each received a low-microbial content diet. On 
admission, oral antimicrobial prophylaxis was begun with acyclovir 1.6 g/day, itraconazole 
200 or 400 mg/day and amphotericin В 4 g/day. The first 29 patients were given 
co-trimoxazole 2.88 g/day with Colistin 400 mg/day from admission until the day prior to 
BMT after which the regimen was replaced by ciprofloxacin 1 g/day (De Pauw, Donnelly, 
DeWitte, Nováková & Schattenberg, 1990). The next cohort of 23 patients received the 
same dose of ciprofloxacin from the time of admission while co-trimoxazole was given twice 
weekly as prophylaxis against Pneumocystis carinii (Hughes, Rivera, Schell, Thornton &. 
Lott, 1987). Following conditioning with chemoradiotherapy, patients were transplanted 
with a graft prepared by counterflow centrifugation (Schattenberg, De Witte, Preijers, et al., 
1990). 
Monitoring procedures 
Patients gargled with 10 mis of saline on admission to the Uni t , two days before transplant 
and on each of the first 14 days after BMT. Specimens were submitted for quantitative 
recovery of aerobic bacteria and yeasts and those obtained two days before BMT and 5,8 and 
12 days afterwards were also cultured for herpes simplex. Ten mis of blood was also obtained 
for pour-plate culture at the start of each day before administration of any antimicrobials 
(Donnelly et al. unpublished data). Mucositis was defined by the presence of ulceration, 
redness, swelling of the tongue and buccal mucosa, pain and difficulty in swallowing and each 
individual sign and symptom was scored numerically from 1-3 and a daily mucositis score 
(DMS) was constructed by summation with values of 1 -4,5-9 and 10 corresponding to mild, 
moderate and severe mucositis respectively (Donnelly, Muus, Schattenberg, et al, 1992). 
Selective and recovery media 
Recovery media comprised Tryptone Soya agar ((Unipath-Oxoid, PCH Diagnostica, 
Haarlem, The Netherlands)) containing 5% sheep blood while MacConkey (Oxoid) , 
Mannitol Salt (Oxoid), Kanamycin-Aesculin agar (Oxoid) and Yeast morphology (Merck, 
Darmstadt, Germany)with 0.1% chloramphenicol media were used for the selection of 
enteric bacilli, staphylococci, enterococci and yeasts respectively. Each of the five media was 
distributed in 2 ml amounts into a row of a 25-section square Petri dish (Repliplates, Stenlin, 
United Kingdom). 
Direct susceptibility to ciprofloxacin 
Ciprofloxacin was prepared from Adatabs (Diamed Diagnostics, Merseyside, UK) and was 
added to Iso-sensitest agar (Oxoid) with 5% sheep blood to yield concentrations of 0 06, 
0.25, 1, 4 and 16 mg/1. Each concentration was then distributed in 2 ml amounts in 
Repliplates to give five rows respectively. 
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Processing of oral samples 
Each medium was inoculated with 201 of the oral sample and a corresponding series of four 
decimal dilutions. Plates were first dried at 37°C then incubated in sealed containers. After 
overnight incubation, the number of colonies which occurred at the highest dilution on 
blixxJ agar were counted unless growth was too dense, in which case the value was assumed 
to be 30 colonies. This process was repeated for each of the selective media and all 
concentrations of ciprofloxacin. Plates apparently yielding no growth were incubated a 
further 24 hours. Vindans streptococci were distinguished by their alpha haemolysis and 
failure to elaborate catatase. Identification was confirmed by the Gram-morphology, 
susceptibility to optochin and an API Strep (Bio-Mérieux, France) as necessary. The 
minimum inhibitory concentration for ciprofloxacin was defined as the least concentration 
which allowed growth of not more than one percent of that occurring on blood agar. 
Table 1. Demography 
Number of patients 
Male female 
age:-
mean 
SD 
range 
Acute leukaemia 
In first complete remission 
Conditioning with 4-demethoxydaunorubicin 
Seropositive for herpes simplex virus 
Empiric therapy with ceftazidime plus clindamycin 
mucositis (mean days after BMT ± SD) :-
day onset 
day onset peak 
day onset improvement 
day of resolution 
Maximum DMS 
granulocyte recovery beyond .-
0 1 x109/l 
0.5x109/l 
onset of fever 
51 
34.17 
32 9 
9.3 
14-48 
42 
31 
44 
38 
39 
1.5 ± 2 1 
5 7± 1 7 
11.2 ±3.0 
17.9 ±4.6 
11.9 ± 3 2 
14 6 ±6.1 
20 9 ± 4 3 
5 1 ± 0.6 
[82%] 
[61%] 
[86%] 
[75%] 
[75%] 
investigation and treatment of fever 
When the patient sustained a temperature of 38°C for two hours, two samples of 10 millilitres 
peripheral blood were obtained for culture together with a further 10 millilitres from the 
catheter. Prophylaxis was discontinued and patients who fulfilled the entry criteria for an 
open study of the treatment of oromucositis and fever (Curative Bacterial Study 14 CEOM 
1988-011892 approved by the Ethics committee) were treated intravenously with 900 mg 
clindamycin every eight hours for 5 days together with 2g ceftazidime (Donnelly, Muus, 
Horrevorts, Sauerwein & Depauw, 1993) while others were given ceftazidime alone at the 
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same dose The cephalosporin was continued in both groups until the patient had been free 
of signs and symptoms for five days while granulocytopenia persisted or two days if bone 
marrow had already recovered although clinicians could modify therapy by adding either 
vancomycin or amphotericin В or as directed by laboratory findings 
Strains isolated from blood were all speciated by means of the API Strep (Bio-Meneux, 
France) and antibiotic susceptibility tests were performed using disc diffusion technique 
following the guidelines of the NCCLS (National Committee for Clinical Laboratory 
Standards, 1990b) except that Iso-sensttest medium was used throughout The minimum 
inhibitory concentration of ciprofloxacin, ceftazidime and clindamycin was determined by 
means of broth micro dilution using the same medium and an log-phase inoculum of IO 1 6 
colony-forming units per ml (Donnelly, Willemse, Horrevorts & De Pauw, 1992) 
Analysis 
The differences between means were tested for significance by the two-sided, unpaired 
student's t-test and mean values are presented together with their 95% confidence intervals 
unless otherwise stated The χ 2 test was used to compare categories 
Results 
Fifty two patients were investigated, but one patient had not taken any ciprofloxacin and was 
therefore excluded from the analysis The majority of évaluable patients were young males 
who had been transplanted in first remission of acute leukaemia having received 
demethoxydaunorubicin as part of the conditioning regimen (Table 1 ) Three out of four 
were seropositive for herpes simplex virus and two patients had persistent infection despite 
acyclovir. A resistant virus was implicated in one case and there was no satisfactory 
explanation for the second Mucositis developed shortly after transplant progressing to a 
peak around the same time as fever occurred and resolved after granulocytes had begun to 
recovery All patients remained neutropenic during the study period 
Table 2. Impact of ciprofloxacin prophylaxis on the composition of the aerobic oral flora 
Number patients 
log,0 total commensal flora3 
log10 vindans streptococci 
log10 coagulase negative staphylococci 
log10 other commensals 
strains (%)" 
1 
2 
3 
4 
before 
46 
4 6 ± 0 6 
4 6 ± 0 6 
0 6 ± 1 6 
31 ± 2 2 
30 
50 
17 
2 
2 days 
prophylaxis 
40 
4 5 ± 0 6 
4 4 ± 0 7 
1 4 + 22 
1 9 ± 2 2 
35 
35 
25 
5 
6 days 
prophylaxis 
31 
4 4 ± 1 1 
4 4 ± 1 1 
1 0 ± 2 0 
2 3 ± 2 4 
39 
42 
19 
-
last day 
of prophylaxis 
44 
4 3 ± 1 0 
4 3 ± 1 2 
0 9 ± 1 8 
1 3 ± 2 2 
53 
38 
9 
-
ρ value 
0 614 
0 573 
0 282 
0 002 
0 257 
Differences were tested by analysis of variance a for each category of organism and by Ihe χ test "for the proportion of strains 
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Patients given ciprofloxacin from admission were treated for an average of 12.1 days 
(SD 1.6) while those who had first been given co-tnmoxazole and Colistin were received the 
quinolone for 6.8 days (SD 1.8). Since oral samples were obtained in relation to the day of 
transplant, comparable samples from both groups of patients were only available before 
prophylaxis and after two days, six days and at on discontinuation because of starting 
empirical therapy for fever. At least 10' cfu/ml of vindans streptococci were recovered from 
all samples on admission and the recovery of vindans streptococci remained virtually 
unchanged at IO4 5 cfu/ml after two and six days prophylaxis and on the last day (Table 2). 
Other commensals (mainly neisseria and diphtheroids) were significantly reduced in 
number during prophylaxis so that by the end of prophylaxis virtually only vindans 
streptococci with a small number of coagulase negative staphylococci were recovered. There 
was also a corresponding increase in the number of samples yielding pure growth from 30% 
to 53%. 
Resistance to ciprofloxacin also increased significantly among the vindans strepto­
cocci from an average MIC of 2.1 mg/L before starting prophylaxis to 9.8 mg/L at its end 
(Table 3). Similarly 59% of patients sampled had organisms that were already resistant to 
4 mg/1 before beginning prophylaxis. This proportion increased after two days to 70% and 
to 83% by the end of six days. All patients became colonised with resistant streptococcal flora 
at some time during prophylaxis although at the onset of fever, two patients had reverted to 
susceptible flora. Moreover, the proportion of samples yielding streptococci resistant to 16 
mg/L or more rose from 17% at the start of prophylaxis to 53% after six days reaching 6 3 % 
by the end of prophylaxis. 
Bacteraemia with vindans streptococci developed in 32 patients (62%) an average of 
4-7 days (SD 1.9) after transplant and was not associated with sepsis as defined by Bone 
(Bone, 1991b). Indeed, 11 patients (34%) were bacteraemic at least a day before becoming 
Table 3. Impact of ciprofloxacin on the selection of resistant oral vindans streptococci 
Number patients 
MIC (mg/L) to ciprofloxacin (%)" -
0 06 
0 25 
1 
4 
16 
32 
Mean log2(MIC)b 
before 
46 
4 
2 
35 
41 
13 
4 
1 3 
2-days 
prophylaxis 
40 
-
-
30 
38 
20 
12 
2 2 
6 days 
prophylaxis 
31 
7 
-
10 
27 
43 
13 
2 7 
last day 
of prophylaxis 
44 
2 
-
2 
32 
48 
16 
3 2 
'Differences between the frequencies of each MIC were significant by the χ2 test (p = 0 002) as was analysis of variance of Ίηβ mean 
log2MIC(p<0 001) 
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febrile. Forty five strains of viridans streptococci were isolated with Streptococcus sanguis 
accounting for 19 strains and S mitis for eight strains. Only five strains (11%) were fully 
susceptible to ciprofloxacin when determined by disc diffusion. The MIC was determined 
for 22 isolates of which only 5 (23%) had an MIC of 1 mg/l. All strains were eradicated from 
blood by the third day of therapy including one strain that was resistant to clindamycin. 
There was a clear correlation between the progression of oromucositis and the 
occurrence of bacteraemia (Figure 1 ) which clustered around the onset of fever. Around four 
of every five patients were colonised with resistant streptococci while oromucositis became 
progressively worse until reaching a peak whereupon fever occurred. Once intravenous 
antibiotics had been started, the proportion of samples yielding streptococci began to decline 
dramatically until only 14% of patients sampled retained their flora. This was principally an 
effect of clindamycin which 76% of patients had received together with ceftazidime since 
the proportion of patients with negative cultures for streptococci was almost twice that of 
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Figure 1. The relationship between oromucositis, bacteraemia and the recovery of viridans streptococci from mouth 
wash samples. Viridans streptococci (lower panel) were recovered from the majority of patients sampled (number 
in brackets). Once intravenous therapy for fever had been initiated, the recovery rate declined. The majority of 
strains were resistant to 4 mg/l. ciprofloxacin (shaded area) and remained so even after the antimicrobial had been 
discontinued for a week. Oromucositis had already been present for around five days (represented by the box-plots 
of the daily mucositis score [DMSJ in the top panel) before fever occurred but streptococci did not appear in the blood 
until after mucositis became severe evidenced by the high DMS scores. Therefore mucosal damage is the principal 
promoting factor rather than resistance to ciprofloxacin. 
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those given ceftazidime alone (data not shown) Moreover, two days after discontinuing 
clindamycin, vindans streptococci were again recovered in 3 1 % of patients 
Discussion 
The use of any antibiotic is apt to lead to selection among the commensal flora of bacteria 
which are either fully or marginally resistant Quinolones are therefore likely to give a 
selective advantage to the oral vindans streptococci because they are only marginally 
susceptible Ciprofloxacin clearly had an impact on the commensal flora of the present study 
population by reducing the range of other aerobic commensals and decreasing their numbers. 
Just over half the patients were colonised with streptococci resistant to 4 mg/1 
ciprofloxacin before prophylaxis had been started which is within range expected ( Al-Wali, 
Wilcox, Winstanley, Douglas & Spencer, 1992) and by the end of the first week, these 
organisms were harboured by four out of five patients The average susceptibility also 
decreased appreciably during prophylaxis suggesting continued selection within the vindans 
streptococci of individual patients This is not inconceivable since the mouth is colonised 
with several different species including both S mitis and S sanguis (Frandsen, Pedrazzoh & 
Kilian, 1991) but little is known about the susceptibility of individual species Full 
characterisation of all isolates was beyond the scope of the present study Even had each 
individual isolate been subjected to biotyping, the results would have been unreliable 
without the additional biochemical techniques now considered necessary for identification 
consistent with the recent changes in taxonomy (Schmidhuber, Kilpper-Balz &. Schleifer, 
1987, Coykendall, 1989, Kilian, Mikkclsen&. Hennchsen, 1989, Douglas, Pease & Whiley, 
1990, Beighton, Hardie & Whiley, 1991) 
Neither is it possible to claim that the same strains were involved in both bacteraemia 
as were recovered from the corresponding oral washings However, the evidence that this 
was so seems compelling since a similar proportion of strains recovered from blood were 
shown to be resistant It also seems likely that the strains isolated from blood emanated from 
the oral cavity given that oral counts remained high until after empirical therapy had been 
started In addition, the majority of strains were resistant to ciprofloxacin just as was found 
among bacteraemic isolates which would confer an advantage on the strains since the drug's 
concentration in the blood is unlikely to exceed 3 mg/1 (Rozenberg-Arska, Dekker δι 
Verhoef, 1985) and is therefore unlikely to suppress any streptococci that have transmi­
grated from the oral mucosa This might also partly explain why the vindans streptococci 
have reached greater prominence during the last decade since the introduction of the 
fluoroquinolones for prophylaxis since both selective pressure on the oral flora and low blood 
concentrations are probably a prerequisite to bacteraemia. 
Co-trimoxazole is also capable of selecting for the streptococci involved in bacteraemia 
since Cohen and colleagues reported that majority of strains were resistant following 
prophylaxis with the antibiotic (Cohen, Donnelly, Worsley, et al, 1983) However, this 
seems to be the exception rather than the rule since the majority of vindans streptococci are 
susceptible at achievable serum concentrations (Donnelly, Willemse, Horrcvorts &. De 
Pauw, 1992) The same considerations might also extend to other antibiotics such as 
penicillin (Fleming, Feigal, Kaplan, Liljemark & Little, 1990) which has been advocated for 
prophylaxis of ARDS associated with vmdans streptococcal bacteraemia (Guiot, Van der 
Meer, Van den Brock, Willemze & Van Fürth, 1992) 
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Resistance alone does not explain the development of bacteracmia since this was 
temporally related to progressive mucositis and independent of the duration of prophylaxis. 
Rather, the predominance of resistant strains in such high numbers might to allow them to 
take advantage of any breaches in the mucosa through which they enter the blood stream. 
Moreover, the especially severe oromucositis in this population appears the only plausible 
explanation for the fact that more than four times as many patients in this study developed 
bacteraemia as has been reported for other allogeneic bone marrow transplant recipients 
( Villablanca, Steiner, Kersey, et al, 1990). The degree rather than the simple occurrence of 
oromucositis might also be important since bacteraemia mostly occurred after the mucositis 
score exceeded a threshold of between 4 and 9 units corresponding to grade II mucositis. This 
might explain why some authors identified either prophylaxis with quinolones as a risk factor 
(Classen, Burke, Ford, et al., 1990) or mucositis (Burden, Oppenheim, Crowther, et al., 1991) 
while others have failed to identify any (Valteau, Hartmann, Brugieres, et al, 1991). 
The dramatic decline in oral streptococci that occurred after starting therapy with 
both ceftazidime and clindamycin was probably due solely to the lincosamide since the drug 
was given at a high dose (Plaisance, Drusano, Forrest, Townsend &. Standiford, 1989) which 
would have been sufficient for tissue and salivary concentrations to exceeded the MIC of the 
streptococci by several orders of magnitude.(Leigh, 1981 ). This might also explain the lack 
of sepsis and ARDS which might otherwise have been anticipated given the high incidence 
of bacteracmia were it not for the fact that a similar rate of bacteraemia occurred in the cohort 
of patients immediately preceding the current population without evidence of accompany-
ing sepsis (De Pauw, Donnelly, DeWitte, Nováková & Schattenberg, 1990). They had also 
been given the same conditioning and prophylaxis and experienced a similar degree of 
oromucositis (Raemaekers, De Witte, Schattenberg & Van Der Lely, 1989). There were also 
more Strep, sanguis than Strep mais, just as in the current study which corroborates the 
observation that Strep, sanguis may be associated with mucositis and Strep mitis with sepsis 
(McWhinney, Gillespie, Kibbler, Hoffbrand &. Prentice, 1991) 
The successful eradication of streptococci from the blood and their suppression in the 
oral cavity by clindamycin suggests an obvious potential for prophylaxis for those patients 
at risk of sepsis, ARDS and other manifestations of the "alpha strep syndrome" particularly 
as extensive gastro-intestinal colonisation is thought to be a major risk factor (Elting, Bodey 
& Keefe, 1992). However, in the current setting, better measures to minimise oromucositis 
would be of greater benefit to the patient than any specific antimicrobial prophylaxis 
designed to reduce the risk of bacteraemia due to vindans streptococci. 
To conclude, prophylaxis with ciprofloxacin leads to the rapid selection resistant oral 
vindans streptococci and a reduction in the other commensal flora. However, bacteraemia 
only ensues after oromucositis has attained a certain degree of severity rather than mucosal 
damage per se. 
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Bacteraemia following bone marrow transplan ω tion 
Abstract 
Blood cultures were obtained 6 and 2 days before and during each of 15 days post 
transplant from 52 consecutive allogeneic bone marrow transplant recipients receiving 
ciprofloxacin as prophylaxis. Cultures were positive on 21 percent of days and all but 
4 yielded Gram-positive cocci. Forty-seven patients (90 percent) had at least one 
positive culture of which the majority involved fewer than 50 colony-forming units per 
10 ml. Coagulase-negative staphylococci comprised 57 percent of single-isolate bacter-
aemic episodes and were isolated in 38 patients of which 32 were asymptomatic. Three 
cases each of infection and catheter colonisation were associated with counts in excess 
of 100 cfu per 10 ml and/or recurrent bacteraemia with Staphylococcus epidermidis which 
was resistant to the antibiotics the patient was receiving. Staphylococcal bacteraemia 
was also independent of fever which developed as mucositis became more severe. Of 3 2 
patients who developed bacteraemia due to vindans streptococci, 11 did so just before 
pyrexia occurred and 90 percent of strains were resistant to ciprofloxacin. All were 
eradicated after starting therapy and there were no instances of sepsis or ARDS. 
Vindans streptococcal bacteraemia therefore appears to be a consequence of progres­
sively severe mucositis in this patient population rather than infection whereas 
coagulase-negative staphylococci indicated contamination or colonisation of an 
intravenous catheter. 
Introduction 
Gram-positive cocci now account for the majority of bacteraemic episodes which occur in 
febrile, granulocytopenic patients (Rubin, Hathorn, Marshall, et al, 1988, The EORTC 
International Antimicrobial Therapy Cooperative Group, 1990; Al-Fawaz, Kambal, Al-
Rabeeah, et al, 1991; Awidi, 1991; Awada, Van Der Auwera, Meunier, Daneau & 
Klaster-Лсу, 1992). The predominance of coagulase-negative staphylococci is most probably 
due to the widespread use of intravascular devices (Kiehn Si Armstrong, 1990, Ehm, Relier 
Si Ellison, 1991 ) while oromucositis induced by intensive chemotherapy (Cohen, Donnelly, 
Worsley, et al, 1983; Bostrom &. Weisdorf, 1984, Burden, Oppenheim, Crowther, et al, 
1991, Elting, Bodey Si Keefe, 1992) and antimicrobial prophylaxis with fluoroquinolones 
(Van der Lelie, Van Ketel, Von dem Borne, et al, 1991, Elting, Bodey & Keefe, 1992) 
predisposes to oral vindans streptococci Patients given high dose therapy with cytarabine 
(Kern, Kurrle Si Schmeiser, 1990; Weisman, Scoopo, Johnston, Altman & Quinn, 1990, 
Devaux, Archimbaud, Guyotat, et al, 1992) and those receiving bone marrow transplants 
( Bostrom &. We ìsdorf, 1984, Henslee, Bostrom, We isdorf, etal., 1984; Mascret, Maraninchi, 
Gastaut, et al, 1984; Classen, Burke, Ford, et al, 1990; ViUablanca, Steiner, Kersey, et al, 
1990; Valteau, Hartmann, Brugieres, et al., 1991; Devaux, Archimbaud, Guyotat, et al, 
1992) appear to be particularly at risk. 
After the introduction of ciprofloxacin as prophylaxis, an increasing number of 
allogeneic bone marrow transplant recipients treated at our hospital began to experience 
bacteraemia due to oral vindans streptococci which were only marginally susceptible in vitro 
to the quinolone (De Pauw, Donnelly, DeWitte, Nováková Si Schattenberg, 1990). 
However, bacteraemia coincided with severe oromucositis induced by the anthracyclines 
that had been included in the conditioning regimen It was therefore assumed that the 
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streptococci had been selected by ciprofloxacin and that these bacteria, together with the 
anthracychnes, were responsible for the oromucositis and fever. If this was the case, then 
bacteraemia would be expected to occur in most, if not all cases and immediately precede 
both oromucositis and fever. A scheme was therefore devised for monitoring bacteraemia 
during each of the first 15 days following BMT using a pour-plate technique for detection 
and enumeration. 
Patients and Methods 
Fifty two patients admitted for allogeneic bone marrow transplantation from January 1988 
to February 1990 were recruited. Preparation, nursing care and conditioning treatment were 
essentially the same for all patients (Schattenberg, De Witte, Preijers, et al., 1990). 
Preventative dental care had already been completed and patients were free of dental canes 
and periodontal disease. Antimicrobial prophylaxis was started 8 days before BMT with oral 
acyclovir, amphotericin В and itraconazole. The first 25 patients were given co-tnmoxazole 
plus cohstin for 8 days prior to transplant which was replaced by ciprofloxacin the day before 
transplant while the next cohort were given ciprofloxacin from the day of admission. 
Co-tnmoxazole was given twice-weekly post-transplant as prophylaxis against Pneumocystis 
carinii (Hughes, Rivera, Schell, Thornton & Lott, 1987). Vascular access was established 
using a Hickman catheter which was inserted the day before conditioning was begun except 
for 3 patients who had been admitted with a Port-a-Cath. Mucositis was defined by the 
presence of ulceration, redness, swelling of the tongue and buccal mucosa, pain and difficulty 
m swallowing and each individual sign and symptom was scored numerically from 1-3 and 
a daily mucositis score (DMS) was constructed by summation with values of 1-4 , 5-9 and 
10 corresponding to mild, moderate and severe mucositis respectively (Donnelly, Muus, 
Schattenberg, et al, 1992). 
Biood culture schedule and technique 
Blood samples were taken by the attending nurse before the first administration of any 
antimicrobials. Nine millilitres of blood was obtained via the catheter, 6 and 2 days before 
BMT and on each of the first fifteen days post-transplant. Peripheral blood samples were only 
obtained 3 times weekly when the concentration of cyclosporin A was to be determined. 
Blood was collected under vacuum using specially designed tubes (Balis Laboratorium, The 
Netherlands) containing concentrated Schaedler anaerobe broth (PCH-Oxoid, The 
Netherlands ) supplemented with saponin and citrate. After gentle mixing, the lysed blood 
was poured aseptically onto partially-dehydrated gel in a 9 centimetre Petri dish (Balis 
Laboratorium, The Netherlands which was rotated gently to ensure an even covering. The 
plate was allowed to set at room temperature following which it was brought to the 
laboratory. It was dried at 37°C in air for 20-30 minutes and then incubated in a candle 
extinction jar. Plates were examined carefully after 18-24 hours with the aid of back-light 
illumination. Colonies were enumerated and representative examples were sub-cultivated 
for further processing. Negative plates were returned for a further 24 hours incubation. 
Investigation of fever 
When the patient sustained a temperature of 38 °C for 2 hours, 2 samples of 10 millilitres 
peripheral blood were obtained for conventional broth culture together with a further 10 
millilitres from the catheter. The broth culture set comprised an aerobic bottle of Trypticase 
Soy broth (Becton Dickinson, T h e Nether lands) supplemented with sodium 
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polyanetholsulphonate (Liquoid) and an anaerobic bottle of Brain Heart infusion 
(PCH -Oxoid, The Netherlands) supplemented with cysteine hydrochloride and saponin. 
Each bottle contained 45 millilitres medium under an atmosphere of carbon dioxide and a 
partial vacuum to which 5 millilitres of blood was added. The aerobic bottle was vented prior 
to incubation. After 24 hours incubation, bottles were subcultivated onto blood agar for both 
aerobic and anaerobic incubation If negative they were incubated a further 6 days, 
subcultivated once more and discarded. 
Antimicrobial therapy 
At the onset of fever, patients were treated initially with either ceftazidime alone or 
combined with clindamycin as part of an open study for the treatment of oromucositis and 
fever (Curative Bacterial Study #14 approved by the Ethics committee CEOM 1988-
011892). When modifying therapy empirically, clinicians were restricted to vancomycin 
and amphotericin B. All other modifications were based on laboratory findings. 
/aenti/tcation and susceptibility testing 
Strains were characterised according standard laboratory techniques. All streptococci and 
staphylococci were biotyped by means of the commercial kits (API Strep or API Staph, 
Bio-Mérieux S.A., France) as appropriate. Identification was only accepted if the likelihood 
was greater than 90% and the quality was considered good. Strains were assumed to be the 
same unless they differed by 3 or more test characteristics. 
Antibiotic susceptibility tests were performed using disc diffusion technique following the 
guidelines of the NCCLS (National Committee for Clinical Laboratory Standards, 1990b) 
except that Iso-sensitest medium was used throughout. 
Analysis 
When the pour-plates of both the catheter and peripheral blood yielded growth, the higher 
count was used and they were treated as a single blood sample. The data derived from both 
pour-plates and broth cultures was integrated with the administration of antimicrobial 
agents, the onset, worsening and resolution of oromucositis as well as its seventy, the period 
of profound granulocytopenia (<0.1 χ 109/1) and the occurrence of any clinical signs of 
infection. 
Resul ts 
The patients' age ranged from 14 to 48 years and averaged 32.9 years and 35 were male. All 
patients remained granulocytopenic throughout the study period. Oromucositis developed 
shortly after transplant (Table 1 ) and progressed to a peak of seventy whereupon fever 
developed. Signs and symptoms persisted a further two weeks finally resolving after marrow 
recovery had begun and granulocyte counts had begun rising beyond 0.1 χ 109/L. 
Blood cultures were obtained on 791 of a possible 884 days (89.5%) with cultures 
yielding growth on 166 days (21 percent), vmdans streptococci were isolated 54 times 
(33.5%), coagulase-negative staphylococci 103 times, Candida albicans twice and Aerococcus 
vmdans, Enterococcus faecahs and Acinetobacter calcoaceticus once each. The vmdans strep­
tococci were the sole isolate in 38 (70 percent) and occurred together with coagulase 
negative staphylococci 13 times, with coagulase-negative staphylococci with Staphylococcus 
aureus twice and with a non-haemolytic streptococcus once. Coagulase negative 
staphylococci comprised the sole isolate from 95 cultures and was recovered three times 
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together with Staph, aureus or 'diphtheroids', with micrococci once and both 'diphtheroids' 
and micrococci once. 
The rate of bacteraemia steadily increased from 5 percent to just over 50 percent on the 
fifth day post transplant after which it gradually declined to around 10 percent where it 
remained (Figure 1). 
Table 1. Mucositis, fever and granulocyte recovery 
mucositis (days after BMT) 
day onset 
day onset peak 
day onset improvement 
day of resolution 
Maximum DMS 
granulocyte recovery beyond :-
0.1 x109/l 
0.5x109/l 
onset of fever 
1.5±2.1 1 
5.7 ±1.7 
11.2 ±3.0 
17.9 ±4.6 
11.9 ±3.2 
14.6 ±6.1 
20.9 ± 4.3 
5.1 ±1.8 
' mean ± standard deviation 
Colony counts were below 50 colony-forming units (cfu) per 10 ml in 29 of 33 (83%) 
quantitative cultures of streptococci and in 80 of 99 cultures (81%) of coagulase-negative 
staphylococci (Table 2). Higher levels of streptococci were encountered in 2 patients. One 
patient had counts of > 300 cfu per 10 ml on each of 3 consecutive days and died of respiratory 
failure 36 days after transplant without any evidence of infection at autopsy. The other was 
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Figure 1. The occurrence of bacteraemia following transplant. There is a steady rise in the number of positive 
cultures until the fifth day post-transplant which coincides, on average, with the onset of fever. As a result of 
empirical therapy, the rate steadily declines until settling around 10 percent. 
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a patient whose counts progressed from 8 to >300 cfu per 10 ml within 3 days He had severe, 
haemorrhagic oral mucositis with infection caused by an acyclovir-resistant strain of herpes 
simplex This patient was also one of 2 who had high, recurring counts for Staph epidermidis 
associated with a colonised Port-a-Cath The other patient admitted with this type of 
catheter had counts of approximately 100 cfu per 10 ml each for Staph epidermidis, 
Staph аитеиь together with another coagulase-negative strain 6 days before transplant and 
a 100 cfu per 10 ml for a different strain 4 days later. Seven other patients had counts of more 
than 50cfuper lOmlforStaph epidermidis which wasrecoveredtogetherwithStaph aureus 
in one case AcmetobocteT cakoaceticus and Enterococcus faecahs were isolated in one patient 
each at 35 and 4 cfu per 10 ml respectively Aerococcus vindans and all isolates of 
diphtheroids and micrococci were each isolated at one cfu per 10 ml. Candida albicans was 
recovered on 2 occasions in one patient at 2 cfu per 10 ml and was ultimately responsible for 
her death There was no difference between samples obtained from peripheral venepuncture 
and those drawn through the catheter (Figure 2) 
Bacteraemia due to vindans streptococci affected 32 (62 percent) patients and first 
occurred within 8 days of transplant with an average time of onset of 4 9±2 0 days after 
transplant Nine patients had two positive blood cultures with the same strain resulting in 
a total of 45 strains of which 19 were identified as Strep sanguis, 8 as Strep mitis while the 
remainder could not be speciated satisfactorily In contrast, coagulase-negative 
staphylococci were recovered on every day of sampling and affected 38 patients (73 percent). 
Staph epidermidis accounted for 41 percent of the strains identified, Staph capitis for 4, 
Staph hominis and Staph saprophyticus 2 each and Staph warnen and Staph xylosus for one 
strain each No acceptable identification was found for the remainder Fifty-three percent 
of coagulase-negative strains were fully susceptible to ciprofloxacin compared with only 10 
percent of streptococci 
The onset of vindans streptococcal bacteraemia was clearly related to the onset of fever 
which, in turn, coincided with the progression of mucositis (Figure 3 ) Cultures were positive 
at least a day before the onset of fever in 34 percent of cases (11/32) In contrast, no 
relationship was apparent for the staphylococci with bacteraemia first occurring before fever 
Table 2. Quantitative counts obtained for vindans streptococci and coagulase negative 
staphylococci 
colony forming streptococci staphylococci 
units per 10 ml η (%) η (%) 
1 
2 10 
11 50 
51 100 
101 500 
>500 
Total positive 
11 
12 
6 
2 
2 
33 
(33) 
(36) 
(18) 
( 6) 
( 6) 
(-) 
40 
30 
10 
7 
5 
7 
99 
(40) 
(30) 
(10) 
( 7) 
( 5) 
( 7) 
(-) 
(%) expressed as percentage 
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Figure 2. Comparison of 
peripheral (•) and catheter 
(D) blood samples. There 
was no difference between 
the counts obtained from 41 
positive peripheral samples 
and the 105 samples 
obtained via the catheter. 
Figure 3. The relationship of bacteraemia to oromucositis and fever. Coagulase negative staphylococci (•) were 
recovered in about 20 percent of cultures obtained each day before the onset of fever reducing to half that following 
the start of empirical antimicrobial therapy. In contrast, bacteraemia due to viridans streptococci (•) occurred 
within two days of fever coinciding with progressive oromucositis as determined by the daily mucositis score 
displayed as box-plots in the upper panel. 
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in 78 percent of cases (30/38). 
Only 5 patients remained free of bacteraemia throughout the study period whereas 
positive blood cultures were obtained on more than one third of days in 9 cases, all involving 
coagulase-negative staphylococci Bacteraemia due to the same strain of Staph epidermide 
recurred in 7 of these cases as well as in 3 other cases who had fewer days with positive cultures 
(Table 3). The strains involved in 2 of the cases with Port-a-Caths in situ (# 120 and #135) 
were susceptible to ciprofloxacin, ceftazidime and clindamycin but persisted in high 
numbers. The other patient with this type of catheter acquired a new strain on the fifth day 
after transplant which was fully susceptible but which recurred 7 days later having become 
resistant to clindamycin and ceftazidime. Vancomycin was given to successfully treat these 
patients and also 5 other patients including those who developed infectious complications. 
Bacteraemia eventually cleared on ceftazidime alone in the 2 remaining patients after 
clindamycin had been discontinued. 
Vindans streptococci were all eradicated within 2 days of starting empiric therapy and 
all other episodes of bacteraemia resolved without changing antimicrobial treatment. 
However, as a result of persisting unexplained fever, a further 15 patients were given 
Table 3. Recurrent bacteremia due to Staphylococcus epidermide 
patient 
089 
102 
108 
120 
123 
128 
131 
134 
135 
138 
counts 
least 
1 
14 
1 
15 
1 
1 
1 
1 
1 
2 
highest 
240 
1000 
300 
1000 
2 
2 
8 
6 
1000 
79 
days post BMT 
when positive 
8 ,11 .15 
2 ,7 ,9 -13 
5,12-15 
3 , 4 , 1 2 - 1 5 
2 , 5 , 7 , 1 2 
2 - 5 , 7 - 1 2 
2 , 3 , 6 
4, 5, 7, 8 
-6 ,2-10,15 
2, 3, 5, 7 
complication 
none 
metastatic abscesses 
tunnel infection 
Port-a-Cath colonisation 
Port-a-Cath colonisation 
metastatic abscesses 
none 
none 
Port-a-Cath colonisation 
none 
susceptible to 
initial therapy 
susceptible 
resistant 
resistant 
susceptible 
susceptible 
resistant 
resistant 
resistant 
susceptible 
resistant 
additional 
therapy 
none 
vancomycin 
vancomycin 
vancomycin 
vancomycin 
vancomycin 
vancomycin 
none 
vancomycin 
vancomycin 
patient 89 received ceftazidime alone whereas all other were given this antibiotic together with clindamycin 
vancomycin empirically because of their previous history of bacteraemia and the presence 
of an indwelling intravascular catheter 
Discussion 
The primary purpose of this investigation was to establish whether or not bacteraemia due 
to oral vindans streptococci was related to the mucositis induced by intensive conditioning 
for bone marrow transplantation This was indeed the case since two-thirds of patients were 
affected and both fever and bacteraemia coincided mucositis. However, the streptococci 
appeared in the blood as mucositis worsened of rather than its onset suggesting that the 
bacteria only transmigrate to the blood stream when a certain threshold is attained, brought 
about, in part, by severe tissue damage induced by radiochemotherapy. The majority of 
strains were resistant to ciprofloxacin which, by providing selective pressure, may have lead 
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to their predominance in the oral cavity where drug levels are thought to be similar to those 
of nasal secretions (Ullman, Giebel, Dalhoff δι Koeppe, 1986) but to which streptococci are 
only marginally susceptible (King & Phillips, 1986; Donnelly, Willemse, Horrevorts &. De 
Pauw, 1992). However this does not explain the predominance of Strep, sanguis over 
Strep, mms among strains that were satisfactorily speciatcd which is the reverse of that 
reported in other leukemic patients (Burden, Oppenheim, Crowther, et al., 1991; Ehm, 
Relier δι Ellison, 1991; Van der Lelie, Van Ketel, Von dem Bome, étal., 1991; Awada, Van 
Der Auwera, Meunier, Daneau δι Klastersky, 1992; Devaux, Archimbaud, Guyotat, et al, 
1992). Strep, sanguis is also less widely distributed in the mouth than Strep mitis being 
mainly restricted to the dental plaque in individuals without caries and the buccal mucosa 
(Frandsen, Pedrazzoli & Kilian, 1991). Patients in the current study all had been given 
remedial dental care and oral hygiene was maintained. Moreover, swelling of the buccal 
mucosa appeared characteristic of the mucositis induced by anthracychnes (Donnelly, 
Muus, Schattenberg, eta/., 1992; Schubert, Williams, Lloid, Donaldson διChapko, 1992). 
Saliva production is also reduced following irradiation (Kolbinson, Schubert, Fluornoy & 
Truelove, 1988) which may reduce the ability of Strep, mitis to adhere to the mucosa and help 
alter the balance in favour of Strep sanguis since this species does not bind to α-amylase 
unlike Strep, mms (Kilian & Nyvad, 1990). 
Whatever is the explanation, the rate of bacteraemia encountered in this population 
was almost twice that reported for comparable patients (Classen, Burke, Ford, et al., 1990; 
ViUablanca, Steiner, Kersey, et al., 1990; Val teau, Hartmann, Brugieres, et ai., 1991 ; Devaux, 
Archimbaud, Guyotat, et al, 1992) and yet there were no cases of ARDS and septic shock 
(Dybedal & Lamvik, 1989; Guiot, Peters, Van Den Broek, et al, 1989; Kern, Kurrle & 
Schmeiser, 1990; Van der Lelie, Van Ketel, Von dem Borne, et al, 1991; Awada, Van Der 
Auwera, Meunier, Daneau & Klastersky, 1992) nordid any patients develop the "alpha-strep 
syndrome" (Elting, Bodey δι Keefe, 1992). Thus McWhinney and colleagues may well be 
correct in assuming Strep, sanguis to signal mucositis (McWhinney, Gillespie, Kibbler, 
Hoffbrand δι Prentice, 1991). Bacteraemia with vindans streptococci also occurred at a 
similar time as that seen in children whom there was an equal numbers of episodes due to 
Strep mitis and Strep, sanguis (Valtcau, Hartmann, Brugieres, et al, 1991 ). However, while 
these authors failed to identify an specific risk factor for bacteraemia, the episodes that 
occurred in the present population appear to be have been a direct consequence, rather than 
a cause, of mucositis. Moreover, the levels of bacteraemia encountered in the current study 
were significantly lower than those reported by others (Andremont, Paulet, Nitenberg δι 
Hill, 1988; Kiehn δι Armstrong, 1990; Rice & Spencer, 1991 ). Were the organism to have 
played a pathogenic rôle, much higher levels would be expected since exotoxins are not 
elaborated by any of the oral vindans streptococci, their cell wall is typical of a Gram-positive 
in lacking endotoxin and no specific virulence factors have yet been described. Therefore, 
taken together, these data strongly suggest vindans streptococcal bacteraemia to be an 
epiphenomenon. 
In marked contrast, bacteraemia with coagulase-negative staphylococci has little 
connection with mucositis Rather, the source appeared to have been the catheter especially 
when it involved a Port-a-Cath when 2 of the 3 patients had recurrent high-level 
bacteraemia. Despite the strains being susceptible to the antibiotics given as treatment, 
bacteraemia was only controlled with vancomycin. This suggests that persistence was more 
likely to be a function of dense colonisation and possibly the production of glycocalyx which 
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is known to impair antimicrobial activity (Costerton &. Marrie, 1983; Hoyle, Jass 6* 
Costerton, 1990; Van Loosdrecht, Lyklema, Norde ókZehnder, 1990). Almost 4 out of every 
5 patients had at least one episode of bacteraemia, again involving low numbers of bacteria 
but infection due to Staph, epidermidis developed in only one in twenty. The rate of positive 
cultures was also so high that their significance could not be determined since there was no 
temporal relationship with either fever or any other sign or symptom of infection and the 
majority of episodes were asymptomatic as has been reported before (Donnelly, Cohen, 
Marcus & Guest, 1985). Those that did develop complications tended to have high counts 
of the order reported previously (Browne, Potter, Gress, et al, 1990; Rice & Spencer, 1991) 
and blood cultures were positive more often. Moreover, the strains all belonged to 
Staph, epidermide sensu stricto and broke through antibiotic prophylaxis and therapy as a 
result of either being or becoming resistant or because of dense colonisation of the catheter. 
Therefore any criteria for assigning significance to bacteraemia due to coagulase-negative 
staphylococci should take account of the species, susceptibility to the antimicrobials the 
patient is receiving, the level of bacteraemia and the number of positive blood samples. 
The origin of the blood did not seem important in the current study although others 
have shown that a positive culture of catheter blood might only indicate colonisation of the 
device in the absence of an accompanying peripheral blood culture ( Andremont, Paulet, 
Nitenberg &. Hill, 1988; Weightman, Simpson, Speller, Mott & Oakhill, 1988; Kiehn & 
Armstrong, 1990). Quantitative culture may also be of value in assigning significance to 
coagulase-negative staphylococci such > 1000 cfu per ml ] and in discriminating catheter-
related bacteraemia (Whimbey, Wong, Kiehn & Armstrong, 1984; Weightman, Simpson, 
Speller, Mott <5t Oakhill, 1988; Ascher, Shoupe, Robb, Maybee & Fischer, 1992; Capdevila, 
Planes, Palomar, et al., 1992; Raad δι Bodey, 1992). Given the lack of specificity of blood 
cultures yielding coagulase- negative staphylococci, particularly at low numbers, it seems 
prudent to always obtain at least one sample peripherally. Greater specificity can be also be 
achieved when there is a time interval between samples since isolation of the same strain on 
each occasion effectively excludes the possibility of contamination while increasing the 
volume might improve sensitivity (Bryan, 1989; Brown & Warren, 1990). Regular monitor­
ing would also assist in identifying clinically relevant colonisation in patients with 
indwelling intravascular catheters since three or more consecutive cultures are predictive of 
significant bacteraemia (Guiot, Helmigschurter & Vantnoordende, 1992). Although con­
suming of time, labour and expense, the costs would be more that offset by the savings which 
would accrue from being able to confidently restrict vancomycin to only those who 
demonstrably require the antibiotic rather than giving it empirically since, as occurred in this 
study, 2 patients were given the drug empirically for every one who actually needed it. 
Moreover, coagulase negative staphylococci does not cause rapidly fatal infection (Rubin, 
Hathorn, Marshall, et ai, 1988; The EORTC International Antimicrobial Therapy Coop­
erative Group and National Cancer Institute of Canada, 1991), a fact which should allow 
sufficient time to define the problem accurately. 
Only by daily culturing of blood could it be shown that the recovery of viridans 
streptococci indicated severe mucositis in every case while culturing staphylococci signified 
colonisation of the intravascular device or infection in only a minority of cases. These results 
urge caution when attempting to diagnose the cause of fever in this and other granulocyto­
penic patients and suggests a need for further studies to define the optimum schedule for 
detecting and assigning significance to bacteraemia due to Gram-positive cocci. 
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Abstract 
Thirty three consecutive allogeneic bone marrow transplant recipients who were likely 
to develop streptococcal bacteraemia were treated for five days with clindamycin (900 
mg i.v. t.d.s.) and ceftazidime (2 g t.d.s.) for the initial management of fever associated 
with severe oral mucositis. Bacteraemia due to vindans streptococci was encountered 
in 23 cases (70%) as mucositis progressed to peak seventy and occurred a day before 
fever in eight cases. At the end of treatment with clindamycin only two patients had 
defervcsced although the streptococci were successfully eradicated. C-reactive protein 
(CRP) levels continued to rise in 18 cases and declined by more than 10% in only seven 
cases. Severe oromucositis rather than infection appeared to induce an acute phase 
response with fever suggesting bacteraemia due to vindans streptococci to have been 
a consequence of mucosal damage. Indeed, oromucositis was the only primary focus of 
inflammation in 22 patients and only after its resolution did both fever and CRP levels 
diminish. By then, patients had also begun to recover from granulocytopenia. These 
data indicate that rather than including a specific antimicrobial like clindamycin in an 
empirical regimen, it would be more beneficial to evolve strategies that minimise 
mucosal damage in this patient population . 
Introduction 
Oral mucositis induced by irradiation and chemotherapy is frequently associated with 
infectious complications in bone marrow recipients (Weisdorf, Bostrom, Raether, et al, 
1989, Bergman, Mogensen & Ellegaard, 1990). In particular, 65% of those given additional 
anthracychnes developed bacteraemia due to vindans streptococci compared to 11% in 
patients given standard transplant conditioning(De Pauw, Donnelly, DeWitte, Nováková 
&. Schattenberg, 1990). AU patients had been given oral ciprofloxacin as prophylaxis which 
has been shown to promote bacteraemia due to oral streptococci (Van der Lelie, Van Ketel, 
Von dem Borne, étal., 1991). Fever persisted for five or more days in half of cases (Van Der 
Lely, De Witte, Raemaekers, Schattenberg &. Haanen, 1989) and agents with more specific 
activity against Gram- positive cocci were increasingly added to the initial empirical 
regimen. Three quarters of patients given anthracychnes also complained of severe 
oromucositis (Raemaekers, De Witte, Schattenberg &. Van Der Lely, 1989) which may have 
created a portal of entry for the streptococci (Cohen, Donnelly, Worsley, et ai, 1983). We 
therefore decided to focus attention on the relationship between fever, vindans 
streptococcal bacteraemia and oromucositis induced by anthracychnes. 
If vindans streptococci had a causal rôle in the development of oromucositis and fever, 
the addition of an antibiotic with excellent activity against these organisms would be 
expected to have a significant impact on both. Consequently initial empirical therapy for 
fever was rationalized to a combination of ceftazidime and clindamycin since the latter 
antibiotic has good activity against streptococci as well as oral anaerobes (Phillips, 1981) 
which might also play a rôle in causing infection associated with oral mucositis (Hathorn, 
Rubin &. Pizzo, 1987). The study was conducted as an open, consecutive recruitment study 
and efficacy was to be evaluated in terms of clearance of bacteraemia, defervescence and a 
reduction in both C-reactive protein and oromucositis. The investigation received the 
approval of the Medical Ethics Committee of the University of Nijmegen (1988-001892) 
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Patients and methods 
From June 1988, all patients receiving an allogeneic bone marrow transplant were eligible 
provided they were not allergic to cephalosporins or lincomycins, had no previous history 
of diarrhoea due to Clostridium difficile, and did not present with proven oro-pharyngeal 
infection due Herpes simplex or yeasts. In addition they were not to have received parenteral 
antibiotics at any time after starting conditioning for BMT and liver and kidney function 
tests were not to exceed three times the normal level. 
The basic conditioning regimen comprised cyclophosphamide and total body irradia-
tion together with 4-demethoxy-daunorubicin and was initiated after a Hickman catheter 
had been inserted (Raemaekers, De Witte, Schattenberg «Si Van Der Lely, 1989). AU 
patients were given orally, ciprofloxacin, co-trimoxazole, itraconazole, amphotericin В and 
acyclovir as prophylaxis (Schattenberg, De Witte, Preijers, et al., 1990). 
Mucositis was defined by the presence of ulceration, redness, swelling of the tongue and 
buccal mucosa, pain and difficulty in swallowing. Signs and symptoms were scored numeri­
cally from 1 -3 and a daily mucositis score (DMS) was constructed by summation with values 
of 1-4 , 5-9 and 10 corresponding to mild, moderate and severe mucositis respectively 
(Donnelly, Muus, Schattenberg, et al., 1992). Mouthwashes were cultured for microorgan­
isms including herpes simplex, 5 and 2 days before transplant and twice weekly thereafter. 
Ten millilitres of blood was obtained via the Hickman catheter every day for the first two 
weeks post-transplant and cultured quantitatively using a cold pour plate technique. Faeces 
was sampled twice-weekly and cultured quantitatively both aerobically and anaerobically. 
Various selective media were used which included cefoxitin-cycloserine fructose agar for 
Clostridium difficile and Gram-preparations were examined for the number and morphologi­
cal types of microorganisms. Haematological and biochemical determinations and C-reactive 
protein (CRP) were undertaken three times weekly with the CRP being assayed by means 
of laser nephelometry. 
When a patient first became febrile (axillary temperature >38 °C for two hours or 
>38.5 °C at a single reading), conventional broth cultures were inoculated with two 10 ml 
venous samples and 10 ml obtained via the Hickman catheter. Further broth cultures were 
obtained every two to three days while the patient remained febrile. Bacteraemia was defined 
as a single positive culture of any organism except for coagulase-negative staphylococci for 
which at least two consecutive cultures were required in which the isolates had the same 
antibiogramme and biotype. 
After blood cultures had been drawn, initial therapy was begun with ceftazidime 
(2g i.v.) and clindamycin given at 900 mg in order to achieve peak concentrations of 
14-20 mg/L (Flaherty, Rodondi, Guglielmo, et al., 1988), which are over 100 times greater 
than that required to inhibit streptococci in vitro (Leigh, 1981 ). Both antibiotics were given 
thrice-daily and treatment with clindamycin was limited to five full days in order to minimize 
the risk of antibiotic-associated colitis, of which pseudomembranous colitis is the most 
serious manifestation (Schwartzberg, Maresca & Remington, 1976). If a response was not 
obtained, ceftazidime with or without further modification was continued until the tempera­
ture had returned to 37.5°C, for at least four days while the patient was neutropenic or two 
days, if marrow recovery had already occurred. 
Organisms isolated from blood were identified according to standard techniques using 
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API biochemical identification kits (Biomcneux, France) for both coagulase-negative 
staphylococci (API staph) and vmdans streptococci (API strep). Strains which yielded a 
profile with a likelihood of less than 95% were assigned to either vindans streptococci or 
coagulase-negative staphylococci Biotypes that differed by three or more tests were assumed 
to represent different strains. Antibiotic susceptibilities were determined by means of disc 
diffusion in accordance with NCCLS recommendations (National Committee for Clinical 
Laboratory Standards, 1990b) 
Serum was obtained for each patient before transplant to ascertain their herpes simplex 
status and mouthwash samples were inoculated onto VERO cell monolayers grown in GLY 
medium supplemented with antibiotics to detect the virus itself. Cultures were incubated for 
one week and examined microscopically every two days for the presence of a cytopathic 
effect. Positive cultures were confirmed using monoclonal antibodies to herpes simplex 1 
and 2 
A response to therapy was defined by a return to a temperature of 37.5°C , a decline 
of CRP to 30 mg/1 and resolution of oromucositis. A microbiological response was registered 
if blood cultures drawn during and for up to two days after stopping clindamycin therapy 
remained sterile 
The two-sided, paired student t-test was used to evaluate measurements at the start and 
end of treatment with clindamycin CRP values were transformed to logarithms in order to 
normalize the values. Mean values are presented together with their 95% confidence 
intervals. 
Results 
Thirty three patients completed treatment of whom the majority were males in first 
complete remission (Table 1). Most patients were seropositive for herpes simplex and all 
developed oromucositis, 30 (92%) having a DMS score of 10 corresponding to severe 
mucositis. They were profoundly granulocytopenic for two weeks following transplant and 
granulocytes remained below 0.5 χ 109/L a further week. 
Mucositis began 1.1 ± 0.6 days after transplant and progressively worsened until 
reaching a peak 4.1 ± 0.6 days later when fever also developed and therapy was begun. 
There was no other clinical evidence of infection except in two cases where one patient 
presented with necrotizing gingivitis while another had a tunnel infection at the site of the 
Hickman catheter. Herpes simplex virus was not cultured from any patient and 'vindans 
'streptococci predominated in oral washings obtained at the onset of fever. 
Bacteraemia was detected in 26 patients (79%) and involved 'vindans streptococci in 
23 episodes (92%) either alone (12 cases) or together with coagulase-negative staphylococci 
(11 cases). Eight patients had already developed bacteraemia the day before onset of fever. 
Coagulase-negative staphylococci accounted for a further two episodes of bacteraemia and 
Aerococcus vindans was isolated in one further case. Of those patients from whom positive 
quantitative blood cultures were obtained, seven had fewer that < 1 colony-forming unit/ml 
(cfu/ml) of streptococci, four had 2-4 cfu/ml and only one had more than 100 cfu/ml. Counts 
for coagulase-negative staphylococci were all less than 1 cfu/ml. 
There were 29 strains of streptococci since six bacteraemic episodes were caused by two 
variants Streptococcus sanguis was identified in 16 cases, Strep mitis in five while the 
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Table 1. Patient characteristics 
Age (yrs) 
Males 
Underlying malignancy:-
acute leukaemia 
chronic leukaemia 
others 
Stage of disease:-
complete remission 
chronic phase 
others 
Sero-positive for herpes simplex 
Highest daily mucositis score (DMS) 10 
Duration of granulocytopenia 
<0.1 x109/l 
<0.5x109/l 
(days):-
32.7±3.61 
22 
21 
4 
θ 
22 
5 
6 
23 
30 
14.0±1.81 
21.0±2.51 
[14-48]2 
(67%) 
(63%) 
(67%) 
(70%) 
(91%) 
[ 7- 33]2 
[ 9 - 37]2 
'mean ± 9 5 % confidence interval with г [ ] range 
remainder could not be fully speciated beyond the viridans group. Twenty seven strains were 
resistant to ciprofloxacin (93%) and 13 to trimethoprim (45%). Two strains were resistant 
to clindamycin and one to ceftazidime (Table 2) but none was resistant to both drugs. 
Nineteen different strains of coagulase-negative staphylococci were recovered of which 
eight were resistant to trimethoprim (42%) seven to ciprofloxacin (37%), six to clindamycin 
(32%) and five to ceftazidime (26%) and four to methicillin (21%). Four strains were 
resistant to both clindamycin and ceftazidime. 
Only two patients became afebrile both of whom had had initial bacteraemia while the 
patient who had presented with necrotizing gingivitis developed acute respiratory distress on 
the last day of clindamycin treatment after initial bacteraemia due to Strep, mitis and died 
as a result. All streptococci were eradicated from blood but Staph.epidermidis persisted in 
three cases, of which one was resistant to both ceftazidime and clindamycin and resulted in 
metastatic abscesses. Staphylococcal bacteraemia also recurred in the patient who had 
presented with the catheter-associated tunnel infection. This strain was also resistant to 
bothof the study drugs. Besides fever, oromucositis persisted in every case and the CRP level 
Table 2. Antibiotic susceptibility patterns for bacteraemic isolates 
organism trimethoprim 
S sanguis 
S mitis 
'viridans' streptococci 
S epidermidis 
Coagulase negative staphylococci 
10/16 
2/5 
4/Θ 
2/8 
9/11 
ciprofloxacin 
0/5 
2/8 
3/8 
9/11 
ceftazidime 
0/16 
4/5 
8/8 
5/8 
9/11 
clindamycin 
16/16 
5/5 
8/8 
4/8 
9/11 
methicillin 
14/16 
-
-
3/8 
1/11 
* number susceptible/total 
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remained above 30 mg/L. There was only a minimal change in the average temperature and 
DMS (Table 3), a decline of 0.5°C being observed in 15 cases (47%) and a reduction in the 
DMS of 5 in six cases (19%). The CRP levels had ranged from 8 to 256 mg/1 at the start of 
therapy and were significantly higher when clindamycin was discontinued ranging from 37 
to 290 mg/1 owing to levels continuing to rise in 18 cases (55%: Figure 1). A decline in CRP 
of more than 10% of the initial value was recorded in only seven instances (22%). 
Table 3. Effect of clindamycin therapy on temperature, CRP and mucositis score 
start end 
mean 95%CI mean 95%CI 
temperature 38.8 
log10CRP 1.79 
mucositis score 9.3 
0.15 
0.16 
1.4 
38.7 
2.04 
8.7 
0.32 
0.09 
1.4 
ns 
p=0.0018 
ns 
Figure 1. C-reactive protein levels 
in relation to the start and end of 
clindamycin therapy. Levels con­
tinued to rise in 18 cases and 
declined by more than 10 percent 
in only 7 cases. 
Fever persisted a further 3.8 ± 3 . 0 days after clindamycin had been stopped and could 
be explained in only nine cases: those who had suffered persistent or recurrent bacteraemia, 
one patient who had developed a catheter-associated infection and four who had lung 
infiltrates diagnosed although the cause was not established. CRP levels took another 
2.2 ± 3.2 days after defervecence before reaching concentrations of <30 mg/1. 
Consequently, antimicrobial therapy was continued for 11.8 + 2.7 days either as 
ceftazidime alone (11 cases) or in combination with vancomycin (15 cases) or other 
antibiotics. Mucositis gradually subsided 8.0 ± 1.7daysafterdiscontinuing clindamycin by 
which time granulocytes had already begun to recover beyond >0.1 χ 109/1· Early graft-
versus-host disease was then observed to occur in 12 cases. 
Clindamycin was well tolerated and there were no cases of antibiotic-associated 
diarrhoea nor was C!. difficile isolated from any stool sample. There were also no disturbances 
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Clindamycin had little effect on the course of fever even though streptococci were 
eradicated in all cases. Moreover, the CRP continued to rise in over half of the patients 
indicating continued inflammation (Starke, De Beer, Donnelly, et ai, 1984; Ligtenberg, 
Hoepelman, Oude Sogtoen, et al., 1991). Had infection been the cause of 
elevated CRP levels and temperature, a response might have been expected by the third day 
of treatment. However this did not occur. Indeed both the temperature and CRP returned 
to normal only after resolution of oromucositis. Persistent bacteraemia due to S taph epidermide 
and infection might explain the lack of response in just under a third of cases. However graft-
versus-host disease which is also associated with elevated CRP levels (Rowe, Worsley, 
Donnelly, et al., 1984) only occurred in a minority of cases and then, only after clindamycin 
had long been discontinued and the granulocytes had begun to recover. Therefore oromuco-
sitis appears to be the only plausible explanation for persistent fever and the sustained acute 
phase response. 
Entry of the streptococci via damaged mucosa would account for levels of bacteraemia 
that were ten times lower than those reported for other septicaemias ( Bryan, 1989) including 
bacteraemia associated with endocarditis (Yagupsky ¿A Nolte, 1990) as well as that 
encountered in neutropenic patients (Brown 6k Warren, 1990; Rice & Spencer, 1991). 
Furthermore, sepsis is usually caused by a single strain whereas one fifth of patients in this 
study had two different strains isolated in the blood. Moreover a third of bacteraemic 
episodes were asymptomatic since they developed the day defore fever. Given the high 
incidence of streptococcal bacteraemia it was also surprising that there was so little evidence 
of morbidity especially the respiratory distress and related syndromes that are associated with 
streptococcal bacteraemia due to Strep, mitts (Guiot, Peters, Van Den Broek, et ai, 1989; 
Kern, Kurrle & Schmeiser, 1990). This might explained by the fact that Strep, sanguis was 
more common in our patient population and is more likely to be associated with oral 
mucositis (McWhinncy, Gillespie, Kibbler, Hofrbrand 6k Prentice, 1991). Indeed Strep mitts 
usually predominates in leukaemic patients (Cohen, Donnelly, Worsley, et ai, 1983, 
Sotiropoulos, Jackson, Woods, et ai, 1989; Kern, Kurrle 6k Schmeiser, 1990; Burden, 
Oppenheim, Crowther, et ai, 1991 ; Van der Lelie, Van Ketel, Von dem Borne, et ai, 1991 ) 
as well as in other bone marrow transplant recipients (Villablanca, Steiner, Kersey, et ai, 
1990). 
Hitherto it has been suggested that herpes simplex plays a rôle in the development of 
bacteraemia due to vindans streptococci particularly in transplant recipients (Ringden, 
Heimdahl, Lonnequist, Malmborg & Wilczek, 1984; Viot 6k Klastersky, 1991 ). However all 
patients in this study had received acyclovir and virus was not isolated at any time. 
Prophylaxis with ciprofloxacin helps explain the occurrence of bacteraemia (Van der Lelie, 
Van Ketel, Von dem Borne, et αϊ., 1991). The majority of isolates were resistant to 
ciprofloxacin and drug levels in the oral mucosa were almost certainly sufficiently high 
(Ullman, Giebel, Dalhoff6k Koeppe, 1986) to inhibit most of the aerobic oral commensals, 
with the exception of the vindans streptococci (King 6k Phillips, 1986) which predominated 
in the oral washings at the onset of bacteraemia. Selective pressure would also lead to 
multiplication of species such as Strep, sanguis which, though less widely distributed on the 
oral mucosa (Hardie δι Marsh, 1978; Frandsen, Pedrazzoli 6A Kilian, 1991 ) are nonetheless 
resistant to ciprofloxacin. However, this alone does not account for the high incidence of 
bacteraemia in this population which was almost twice that of other patients who also 
received the quinolonc as prophylaxis (Dekker, Rozenberg-Arska 6k Verhoef, 1987; 
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Maschmeyer, Haralambie, Gaus, et al, 1988; Arning, Wolf, Aul, et al, 1990; Warren, 
Wimperis, Baghn, Constantine & Marcus, 1990), neither does mucositis per se since 
bacteraemia occurred three days after onset of oromucositis by which time the DMS had 
reached an average of nine units. This suggests that bacteraemia occurs only after a certain 
threshold of seventy has been attained at which point the mucosal injury is sufficient to allow 
transmigration from areas of profound damage to the bloodstream by means of "spillover" 
rather than invasion. 
Rather than being the cause of fever and the acute phase response, bacteraemia due to 
vindans streptococci may itself be an indication of the intensity of oromucositis. Thus, a 
strategy designed to minimize mucosal injury may be more effective in reducing morbidity 
than the use of specific antimicrobial agents to either prevent or treat bacteraemia due to 
vindans streptococci. 
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Inflammatory response to oromucositis and vindans streptococci 
Abstract 
Interleukin 6 and C-reactive protein concentrations were determined during 
granulocytopenia for 25 recipients of an allogeneic bone marrow transplant All 
patients developed oromucositis but fever only occurred when this became severe when 
both CRP and interleukin 6 concentrations became elevated Interleukin 6, CRP 
and temperature correlated significantly with the mucositis score (r=0.56, 0.51 and 
0.33 respectively, ρ 0 0001 ) and each became elevated as oromucositis progressed to its 
peak. Vindans streptococci were recovered from blood cultures of 18 patients and 10 
patients had clinically manifest infection but in neither case were the interleukin 6 
and CRP levels significantly different from those without either bacteraemia or 
infection Only as oromucositis began to resolve, did the concentrations of the cytokine 
decline whereas those for CRP remained elevated until after mucosal healing was 
complete. The inflammatory response observed in these patients was therefore the 
result of severe oromucositis rather than infection and it seems more likely that 
bacteraemia due to oral vindans streptococci was a direct consequence of mucosal 
damage. 
Introduction 
In a study on the efficacy of ciprofloxacin as prophylaxis in allogeneic bone marrow 
transplant recipients, we observed that bacteraemia with ciprofloxacin resistant vindans 
streptococci occurred in two-thirds of patients who had been given idarubicin or daunorubicin 
to augment pre-transpljnt conditioning (De Pauw, Donnelly, DeWitte, Nováková & 
Schattenberg, 1990). These patients also complained of severe oromucositis (Raemaekers, 
De Witte, Schattenberg & Van Der Lely, 1989) which is frequently associated with 
infectious complications in bone marrow transplant recipients (Kolbmson, Schubert, 
Fluornoy & Truelove, 1988; Weisdorf, Bostrom, Raether, et ai, 1989) and patients tended 
to remain febrile until after oromucositis had subsided despite broad-spectrum antimicrobial 
therapy which frequently included a glycopeptidc and amphotericin B. In order to 
understand the relationship between bacteraemia with oral vindans streptococci, 
oromucositis and persistent fever, a prospective series of parallel investigations was 
undertaken to monitor the progression of oromucositis, identify the onset of bacteraemia and 
assess the impact of oral prophylaxis with ciprofloxacin. C-reactive protein (CRP) 
concentrations were measured since they might provide a more objective means of 
distinguishing infection from other causes of fever (Ligtenberg, Hoepelman, Oude Sogtoen, 
et al., 1991; Rintala, Irjala 6k Nikoskelainen, 1992) and for monitoring the efficacy of 
antibiotic therapy (Starke, De Beer, Donnelly, et al., 1984; De Bel, Gerritsen, De Maaker, 
Moolcnaar & Vossen, 1991). Interleukin 6 levels were determined to investigate its utility 
in distinguishing inflammation due to oromucositis from that due to bacteraemia and 
infection. The results for neither CRP nor interleukin 6 were available to the clinician at 
the time and therefore played no role in either diagnosis or decisions on therapy. 
Patients and methods 
All patients receiving an allogeneic bone marrow transplant from December 1987 to January 
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1990 were entered into the laboratory protocol However only those prepared for transplant 
with 4-demethoxy-daunorubicin in addition to the basic conditioning regimen of 
cyclophosphamide and total body irradiation were included in this analysis being those with 
the highest risk of bacteraemia due to vindans streptococci Patients were nursed in single 
isolated rooms using reverse-barrier nursing techniques and were given orally, ciprofloxacin, 
co-tnmoxazole, itraconazole, amphotericin В and acyclovir as prophylaxis (Schattenberg, 
De Witte, Preijers, et al, 1990) Chemotherapy was initiated after a Hickman catheter had 
been inserted (Raemaekers, De Witte, Schattenberg 6k Van Der Lely, 1989) 
Sampimg Schedule 
All samples were obtained according to a predetermined schedule Six and two days before 
transplant, a 10 ml sample of blood was obtained for pour-plate culture via the Hickman 
catheter before administration of any antimicrobials At the same time a saline mouthwash 
specimen was collected and subjected to culture for bacteria, yeasts and herpes simplex 
During the first two weeks post transplant, blood and oral samples were obtained for culture 
at the start of each day to monitor the oral vindans streptococci and to detect bacteraemia 
respectively Culture and serum for herpes virus was also obtained six and two days before 
transplant but continued only twice weekly after transplant Samples for assaying CRP and 
interleukin 6 were obtained eight and two days before transplant and then every seond or 
third da\ during each of the next two weeks At the start of the third week post-transplant, 
daily blood cultures and oral sampling were suspended while sampling of serum to monitor 
interleukin 6 and CRP continued every 3 to 4 days during each of the next two weeks 
Quantitative blood culture 
Blood was mixed immediately with concentrated Schaedler medium (Oxoid, United 
Kingdom), allowed to lyse and then poured directly onto a Petri dish containing a gel which 
permitted resorption of fluid within 20-30 minutes (Balis BV, Boven-Leeuwen, The 
Netherlands) After setting, plates were dried in air at 37°C and then incubated at the same 
temperature in a candle extinction jar Plates were examined on each of three consecutive 
days 
Oral Samples 
Orals samples were homogenised using a vortex mixer and the diluted decimally to give 
diutionsof 10 ' 10 2 1 0 ' a n d l O 4 Each dilution was then cultured quantitatively aerobically 
on various selective media including one which contained ciprofloxacin (Donnelly et al, 
submitted for publication) After incubation overnight, the total number of commensal flora 
and vindans streptococci was estimated and the resistance to ciprofloxacin determined 
An aliquot of the same mouthwash samples were inoculated onto VERO cell monolayers 
grown inGLY medium supplemented with antibiotics Cultures were incubated for one week 
and examined microscopically every two days for the presence of a cytopathic effect Positive 
cultures were confirmed using monoclonal antibodies to herpes simplex 1 and 2 
Processing of %erum 
The patient's herpes simplex status was determined for IgG, IgM and IgA using an ELISA 
method Serum for CRP and interleukin 6 assay was first inactivated at 56°C for 30 minutes 
and then stored at -20°C until used All determinations were performed in triplicate CRP 
was assayed by means of laser nephelometry while interleukin 6 was detected using the B9 
murine hybndoma bioassay which is sensitive to 1 ng/L (Hack, De Groot, Felt-Bersma, 
74 
Inflammatory response to oromucositis and viridans streptococci 
et al., 1989). Specificity was confirmed when the reaction was abolished after neutralising 
with the monoclonal antibody CLB IL6/8. 
Mucositis 
Mucositis was defined by the presence of ulceration, redness, swelling of the tongue and 
buccal mucosa, pain and difficulty in swallowing and each individual sign and symptom was 
scored numerically from 1-3 and a daily mucositis score (DMS) was constructed by 
summation with values of 1-4 , 5-9 and 10 corresponding to mild, moderate and severe 
mucositis respectively (Donnelly, Muus, Schattenberg, et al, 1992). 
investigation and empirical treatment of fever 
When a patient first became febrile (axillary temperature >38°C for two hours or >38.5 °C 
at a single reading), two 10 ml venous samples and 10 ml obtained via the Hickman catheter 
were inoculated in conventional broth cultures. Further broth cultures were obtained every 
two to three days while the patient remained febrile. After blood cultures had been drawn, 
initial therapy was begun with ceftazidime 2g IV and clindamycin 900 mg IV in order to 
achieve high enough tissue concentrations to exceed the MIC for streptococci (Donnelly, 
Muus, Horrevorts, Sauerwein & De Pauw, 1993). Both antibiotics were given thrice-daily 
but treatment with clindamycin was limited to five full days in order to minimise the risk of 
antibiotic-associated colitis, of which pseudomembranous colitis is the most serious 
manifestation (Schwartzberg, Maresca & Remington, 1976). If a response was not obtained, 
ceftazidime with or without further modification was continued until the temperature had 
returned to 37.5°C, for at least four days while the patient was neutropenic or two days, if 
marrow recovery had already occurred. 
Identification of bacteria 
Organisms isolated from blood were all identified by standard techniques and API 
biochemical identification kits (Biomericux, France) were employed for both coagulase -
negative staphylococci (API Staph) and viridans streptococci (API strep). Strains which 
yielded a profile with a likelihood of less than 95% were assigned to either viridans 
streptococci or coagulase-negative staphylococci. Biotypes that differed by three or more 
tests were assumed to represent different strains. Antibiotic susceptibilities were determined 
by means of disc diffusion in accordance with NCCLS recommendations (National 
Committee for Clinical Laboratory Standards, 1990b). 
Definitions 
A single positive blood culture was accepted as evidence for bacteraemia with streptococci 
whereas at least two separate blood cultures yielding the same biotype and antibiotigramme 
were required for coagulase-negative staphylococci. Bacteraemia was deemed persistent if 
cultures remained positive on three or more occasions with not more than two days in 
between. Pulmonary infiltrates were assumed infectious unless there was clear evidence to 
the contrary. 
Statistics 
Concentrations of CRP and interleukin 6 and granulocyte counts were first transformed to 
decimal logarithms in order to normalise the values. Correlation coefficients (Pearson) on 
any given day were calculated for these data together with the daily mucositis score and the 
maximum daily temperature. Regression analysis was restricted to the period of oromucositis 
which included the last normal day before onset and the first day after resolution. Univariate 
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analysis was performed using the student-t test with a two-sided significant level of 5%. Only 
values obtained immediately prior to BMT and bacteraemia, the highest values obtained 
during the remainder of granulocytopenia and the first value after granulocyte recovery 
beyond 0.1 χ 109 granulocytes/L were selected for repeated analysis of variance to test the 
influence of bacteraemia on the inflammatory response indicators (1RI) temperature and 
levels of CRP and interleukin 6. Data are presented for comparisonasbox-plots(Williamson, 
Parker &. Kendrick, 1989) since this technique makes no assumptions of the data but allows 
for ready comparison by displaying the location of the median values as well as the spread 
and symmetry of the distribution of data values. 
Table 1 . Patient characteristics 
Number 
Age (yrs) 
Males 
Acute leukaemia 
Sero-positive for herpes simplex 
Duration of granulocytopenia (days):-
<0.1 x109/l 
<0.5x109/l 
Patients with viridans streptococcal bacteremia 
'mean ± standard deviations with * [ ] 10'" and 9СГ percentiles 
Results 
Twenty five patients were included in this study of whom the majority were adult males 
transplanted in complete remission of acute leukaemia (Table 1 ). Oromucositis developed 
in every case shortly after BMT and became progressively more severe with fever developing 
shortly before the severity attained a peak. Bacteraemia due to viridans streptococci occurred 
in 18 cases (72%) between 2 and 8 days post transplant. Significant bacteraemia due to 
Staphybcoccus epidermidis in occurred in two of these cases and was the only isolate in another 
two instances. One further patient had a single culture positive with Аетососсш viridans and 
remaining four patients had sterile blood cultures. A pulmonary infiltrate developed in six 
cases occurring together with a tunnel infection and follicultis in one case each. Two other 
patients developed metastatic abscesses after persistent bacteraemia with Staph, epidermidis 
while another had folliculitis. In addition, there was a single case with chronic oral herpes 
simplex infection which was associated with haemorrhagic oromucositis. At the end of 
treatment with clindamycin only two patients had defervesced although all streptococci 
were successfully eradicated. Antibacterial therapy was continued for a total of 10.4±8 days 
either as ceftazidime alone (12 cases) or in combination with vancomycin (13 cases). 
Relationship of measures with the course of oromucositis 
All but three patients developed severe oromucositis and signs and symptoms only declined 
gradually over a period of around a week until finally resolving after granulocytes had begun 
to recover during the third week post-transplant (Table 2). CRP, interleukin 6 and 
temperature became elevated as oromucositis became progressively worse and remained 
relatively high while interleukin 6 declined in line with the DMS values. Bacteraemia 
25 
33.8 ± 9.81 
17 
17 
17 
14.0 ±4.81 
21.3 ±6.81 
18 
[18 -44]2 
(68%) 
(68%) 
(68%) 
[10-17]2 
[14-29]2 
(72%) 
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Table 2. The course of oromucositis and corresponding values for the inflammatory response 
indicators 
Stage of mucositis 
onset 
onset of peak 
mid-peak 
improvement 
last day 
day after BMT 
0 6 ± 1 7 
5 3 1 2 0 
6 9 ± 1 11 
1 0 0 1 4 2 
1 5 2 1 3 0 
DMS 
2 2 1 1 3 
11 1 1 2 5 
2 5 1 4 2 
7 3 1 2 7 
1 8 1 1 2 
log10[IL6| 
0 65 1 0 34 
1 80 1 0 32 
1 61 1 0 36 
1 90 1 0 61 
1 10 1 0 28 
log10[CRP] 
0 82 1 0 43 
2 0 5 1 0 1 6 
1 97 1 0 49 
2 20 1 0 21 
1 64 1 0 5 
Temperature 
37 3 1 0 6 
38 4 1 0 6 
38 8 1 0 7 
38 8 1 0 9 
38 2 1 0 9 
developed just before peak oromucositis occurred and did not lead to higher temperature or 
CRP and interleukin 6 compared with values obtained from those with sterile blood 
cultures. 
Correlation of CRP, ішетіеи/сіп 6 and temperature with each other and the daily mucositis score 
The concentrations of interleukin 6 and CRP taken as a whole correlated significantly with 
the corresponding DMS values as did the granulocyte count (Figure 1 ) while temperature 
showed a similar but less marked trend CRP and interleukin 6 also correlated significantly 
with each other (r=0 47) and to a lesser extet with the temperature (r=0.34 and 0 33 
respectively) but not the granulocyte count (r=-0.07 and 0 04 respectively). 
Relationship oflRl's to the midVpeafc of mucositis 
The mid-peak was defined as the half-way point during peak seventy of oromucositis. All 
the IRI's became elevated with progressive oromucositis (Figure 2) Interleukin 6 showed 
the closest relationship with the DMS, declining as oromucositis began to improve whereas 
both the temperature and CRP remained elevated Bacteraemia with vindans streptococci 
Figure 1. The inflammatory response 
and oromucositis Correlation coeffi­
cients for the daily mucosi tis score (DMS) 
with (a) C-reactive protein (r = 0 51), (b) 
interleukin 6 (r = 0 56), (c) the maximum 
daily temperature (r = 0 33) and (d) the 
granulocyte counts (r = 0 56) all differ 
significantly from zero (P<0 0001 ) How­
ever, it is clear from the wide dispersion 
of values, that the correlation is less than 
perfect 
4 1 j 
4 0 -
3 9 -
3 8 
3 7 -
3 B -
0 5 10 
Daily mucositis score 
I S 
С 
5 10 
Daily mucositis score Daily mucosi Us score 
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only occurred after oromucositis had begun when it was approaching its peak severity. 
Granulocytopenia also corresponded closely with both oromucositis and the IRI's, particu-
larly interleukin 6. 
Viridans streptococcal bacteraemia, infection and IRI's 
Two-factor, repeated analysis of variance showed that the concentrations of interleukin 6 
were not significantly different for patients with or without bacteraemia due to viridans 
streptococci (p= 0.95) nor between those with clinically manifest infection or none (p = 
0.056), whereas the timing of the sample was highly significant (p<0.001) in both cases 
(Figure .3). Similar results were obtained for both the temperature and the CRP (data not 
shown). 
Discussion 
The primary objective of this investigation was to determine whether or not measuring CRP 
and interleukin 6 would assist in distinguishing infection from other causes of fever. Serum 
concentrations of both the cytokine and CRP increased as oromucositis progressed and 
correlated significantly with the 
scoring of oromucositis. Levels of 
interleukin 6 were also consistent with 
inflammatory diseases (Debenedetti, 
Massa, Robbioni, et al, 1991; Hollen, 
Henthorn, Koziol ¿k Burstein, 1991; 
Shacter, Arzadon &. Williams, 1992; 
Viedma, Perezmateo, Domínguez ¿к 
Carballo, 1992) and burns (Nijsten, De 
Groot, Ten Duis, et ai, 1987) rather 
t h a n sepsis (Hack, De G r o o t , 
Felt-Bersma, et ai, 1989; Calandra, 
Gerain, Heumann, Baumgartncr &. 
Glauscr, 1991 )but were within the range 
associated with Gram-positive infection 
(Heney, Lewis, Evans, et al., 1992). Most 
patients in this study had indeed 
experienced bacteraemia with viridans 
Figure 2. Inflammatory response indicators and 
their relation to the mid-peak of oromucositis. 
Temperature, C-reactive protein and interleukin 
6 become progressively elevated as mucositis 
reaches i ts peak severi ty (day 0) while granu locy te 
counts diminish. Bacteraemia with viridans 
streptococci develops shortly before the peak 
occurs but not afterwards since empirical 
antimicrobial therapy was begun around this time 
in most cases. Interleukin 6 levels begin to decline 
as oromucositis resolves while concentrations of 
CRP and the temperature remain elevated until 
the mucosal damage has all but passed and 
granulocytes have recovered. 
Hay Ol Peak Mucositis 
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Figure 3. Box-plot displays of log
ul concentrations of interleukin 6. Interleukin 6 concentrations for 18 patients with 
bacteraemia due to viridans streptococci compared with 7 patients with negative cultures (upper panel) and 10 
patients with and 15 patients without clinically manifest infection (lower panel). Two-factor repeated measure 
ANOVA showed the contribution of bacteraemia to be insignificant (p = 0.95 and 0.056 respectively) whereas the 
timing of the sample was highly significant in both cases (p<0.0001). 
s t reptococci but these organisms were eradicated in every case once 
empirical therapy had been started. Yet the concentrat ions of interleukin 6 
remained elevated for over two weeks only declining as oromucositis resolved. 
The concentrations of CRP were also within the range reported for infection during 
neutropenia (Ligtcnberg, Hoepelman, Oude Sogtoen, et ai, 1991; Heney, Lewis, Evans, et 
ai, 1992) although oromucositis might also have been responsible since this is common side-
effect of cytotoxic therapy. Interestingly, De Bel and colleagues found CRP only useful as a 
negative predictor when CRP concentrations were below 50 mg/L (De Bel, Gerritsen, De 
Maaker, Moolenaar 6k Vossen, 1991 ) while Ligtenberg and associates suggested that levels 
of 25 mg/L could be used to distinguish infection from other causes of fever with a sensitivity 
of 100% and a specificity of 89% (Ligtenberg, Hoepelman, Oude Sogtoen, et al, 1991). 
Clearly, such a cut-off value could not apply to a population who experience severe 
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oromucositis which itself provokes a powerful inflammatory response The higher cut-off 
level of 100 mg/L was found useful a decade ago when chemotherapy was generally less 
intensive (Mackie, Crockson & Stuart, 1979, Rose, Johnson, Meakin, Mackie & Stuart, 
1981) but in a more recent study, most patients with unexplained fever had levels which 
exceeded this threshold (Rimala, Irjala &. Nikoskelainen, 1992 ) Consequently the authors 
advocated interpreting a series of CRP measurements in the context of the clinical condition 
which should now include oromucositis. 
The value of measuring either CRP or mterleukm 6 to monitoring therapy in 
neutropenic patients would be also be severely limited since levels of both were elevated 
apparently in response to oromucositis rather than bacteraemia due to vindans streptococci 
or infection and concentrations remained high until mucosal damage had all but healed 
Therefore, rather than leading to a rationalisation of therapy, relying on either to manage 
therapy might have the opposite effect of prolonging treatment and increasing the number 
of antibiotics given, just as occurred in this study, . 
Since both fever and elevated concentrations of interleukin 6 and CRP were 
attributable to oromucositis, bacteraemia due to vindans streptococci may have little 
clinical significance. Moreover, despite the extremely high incidence of bacteraemia with 
vindans streptococci, none of the patients developed the shock or ARDS, nor had any signs 
or symptoms associated with the sepsis syndrome (Bone, 1991b) Neither did specific 
antimicrobial therapy with clindamycin alter the clinical course of any of the inflammatory 
response indicators. 
Therefore, vindans streptococci appear to have little, if any, pathogenic significance 
in this patient population. On the contrary, it seems more likely that their presence in the 
bloodstream is a direct consequence of mucosal damage and that bacteraemia is merely 
another indication of a breach in the natural defences It would therefore be more productive 
to consider new approaches to the prevention or amelioration of oromucositis rather than 
designing antimicrobial therapy or prophylaxis to deal with what may only be a 'spillover' 
of oral commensal flora. 
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Abstract 
Box-plots may provide an alternative to standard approaches to presenting MIC data 
by making it possible to see directly the level, spread and symmetry of the distribution 
of data values as well as providing the more traditional MIC50, MIC90 and range. The 
method was employed to illustrate its potential as a means of comparing the in-vitro 
activity of meropcnem with that of various antimicrobial classes as well as other 
ß-lactams. Besides supplying basic information such as the MIC5C, the devices made it 
easier to visually compare antimicrobials and select any features for further exploration. 
Thus while the in-vitro activity of carbapenems was generally very similar, the use of 
box-plots made it easier to demonstrate precisely those differences that exist, for 
instance among the Gram-negatives and staphylococci. Box-plot analysis therefore 
appear to be a useful technique to enhance the assimilation and communication of 
information simply and efficiently. 
Introduction 
Standard approaches of presenting in-vitro MIC data are satisfactory in demonstrating the 
activity of individual agents against microbial populations. However, tabular data including 
cumulative percentage distributions often conceal relationships between classes of antibi-
otics and do not lend themselves readily to comparing a range of agents against a variety of 
different species. Mathematical modeling offers one means of exploring correlations 
(Hunter, George & Griffiths, 1990) but the techniques require considerable expertise, an 
understanding of the assumptions involved and a good working knowledge of multivariate 
statistical analysis. A much simpler approach is to make use of cumulative percentile 
distributions to construct box-plots. These graphical devices have several attractive features 
since they convey the same information as is usually presented but also make it possible to 
see directly the level, spread and symmetry of the distribution of data values and identify 
outlier values (Williamson, Parker & Kendnck, 1989) and to compare different populations 
visually. The technique requires few prior assumptions about the data, is only minimally 
affected by the extreme values arising from exceptionally susceptible and resistant strains 
and gives a representative impression of the shape of the distribution. The MIC50, MIC^ and 
the range can also be read directly (Figure 1 ) .The plot can be constructed either by hand (see 
for instance Willamson, Parker and Kendnck 1989 ) or using a statistics package as done here. 
However the principle advantage of using a computer derives from the ability to explore any 
features of interest and complete the analysis in a in a very short period of time. 
Figure 1. The Box-plot The rectangle defines the boundaries 
within which the middle 50% of \alues fall while the steins 
encompass 80% of the data The line through the box 
represents the median while the upper and lower stems are 
the 90,h and IO"1 percentiles respectively The location of the 
outliers indicates the range of values 
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For the last ten years, ceftazidime has been used in our institution for single agent therapy 
in the febrile neutropenic patient (De Pauw, Kauw, Muyrjens, Williams & Bothof, 1983, De 
Pauw, Williams, De Neeff.etaí., 1985; Verhagen, De Pauw, Donnelly, étal., 1986; Verhagen, 
De Pauw, De Witte, et ai, 1987; Nováková, Donnelly & De Pauw, 1990; Nováková, 
Donnelly & De Pauw, 1991b; Nováková, Donnelly & De Pauw, 1991a). However, 
alternatives were being sought and attention had been drawn to meropenem, a new 
carbapenem with broad-spectrum activity in-vitro (Bauernfeind, Schweighárt&Jungwirth, 
1989; Clarke & Zemcov, 1989; Edwards, Turner, Wannop, et al., 1989, Jones, Barry & 
Thomsberry, 1989; Kayser, Morenzoni, Strassle &. Hadorn, 1989; King, Boothman &. 
Phillips, 1989; Neu, Novelli & Chin, 1989; Sentochnik, Eliopoulis, Ferraro & Moellering 
Jr, 1989). The data were generated for conventional publication (Donnelly, Willemse, 
Horrevorts &. De Pauw, 1992) and were employed to illustrate the potential of Box-plot 
analysis as a means of comparison. 
Materials and methods 
T h e MIC's of blood stream 
isolates (Table 1) from both 
granulocytopenic patients and other 
patients with bacteraemia were 
de termined for meropenem, 
imipenem, cefepime, cefotaxime, 
c e f t a z i d i m e , p i p e r a c i l l i n , 
ciprofloxacin and amikacin . 
Cefepime and meropenem were 
donated as pure substance from 
Bnstol-Myers-Squibb ( Belgium) and 
ICI Pharmaceuticals Ltd) Cheshire, 
UK). All determinations were 
performed in duplicate in Iso-
sensitest broth (Oxoid, Basingstoke, 
UK) using a micro t i t ra t ion 
technique. An inoculum of 105 cfu 
per 200 μ\ was prepared from log-
phase cultures and trays were read 
after 18 hours of aerobic incubation to identify the MIC which was the last concentration 
to inhibit growth. There was excellent agreement between duplicates with 99.7% of all tests 
being within a single dilution but where discrepancies occurred, the higher of the two values 
was entered into an Apple Macintosh computer and transformed to the log2 value. The ratio 
of the MIC to the breakpoint was calculated using values recommended by the BSAC 
Working party (Report of the Working Party on Antibiotic Sensitivity Testing, 1991 ) to 
provide an estimate of the factor by which the MIC exceeds or is exceeded by the breakpoint 
thereby taking account of the pharmacology of the antibiotics. Finally, the log, MIC for 
meropenem was subtracted from each of the individual log2 MIC's of the comparator 
antibiotics resulting in another ratio which allowed for more direct comparison of relative 
activity. Percentile distributions were calculated using a statistics package (Statview512+, 
Abacus Concepts Inc.) which allowed box plots to be constructed. 
Table 1. Box-plot analysis, strains investigated 
Bacterial strains 
Escherichia coli 
Klebsiella spp 
Enterobacter cloacae 
enteraba ctena 
Pseudomonas aeruginosa 
non-fermenting G-negative rods 
Staphyloc occus aureus 
Staphylococcus epidermidis 
coagulase-negative staphylococci 
Streptococcus mitis 
Streptococcus sanguis 
vindans streptococci 
other streptococci 
enterococci 
number 
11 
22 
21 
27 
33 
16 
22 
48 
Θ0 
17 
15 
15 
8 
8 
84 
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Results 
Gravimetric comparison of MIC distributions and the ratio of the mie to the breakpoint 
The lack of symmetry of each MIC distribution for the whole population is apparent for all 
drugs (figure 2a) as might be expected for a range of different organisms. Meropenem and 
imipenem have almost equivalent activity with 90% of strains being inhibited by 2 mg/L 
while the median activity of both cefepime and cefotaxime correspond with the M I C ^ of the 
carbapenems. The cephalosporins are about 16 times less active than the carbapenems with 
90%, 80% and 50% of strains being inhibited by 8 mg/L for cefepime, cefotaxime and 
ceftazidime respectively. There is a wide variation in MIC's for ciprofloxacin, the MIC
№ 
being 32 times higher than the MIC,0. Nonetheless the distribution coincides with that of 
the ß - l ac tams . Amikac in 
exhibits a narrower range with 
75% of strains being inhibited 
by 16 mg/L and shares no over-
lap with the carbapenems. 
Comparison of Figure 2b 
with Figure 2a shows clearly 
that each of the plots has 
retained its integrity and that 
the ca lcula t ion of MIC/ 
breakpoint ratios has simply 
resulted in a shift of location to 
a common reference point. 
W i t h respect to the 
carbapenems and cefepime, 
fewer than 10% of MICs 
exceed the breakpoint and it is 
more obvious tha t these 
antibiotics have very similar 
activity. In contrast, over half 
of the MIC's are in excess of 
the breakpoint for both ceftaz-
idime and piperacillin com-
pared with 25% for cefotaxime, 
amikacin and ciprofloxacin. 
These results are explained by the resistance of Pseudomonas aeruginosa to cefotaxime, the 
lower susceptibility of the coagulase-negative staphylococci to both it and ceftazidime, and 
the relative resistance of the streptococci to both amikacin and ciprofloxacin. 
Relative activity of meropenem to comparator agents 
Meropenem is more active than cefepime and considerably more so against ceftazidime 
( Figure 3 ). However its activity is less than or equal to that of imipenem against half of the 
strains while being more active against the other half. Separating the MIC ratios of 
imipenem to meropenem into those for the Gram-negatives, streptococci, staphylococci and 
enterococci show the reduced susceptibility of the staphylococci and enterococci to 
meropenem (Figure 4) and the greater susceptibility of the Gram-negatives to be responsible. 
Figure 2. Comparison of meropenem to reference antibiotics. The 
location of each MIC distribution indicates relative gravimetric 
activity as well as dispersion (Figure 2a). However relating the 
MIC to the breakpoint allows a more meaningful comparison 
(Figure 2a). It is now more obvious that while the vast majority of 
strains are susceptible to meropenem (A), imipenem (B) and 
cefepime (C), neither ceftazidime (E) nor piperacillin (F) are as 
broad in their spectrum since 50% of MIC's exceed the breakpoint. 
Cefotaxime (D), ciprofloxacin (G) and amikacin (H) occupy an 
intermediate position. 
ЯЧ 
Vindans streptococci and allogeneic bone manow transplant recipients 
32768 
1024 
1 
1/32 
о 
о 
τ-
1 
О 
О 
о 
о 
о 
-г 
I 1 
1 
о 
о 
e 
о 
о 
о 
о 
о 
-Ι­
ο 
о 
о 
о 
о 
s 
τ 
1 
î 
О 
0 
8 
τ 
J_ 
о 
о 
о 
о 
О 
imipenem ceftazidime piperacillin amikacin ciprofloxacin 
Figure 3. Ratio of the reference 
antibiotic MIC's to that for 
meropenem Meropenem is clearly 
more active than ceftazidime, 
piperacillin and amikacin However 
it is moreactiveagainsthalf of strains 
compared with imipenem and 
ciprofloxacin, while less active 
against the other half. 
16 
1/16 
1/64 
о 
τ 
I I 
_L 
° 
О 
о 
О 
О 
1 
О 
о 
° 
і-І-і 
± 
о 
о 
+ 1 1 
Gram-negatives streptococci staphylococci enterococci 
Figure 4. Comparison of imipenem 
and meropenem The separation of 
strains indicates that while 
meropenem is more active than 
imipenem against Gram negatives 
it is less active against staphylococci 
and enterococci Both drugs are 
equally active against streptococci 
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Figure 5. The activity of meropenem against various different groups and species Meropenem ismost active against 
the enterobacteria ι e. £ coli (A), Klebsiella spp (B) Ent cloacae (C) and others (D), the streptococci ι e S mitb (G), 
S sanguis (H), 'viridans' streptococci (I) and other streptococci 0) and Staph aureus (L), less active against 
Ps aerugmoba (E), non-fermenting Gram-negative rods (F), Staph epidermidi^ (M) and other coagulase-negative 
staphylococci (N) and least active against the enterococci (K). 
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Figure 6. The activity of meropenem, ceftazidime 
and vancomycin versus 81 methicillin susceptible 
(MS) and 47 methicillin resistant (MR) strains of 
coagulase-negative staphylococci. Susceptibility 
to meropenem and ceftazidime corresponds to 
that for methicillin but not vancomycin. 
Both antibiotics are equally active against the streptococci. The insight afforded by this 
analysis therefore appears to outweigh any inherent limitations of gravimetric comparisons. 
Comparative activity of meropenem against inividual species 
Having seen that spectrum of activity of meropenem compares favourably with that of other 
comparable agents, attention was drawn to the responses of individual species. All strains of 
enterobacteria and the majority of streptococci are inhibited by 0.25 mg/L (Figure 5) while 
enterococci require 2-32 mg/1. MIC's for Pseudomonas aeruginosa and other non-fermenters 
are 16-32 times higher than those for enterobacteria with MIC90's of 2-4 mg/L. 
Staphylococcus aureus comprises a majority which are susceptible, the two outliers being also 
resistant to methicillin. Staphylococcus epidermide and the other coagulase-negative staphy-
lococci are much more heterogeneous having MIC values that are very widely dispersed. This 
suggests a bi-modal distribution which is in fact due to methicillin resistance (Figure 6) and 
is a feature shared by other ß-lactams (represented in the figure by ceftazidime) but not 
vancomycin. Methicillin resistance of 8mg/l is not totally predictive of resistance to other 
ß-lactams but the visual association is supported by correlations coefficients for methicillin 
for meropenem (0.73), imipencm (0.6), ceftazidime (0.86), cefotaxime (0.77) and cefepime 
(0.75) compared with 0.46 and 0.3 for teicoplanin and vancomycin respectively, therefore 
justifying the assumption of cross-resistance as noted by Kayser and colleagues (Kayser, 
Morenzoni, Strässle &. Hadorn, 1989). 
Discussion 
These data confirm that the in-vitro activity of meropenem, imipenem, cefepime and 
ceftazidime is similar thereby increasing the potential options for monotherapy. However, 
more information is conveyed by the box-plots than is possible in columns of figures and 
analysis was achieved rapidly, once the data had been entered into the computer. In 
particular, the use of box plots to display the MIC/breakpoint distributions shows clearly that 
the carbapenems and cefepime have similar spectra of activity which are all broader than that 
of ceftazidime. Thus, the in-vitro data would be expected to translate into at least similar 
efficacy in the clinic provided that safety is comparable. The relative activity of the agent of 
immediate interest, meropenem, is more obvious when the ratio of its MIC to those of other 
agents is displayed as box plots. In particular, the differences between the carbapenems is 
readily apparent once the MIC's of the different microbial families are examined, meropenem 
being more active than its counterpart against Gram-negative rods while the converse is true 
for the staphylococci. Further separation into species allows comparison that is more akin to 
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the conventional presentation of data although the visual impression is easier to assimilate. 
The use of box-plots to display the results of computer analysis renders basic information 
and other important features within the complex body of data more accessible than is 
possible using only the MIC50, MIC90 and geometric mean values. Moreover, any correla-
tions that are identified visually can then be explored further using formal statistics. Box 
plots are therefore one of those techniques which enhance the assimilation of information. 
They therefore deserve the attention of all who wish to communicate simply and efficiently 
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Antimicrobial activity of теторепет against bacteraemic isolates 
Abstract 
The in-vitro activity of meropenem was compared to that of ïmipenem, cefepime, 
ceftazidime, ciprofloxacin, aminoglycosides and other antibiotics against Gram-
positive cocci which predominated in bloodstream infections of granulocytopenic 
patients. Strains of Gram- negative rods and Staphylococcus aureus isolated from other 
patients were employed as surrogates since only 10 bacteraemic episodes due to these 
bactertena had occurred in leukaemic patients. Overall, 9 1 % of Gram-positive cocci 
and almost all of Gram-negative rods were inhibited by meropenem at 4 mg/L. MIC's 
for meropenem were 8-16 times higher than those for ïmipenem versus staphylococci, 
but lower by the same factor against Gram-negative rods. Both carbapenems had 
comparable activity to ampicilhn against streptococci all of which were susceptible. 
Methicilhn resistance in staphylococci resulted in higher MIC's to all ß-lactams which 
exceeded the breakpoint for susceptibility for meropenem (8mg/L) in two strains 
whereas all were susceptible to ïmipenem ( 4 mg/L). The in-vitro activity of meropenem 
encompasses most of the organisms that frequently cause primary bacteraemia in 
granulocytopenic patients. This broad-spectrum activity is expected to translate into 
significantly improved efficacy of empiric therapy with meropenem alone without the 
need for initial combination with other agents or later modification. 
Introduction 
Modern empiric regimens for the febrile, granulocytopenic patient are effective against 
Gram-negative rods and Staphylococcus aureus (Hathorn, Rubin & Pizzo, 1987) but not 
always against coagulase-negativc staphylococci (The EORTC International Antimicrobial 
Therapy Cooperative Group and National Cancer Institute of Canada, 1991). Regimens 
based on cephalosporins may also be less effective against vindans streptococci which have 
increased in frequency due to more intensive chemotherapy (Van der Lelie, Van Ketel, Von 
dem Borne, et al., 1991) particularly following higher doses of cytarabine (Kern, Kurrle &. 
Schmeiser, 1990) and conditioning therapy for bone marrow transplantation (De Pauw, 
Donnelly, DeWitte, Nováková & Schattenberg, 1990). Currently in our hospital, almost 
nine of every ten leukaemic patients with bacteraemia are due to either coagulase-negative 
staphylococci or vindans streptococci (Nováková, Donnelly & De Pauw, 1990). Therefore 
an agent which affords reliable activity bactericidal against these bacteria while retaining its 
Gram-negative spectrum would clearly be desirable. 
Carbapenems such as ïmipenem and meropenem offer most promise in this setting 
since both antibiotics have broad-spectrum, bactericidal activity ( Bauernfeind, Schweighart 
6*. Jungwirth, 1989; Clarke &. Zemcov, 1989; Jones, Barry &. Thomsberry, 1989) although 
meropenem is more stable to renal aminopcptidases (Harrison, Moss, Featherstone, et al., 
1989) and therefore does not require a co-drug. Meropenem has been shown to be active 
against against a wide range of both Gram-negative and Gram-positive organisms (Edwards, 
Turner, Wannop, etal, 1989;Kayser, Morenzoni.Strassle&Hadorn, 1989; King, Boothman 
& Phillips, 1989; Neu, Novelli & Chin, 1989; Sentochnik, Ehopoulis, Ferraro & Moellcnng 
Jr, 1989). However there has been no report dealing specifically with bacteraemic isolates 
of vindans streptococci and coagulase negative staphylococci from granulocytopenic 
patients. We wished to explore the potential of using meropenem for empiric monotherapy 
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and to estimate its advantage over ceftazidime, which is deficient in treating Gram-positive 
bacteraemia(Nováková, Donnelly, De Pauw ¿к Verhagen, 1990) We therefore undertook to 
establish the in-vitro activities of meropenem, ß-lactam antibiotics including ceftazidime 
and representatives of other antibiotic classes. 
Materials and methods 
Strain selection 
Gram-positive cocci comprising 106 strains of coagulase-negative staphylococci, 44 strains 
of viridans streptococci and 8 strains of enterococci had been isolated from from 149 
bloodstream infections which occurred during granulocytopenia in 102 patients during 
1988-89. Speciation was achieved biochemically for streptococci and enterococci (API 
Strep profiles: API-Biomerieux, France) and staphylococci (API-staph: API-Biomerieux, 
France). Strains which yielded profiles of less than 95% likelihood were consigned to the 
general category of 'viridans' for the streptococci and 'coagulase-negative' for the 
staphylococci. 
Selective oral antimicrobial prophylaxis resulted in only five episodes of bacteraemia 
due to Gram-negative rods and and four to Staphylococcus aureus in granulocytopenic 
patients. Additional strains were therefore selected from isolates obtained from episodes of 
bacteraemia which had occurred in other patients during the same period as surrogates for 
the enterobacteria, Pseudomonas aeruginosa and Staph aureus. All strains were stored at 
—70°C until required for use. 
Table 1 Range of antibiotic concentrations (mg/L) 
Antibiotic 
Amikacin 
Ampicillin 
Cefepime 
Cefotaxime 
Ceftazidime 
Ciprofloxacin 
Clindamycin 
Co-trimoxazole* 
Gentamicin 
Imipenem 
Meropenem 
Methicillin 
Pefloxacin 
Piperacillin 
Teicoplanin 
Tobramycin 
Vancomycin 
minimum 
0.125 
0.063 
0.063 
0.063 
0.063 
0.008 
0.008 
0.25/0.013 
0.031 
0.031 
0.031 
0.031 
0.008 
0.5 
0.031 
0.031 
0.031 
maximum 
128 
64 
64 
64 
64 
8 
8 
256/12.8 
32 
32 
32 
32 
8 
512 
32 
32 
32 
susceptible 
4 
1 
8 
8 
8 
1 
0.5 
8/0.4 
1 
4 
8 
4 
1 
2 
4 
1 
4 
* sulphamethoxazole/trimethoprim 
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Determination of the minimum inhibitory concentrations 
Cefepime, and meropenem solutions were prepared from pure substance given by Bristol-
Myers-Squibb (Bristol-Myers-Squibb, Brussels, Belgium) and ICI Pharmaceuticals (ICI, 
Cheshire, UK) respectively whereas Adatabs (Diamed Ltd, Poole, UK) were used as the 
primary source of drug for all other antibiotics. Antibiotics were dissolved in Iso-sensitest 
broth (CM 473: Unipath-Oxoid, Basingstoke, United Kingdom) and two-fold dilutions of 
each drug were distributed in duplicate as 100 μΐ aliquots in flat-bottomed microtitration 
trays (Sterilin, UK). The last column was filled with antibiotic-free broth and used as a 
control. An inoculum of 101'6 cfu/ml was prepared from 18 hour agar cultures and ΙΟΟμΙ was 
added to each well resulting in the final concentrations for each antibiotic shown in 
Table 1. Plates were incubated in air at 37°C for 18-20 hours following which each well was 
examined for growth and then the optical density was recorded at 405 nm. The MIC was 
taken to be the last concentration which inhibited visible growth and which resulted in a 
density of less than 10% of that for the control. A strain was defined as being susceptible to 
meropenem if its MIC was 8 mg/L and to other antibiotics if the MIC was less than or equal 
to the breakpoints defined by the Working Party of the British Society of Antimicrobial 
Chemotherapy(Working Party report of the British Society for Antimicrobial Chemo­
therapy, 1991) 
Results 
Details of the activities of the various antimicrobial agents tested are given in Table 2. 
Meropenem was as active as imipenem against the streptococci all strains being inhibited by 
2 mg/L. The majority of strains were resistant to both ciprofloxacin and co-trimoxazole 
reflecting the fact that patients had developed bacteraemia while receiving prophylaxis with 
these agents. Cefepime had similar activity to cefotaxime and MIC's were 16 times lower 
than those for ceftazidime. All strains were susceptible to the glycopeptides but two strains 
of Strep, sanguis and two of Strep, miti's were resistant to clindamycin and ampicillin 
respectively. 
All but one strain of enterococci was susceptible to imipenem meropenem. The 
organisms were resistant to the cephalosporins, half were susceptible to co-trimoxazole and 
all were inhibited by tcicoplanin at 1 mg/L. MIC's to vancomycin were 4-16 mg/L while one 
strain had an MIC of 8 mg/I for ampicillin. 
Imipenem was about 8-fold more active than meropenem against coagulase-negative 
staphylococci. However methicillin resistance resulted in higher MIC's for carbapenems, 
the cephalosporins and, to a lesser extent, the aminoglycosides. All strains of methicillin-
resistant strains were susceptible to imipenem while two strains of methicillin-resistant 
coagulase-negative staphylococci were resistant to meropenem. However imipenem was 
8-16 times more active than meropenem. Almost three-quarters of the coagulase-negative 
staphylococci were resistant to co-trimoxazole as a result of prior prophylaxis with co-
trimoxazolc while almost one half were also resistant to the aminoglycosides and ciproflox­
acin. Two-thirds of Staph, epidermidis and four-fifths of other coagulase-negative staphylo­
cocci were susceptible to clindamycin. Staph, epidermidis was one-fold less susceptible to 
vancomycin than were the other coagulase-negative staphylococci with one-third of strains 
having an MIC of 8 mg/L. Two strains, one of Staph, epidermidis and one unspeciated 
required 16 mg/L of teicoplanin for complete inhibition. 
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Table 2 Cumulative percentage distribution of minimum inhibitory concentrations 
Minimum inhibitory concentration (mg/L) 
0 01 0 02 0 03 0 06 0 13 0 25 0 5 1 
Streptococcus mitis π = 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
co-trimoxazole 
ampicillm 
teicoplanin 
vancomycin 
clindamycin 47 77 
Streptococcus sanguis 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotrimoxazole 
ampicillm 
teicoplanin 
vancomycin 
clindamycin 40 47 
vmdans streptococci η •. 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotrimoxazole 
ampicillm 
teicoplanin 
vancomycin 
clindamycin 42 58 
Enterococcus species η 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotrimoxazole 
ampicillm 
teicoplanin 
vancomycin 
clindamycin 
17 
71 
82 
24 
94 
η =15 
53 
67 
20 
73 
=12 
67 
83 
17 
83 
=8 
76 
82 
71 
29 
65 
0 
76 
59 
100 
93 
80 
67 
7 
67 
0 
87 
40 
87 
92 
100 
58 
8 
58 
0 
92 
33 
92 
0 
82 
88 
76 
41 
82 
6 
82 
100 
93 
93 
80 
13 
73 
7 
93 
80 
87 
100 
75 
17 
100 
17 
100 
75 
100 
25 
0 
82 
88 
82 
53 
82 
12 
82 
0 
100 
100 
87 
33 
93 
0 
20 
93 
93 
0 
87 
100 
33 
0 
25 
92 
0 
38 
0 
25 
88 
94 
88 
71 
88 
0 
24 
88 
12 
93 
47 
93 
7 
27 
93 
93 
7 
87 
42 
8 
42 
100 
8 
0 
50 
25 
38 
94 
100 
100 
76 
94 
6 
35 
88 
94 
93 
67 
93 
13 
33 
100 
100 
80 
87 
67 
17 
58 
83 
0 
25 
0 
0 
50 
88 
100 
0 
2 
100 
76 
100 
29 
41 
88 
100 
100 
67 
100 
27 
60 
100 
87 
92 
25 
83 
100 
25 
88 
13 
63 
50 
88 
50 
4 
82 
65 
71 
88 
93 
53 
87 
87 
100 
58 
92 
25 
88 
13 
75 
63 
86 
63 
8 
88 
82 
71 
100 
93 
87 
100 
87 
83 
100 
88 
88 
0 
0 
13 
88 
63 
100 
75 
0 
16 
88 
83 
82 
93 
88 
88 
84 
88 
88 
13 
13 
13 
89 
63 
100 
1 
32 
100 
100 
100 
88 
88 
13 
25 
13 
64 
64 
89 
89 
25 
25 
13 
94 
Table 2 continued 
Antimicrobial activity of теторепет against bacteraemic isolates 
Minimum inhibitory concentration (mg/L) 
0 01 0 02 0 03 0 06 0 13 0 25 0 5 
Staphylococcus epidermide methicillm susceptible η 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicin 
tobramycin 
teicoplanin 
vancomycin 
clindamycin 
0 
40 
3 
3 
0 
6 
51 
14 
6 
6 
37 
89 
0 
0 
0 
14 
0 
34 
20 
0 
43 
43 
97 
3 
3 
3 
26 
3 
51 
37 
14 
60 
Staphylococcus ep/derm/d/s-methicillin resistan t η = 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicin 
tobramycin 
teicoplanin 
vancomycin 
clindamycin 0 
0 
0 
0 
6 
θ 
0 
23 
8 
46 
62 
0 
23 
0 
23 
23 
0 
54 
0 
77 
69 
23 
8 
23 
23 
7 
54 
1 
=35 
51 
100 
20 
11 
34 
26 
17 
54 
40 
40 
0 
63 
13 
8 
92 
0 
69 
23 
23 
23 
23 
46 
0 
54 
2 
77 
40 
37 
46 
29 
26 
54 
40 
77 
6 
66 
38 
100 
15 
0 
69 
23 
23 
23 
23 
77 
54 
54 
coagulase-negative staphylococci-methicillm susceptible η =31 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicin 
tobramycin 
teicoplanin 
vancomycin 
clindamycin 
16 
52 
3 
10 
3 
0 
19 
77 
0 
13 
10 
13 
16 
13 
45 
90 
13 
13 
0 
23 
3 
29 
35 
0 
52 
68 
97 
23 
0 
16 
23 
26 
3 
39 
42 
13 
0 
65 
68 
100 
29 
10 
23 
58 
35 
13 
48 
45 
39 
3 
81 
94 
45 
10 
35 
71 
42 
26 
52 
52 
58 
23 
84 
97 
84 
13 
61 
71 
45 
34 
65 
52 
71 
65 
84 
4 
97 
66 
49 
49 
34 
37 
54 
40 
89 
66 
66 
69 
54 
15 
69 
23 
54 
23 
23 
100 
100 
62 
100 
94 
19 
81 
71 
52 
58 
65 
52 
94 
100 
84 
8 
97 
94 
0 
71 
49 
34 
43 
54 
43 
97 
97 
66 
100 
77 
0 
54 
69 
23 
54 
23 
31 
62 
100 
42 
97 
84 
55 
68 
68 
55 
100 
84 
16 
100 
100 
37 
91 
50 
34 
49 
54 
43 
97 
100 
67 
100 
8 
92 
70 
38 
62 
31 
38 
63 
81 
100 
85 
61 
87 
71 
68 
85 
32 
77 
100 
69 
83 
54 
43 
100 
54 
100 
100 
77 
62 
54 
90 
100 
97 
74 
71 
64 128 
94 95 
70 
100 
55 
44 
100 
100 
63 
55 
100 
97 100 
75 
72 
95 
Vindans streptococci and allogeneic bone marrow transplant recipients 
Table 2. continued 
Minimum inhibitory concentration (mg/L) 
0 01 0 02 0 03 0 06 0 13 0 25 0 5 1 
coagulase-negative staphylococci -
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicm 
tobramycin 
teicoplanin 
vancomycin 
clindamycin 
θ 
4 
7 
4 
0 
Staphylococcus aureus η =18 
meropenem 
imipenem 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicm 
tobramycin 
teicoplanin 
vancomycin 
clindamycin 
Enterobacter cloacae η 
meropenem 
imipenem 
piperacillin 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 5 14 
cotnmoxazole 
amikacin 
gentamicm 
tobramycin 
0 
67 
=21 
33 
67 
0 
37 
4 
11 
4 
7 
11 
100 
0 
0 
71 
33 
5 
71 
•methicillin resistant η = 
4 
70 
0 
22 
0 
37 
11 
48 
56 
0 
27 
0 
17 
81 
0 
52 
0 
5 
86 
0 
26 
78 
11 
30 
4 
41 
33 
0 
67 
89 
17 
40 
6 
0 
0 
83 
100 
38 
62 
10 
24 
95 
52 
0 
41 
93 
0 
0 
44 
30 
7 
41 
37 
15 
70 
89 
61 
40 
28 
22 
17 
0 
89 
95 
67 
29 
52 
100 
57 
33 
0 
63 
100 
8 
4 
56 
37 
26 
41 
41 
15 
0 
74 
100 
0 
0 
89 
73 
67 
67 
83 
33 
89 
100 
0 
67 
57 
67 
67 
0 
62 
48 
2 
27 
70 
33 
19 
56 
41 
37 
41 
41 
44 
67 
74 
28 
28 
100 
93 
0 
83 
89 
100 
83 
89 
10 
86 
62 
71 
71 
29 
62 
81 
4 
81 
67 
30 
63 
41 
59 
41 
41 
81 
100 
74 
94 
0 
89 
100 
22 
89 
89 
100 
89 
43 
90 
62 
76 
71 
76 
67 
81 
8 
93 
89 
0 
37 
63 
48 
78 
41 
41 
96 
78 
94 
28 
100 
72 
89 
89 
89 
52 
95 
71 
81 
76 
95 
71 
86 
16 
100 
89 
19 
85 
64 
70 
89 
41 
41 
100 
79 
94 
89 
89 
89 
89 
90 
52 
100 
71 
81 
81 
100 
81 
86 
32 
96 
59 
93 
100 
96 
59 
70 
100 
100 
100 
94 
89 
57 
76 
86 
100 
90 
95 
64 
96 
74 
96 
100 
60 
71 
95 
90 
62 
81 
86 
91 
96 
128 
97 
75 
97 
67 
82 
87 
76 86 
96 
Antimicrobial activity of meropenem against bacteraemic isolates 
Table 2. continued 
Minimum inhibitory concentration (mg/L) 
0 01 0 02 0 03 0 06 0 13 0 25 0 5 1 θ 16 32 64 128 
5 41 77 91 91 91 95 95 95 
Klebsiella species η =22 
meropenem 45 100 
imipenem 0 14 95 95 100 
piperacillin 0 
cefepime Θ2 86 95 95 100 
ceftazidime 0 59 82 82 86 95 95 95 100 
cefotaxime 82 82 86 91 95 100 
ciprofloxacin 5 50 91 95 100 
cotnmoxazole 0 45 86 86 86 91 91 91 91 100 
amikacin 0 36 86 100 
gentamicin 0 5 50 77 82 82 86 91 95 96 
tobramycin 0 77 91 95 95 95 95 96 
Escherichia and Citrobacter species η =16 
meropenem 
imipenem 
piperacillin 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicin 
tobramycin 
Pseudomonas 
meropenem 
imipenem 
piperacillin 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicin 
tobramycin 
6 31 
50 
86 
0 
aeruginosa η 
0 
0 
88 
0 
75 
19 
88 
6 
=33 
3 
7 
0 
9 
0 
100 
6 
81 
0 
56 
88 
31 
0 
15 
7 
0 
13 
27 
0 
0 
3 
Non fermenting Gram-negative rods η = 
69 
88 
25 
81 
88 
56 
31 
33 
27 
7 
13 
64 
3 
3 
3 
15 
94 
100 
56 
81 
100 
56 
63 
0 
48 
0 
7 
47 
13 
13 
79 
3 
3 
18 
100 
0 
81 
88 
56 
0 
94 
31 
73 
9 
7 
47 
33 
20 
91 
0 
6 
36 
70 
25 
94 
94 
63 
31 
100 
81 
85 
42 
13 
60 
47 
33 
94 
7 
18 
73 
85 
56 
94 
94 
63 
81 
88 
97 
82 
33 
67 
67 
47 
97 
7 
64 
82 
91 
63 
94 
94 
63 
100 
100 
100 
94 
53 
93 
87 
67 
100 
14 
82 
88 
91 
63 
94 
94 
69 
94 
73 
93 
93 
87 
36 
88 
91 
91 
63 
100 
100 
100 
100 
93 
100 
93 
87 
37 
97 
91 
91 
69 
93 
100 
100 
100 
92 
92 
meropenem 
imipenem 
piperacillin 
cefepime 
ceftazidime 
cefotaxime 
ciprofloxacin 
cotnmoxazole 
amikacin 
gentamicin 
tobramycin 
7 13 40 67 80 87 100 
0 13 33 74 93 93 100 
7 
0 
13 13 13 20 33 47 67 87 87 100 
88 88 88 
93 100 
7 7 13 33 53 73 93 93 93 100 
27 47 47 60 67 93 93 100 
7 13 33 47 67 87 93 93 100 
0 13 27 33 53 80 87 100 
0 20 40 47 67 73 80 80 87 87 88 
0 20 47 60 67 80 80 80 93 93 94 
0 13 40 53 60 67 67 80 80 87 88 
0 20 47 60 73 80 80 80 80 81 
97 
Vindans streptococci and allogeneic bone marrow transplant recipients 
The same differential in carbapenem susceptibility was observed for Staph aureus as was 
noted for the coagulase-negative staphylococci, MICs for meropenem being almost 16 times 
higher than those for ïmipenem None of the strains was resistant to either drug nor to 
methicilhn Both cefotaxime and cefepime were more active than ceftazidime, although the 
MIC^'s for these drugs bordered on resistance at 4 mg/L Other results were typical for this 
species except that almost 80% of strains were resistant to co-tnmoxazole 
All strains of Gram-negative rods were susceptible to both carbapenems although 
meropenem was 4-16 times more active than ïmipenem Cefepime and ceftazidime had 
similar activity which was slightly greater than cefotaxime One isolate of Ps aeruginosa was 
resistant to every antibiotic other than meropenem and had been obtained from blood 
cultures of a patient with cystic fibrosis The MIC^'s for piperacillin and the aminoglycosides 
were 4-fold higher than the breakpoint although within the range recommended by the 
Table 3. Rank order for susceptibility to meropenem 
Minimum inhibitory concentration (mg/L) 
Klebsiella species 
Escherichia/Citrobacter species 
vindans streptococci 
Streptococcus sanguis 
Enterobacter cloacae 
Staphylococcus aureus 
Streptococcus mitis 
Non termenting Gram negative rods 
Coagulase negative staphylococci MS 
Pseudomonas aeruginosa 
Staphylococcus epidermidis MR 
Staphylococcus epidermidis MS 
Coagulase negative staphylococci MR 
Enterococcus species 
π 
22 
16 
12 
15 
21 
18 
17 
15 
31 
33 
13 
35 
27 
θ 
0 06 
100 
88 
92 
93 
71 
11 
76 
13 
19 
3 
0 
0 
013 
100 
100 
93 
81 
56 
82 
40 
45 
15 
6 
4 
0 25 
100 
100 
89 
82 
67 
68 
33 
37 
26 
0 5 
89 
88 
80 
68 
48 
0 
43 
41 
1 
100 
94 
87 
94 
73 
8 
51 
63 
0 
2 
100 
100 
97 
85 
38 
77 
70 
25 
4 
100 
97 
69 
97 
81 
25 
8 
100 
100 
97 
93 
88 
16 
100 
100 
88 
MS = methicillin susceptible 
MR=methicillm resistant 
numbers in bold are the percentage strains inhibited by the breakpoint concentration 
NCCLS for Gram-negative rods (National Committee for Clinical Laboratory Standards, 
1990a) 
Overall, 98% of Gram-positives and all Gram-negative rods were susceptible to 8 mg/L 
meropenem The drug was most active against the entcrobactena, Staph aureus and 
streptococci with MICs less than 2 mg/L (Table 3) Ps aeruginosa was less susceptible but 
still within the therapeutic range Coagulase-negative staphylococci had higher MICs 
particularly when resistant to methicilhn The MICs for enterococci were 4-8 mg/L and 
typical for these organisms 
Discussion 
Our data confirm earlier reports that meropenem is an agent with a broad-spectrum of 
activity against Gram-negative rods and Staph aureus However we were particularly 
98 
Antimicrobial асаш у of meropenem against bacteraemtc isolates 
interested in exploring its potential as monotherapy in the febrile, granulocytopenic patient 
in a setting where Gram-positive cocci predominate as causes of bacteraemia and also how 
the drug compares with the most widely used single agent ceftazidime (Sanders, Powe & 
Moore, 1991 ). The paucity of strains of Gram-negative rods and Staph, aureus obliged us to 
selected surrogates from other bacteraemic episodes which developed over the same period 
of time. Thus we had some reflection of what might occur in granulocytopenic patients. The 
results showed meropenem to be the most active antibiotic against these strains even more 
so than either imipenem or cefepime. Meropenem also had equivalent activity to ampicillin 
against the vindans streptococci, the second most frequent cause of bacteraemia in 
granulocytopenic patients(Viot & Klastersky, 1991) obviating the need for the addition of 
penicillin to the empirical regimen. However methicillin resistance may limit the activity 
of meropenem as it does for other ß-lactams. The MIC's for imipenem against coagulase-
negative staphylococci seems more likely to remain within the margins for susceptibility 
although its MIC's and those for meropenem were higher for methicillin resistant strains as 
has been noted previously (Bauernfeind, Schweighart Sijungwirth, 1989; Edwards, Turner, 
Wannop, et al., 1989). No attempt was made to determine whether any of the strains was 
heteroresistant to methicillin but such strains harbour the mec-determinant for expression 
of PBP 2 ' which has reduced affinity for meropenem and other ß-lactams ( Kayscr, Morenzoni, 
Strassle &. Hadorn, 1989). The majority of methicillin-resistant strains were also resistant 
to tobramycin and trimethoprim suggesting the presence of plasmid mediated resistance 
(Hedin &. Hambraeus, 1991 ). However, the actual incidence of methicillin resistance differs 
from centre to centre and only where it is high, would the addition of glycopeptidcs ab initio 
be necessary (Nováková, Donnelly, De Pauw &. Verhagen, 1990; Nováková, Donnelly &. De 
Pauw, 1991a; The EORTC International Antimicrobial Therapy Cooperative Group and 
National Cancer Institute of Canada, 1991). 
In conclusion, meropenem exhibits an extended spectrum of in-vitro activity 
encompassing most potential causes of primary bacteraemia in granulocytopenic patients 
which is equalled only by imipenem. Clinical studies are therefore warranted to confirm 
whether the the in-vitro activity actually translates into significantly improved efficacy of 
empiric monotherapy over existing alternatives without the need for later modification. 
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Chapter 12 
Summary/Samenvatting 

Summary 
Summary 
Vindans streptococci are part of the normal oral commensal flora and were once regarded 
as opportunistic pathogens only for patients with defective heart valves who develop 
endocarditis as a result. However, as was discussed in Chapter 1, bacteraemia with vindans 
streptococci now affects a substantial proportion of patients rendered neutropenic by 
intensive chemotherapy. A high temperature was the only clinical manifestation of 
bacteraemia in most cases although some patients developed ARDS and sepsis. 
During the last several years there has been an increase in vindans streptococcal 
bacteraemia. Prophylaxis has been identified as a major risk factor since most authors 
reported an increase in the incidence of bacteraemia after the introduction of quinolones to 
which the streptococci are only marginally susceptible. However patients given co-mmoxazole 
are also at risk. Oral lesions, particularly those associated with oromucosms, have been 
shown to predispose some patients to bacteraemia but not others. The higher risk of 
bacteraemia was also attributed to cytostatic regimens containing cytarabine 
In Chapter 2 it was postulated that selection by antimicrobial prophylaxis and the 
presence of oromucosms were both necessary prerequisites for the occurrence of bacteraemia 
with vindans streptococci. This hypothesis was designed to reconcile the apparently 
conflicting data and to provide a model which could be tested by investigating a relatively 
homogeneous cohort of patients namely allogeneic bone marrow transplant recipients. A 
consecutive series of 78 recipients had been given ciprofloxacin as prophylaxis (Chapter 3) 
and bacteraemia due to vindans streptococci did indeed occur more frequently than in the 
previous cohort of similar patients given other antibiotics for prophylaxis Ciprofloxacin 
therefore did not prevent bacteraemia due to vindans streptococci which were, in fact, 
resistant in all but one case. Ninety four percent of the patients had been given anthracychnes 
as part of their conditioning regimen and this resulted in more severe oromucositis than had 
been observed previously. Mucosal damage was therefore an important predisposing factor 
although the streptococci had probably been subjected to selective pressure by the 
ciprofloxacin. 
The severity of oromucosms had been previously graded according to the rather limited 
scheme of the W H O scheme. The alternative approach discussed in Chapter 4 provided 
a simple and reliable means for the daily monitoring of oromucositis by grading lesions, 
erythema, oral oedema, pain and dysphagia to three levels and summing the results to give 
a daily mucositis score or DMS It was then possible to show that oromucosms actually began 
shortly after transplant and became progressively more severe during the next few days 
culminating in both fever and bacteraemia. Oromucositis remained severe until the bone 
marrow began to recover but only completely resolved after granulocytes counts exceeded 
0 5 χ 10%. 
The role of prophylaxis was addressed specifically in Chapter 5. Ciprofloxacin was 
shown to have a clear impact on the oral flora by causing a transformation from the more 
susceptible flora to vindans streptococci resistant to at least 4 mg/L. This shift in flora 
occurred rapidly and resistant oral streptococci were already present in 90% of patients 
before mucosal damage began to become apparent but bacteraemia only developed after 
oromucositis approached peak severity. Neither colonisation nor infection with Gram-
negative rods was observed Despite the presence of resistant streptococci, bacteraemia only 
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developed once oromucositis had become severe. 
The occurrence and significance of Gram-positive bacteraemia was examined more 
closely in the following chapter (Chapter 6). Of the 52 patients investigated, staphylococci 
were recovered from at least one blood culture in 90% of patients whereas bacteraemia due 
to vindans streptococci was experienced by 62% of patients. Almost all episodes of 
bacteraemia due to the streptococci occurred with the first week after transplant during 
progressive oromucositis whereas staphylococcal bacteraemia showed no temporal relationship 
to either granulocytopenia or mucosal damage. Furthermore, only two patients had bacterial 
counts exceeding 5 cfu per ml of streptococci while the numbers of staphylococci were 
generally higher Moreover, infection due to Staphylococcus epidermide only became manifest 
clinically in those cases in which counts exceeded 10 cfu per ml or when bacteraemia was 
sustained. Therefore bacteraemia due to coagulase negative staphylococci appeared to be 
significant in only 20% of cases and was associated with clinical infection in only 10% of 
cases. This was in marked contrast to bacteraemia with the streptococci which was transient 
and invariably associated with oromucositis. 
Were streptococci to have played a role in the development of oromucositis and fever, 
treatment with an active antimicrobial agent would be of benefit. However therapy with 
high-dose clindamycin together with ceftazidime did not alter morbidity (Chapter 7). On 
the contrary, fever persisted and CRP levels continued to rise in over half of cases and 
patients only defervesced once oromucositis had resolved. Only then did CRP levels return 
to normal. Therefore oromucositis and not infection seemed the only explanation for a 
protracted inflammatory response in two-thirds of cases. This lead to the conclusion that, 
provided adequate coverage against Gram-negative infection is maintained, further 
modification of empirical therapy is only necessary when a focus of infection is actually 
documented or bacteraemia persists. 
Further exploration of the data showed that there was a clear relationship between 
CRP, interleukin 6 and, to a lesser extent, fever and oromucositis (Chapter 8). Not only 
was there a significant correlation between the daily mucositis scores and these measures of 
the inflammatory response, but their temporal relationship was readily apparent. The 
concentrations of both CRP and interleukin 6 became elevated as oromucositis progressed 
and only declined after mucosal damage had been resolved. There was no difference in the 
concentrations of either CRP or interleukin 6 between patients with bacteraemia and those 
without Neither were the levels that occurred in patients with focal infection or persistent 
bacteraemia any different from those who only had oromucositis. These data suggest tend to 
confirm that bacteraemia due to vindans streptococci is a consequence of oromucositis and 
that this, rather than infection, accounts for the morbidity that occurs during neutropenia. 
Greater attention should be therefore be paid to preventing and ameliorating oromucositis 
since this accounted for the greater part of the morbidity suffered during neutropenia. 
While the data presented in Chapter 7 showed that the addition of clindamycin did not 
offer any clinical benefit, ceftazidime may prove inadequate as therapy for other neutropenic 
patients who develop bacteraemia involving streptococci since the antibiotic is less actve 
against Gram-positive bacteria. Meropenem might provide a suitable alternative since it was 
shown to possess superior activity in vitro to that of the other ß-lactams including cefepime 
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and ceftazidime. These data were displayed by box-plots in Chapter 9 and presented in the 
more conventional manner in Chapter 10. The box-plots allowed for a more comprehensive 
analysis and presentation of the data but it remains to be seen whether or not the technique 
will gain general acceptance. 
Conclusion: Antimicrobial prophylaxis with ciprofloxacin helps promote bacteraemia 
due to oral viridans streptococci by selecting resistant organisms in the oral cavity. 
Oromucositis then appears to play a pivotal role since bacteraemia only occurs once mucosal 
damage has become severe. The morbidity that occurs during neutropenia appears to be the 
result of the inflammatory processes induced by oromucositis and not bacteremia due to 
viridans streptococci. Rather, the appearance of these bacteria in the bloodstream appears 
to be a consequence of severe damage to the oral mucosa. The rare cases of sepsis or ARDS 
that follow bacteraemia with viridans streptococci may actually represent an entirely 
different infectious process involving other determinants. Further investigation is therefore 
necessary to identify such putative factors as might help distinguish between these 
phenomenon. 

Sammenvamng 
Samenvatting 
Vergroenende Streptococcen vormen een onderdeel van de normale, orale commensale flora 
en werden tot voor kort alleen beschouwd als opportunistische pathogenen voor patiënten 
met hartklepafwijkingen die risico zouden lopen op een endocarditis In Hoofdstuk 1 werd 
besproken dat bactenemie met vergroenende Streptococcen tegenwoordig een bedreiging 
vormt voor haematologische patiënten in de neutropenische fase. Hoge temperatuur was 
meestal het enige symptoom van de bactenemie, maar sommige patiënten ontwikkelden een 
ARDS en sepsis. 
De laatste jaren is er wereldwijd een toename van deze soort bactenemieen. Hiervoor 
zijn een aantal factoren in de literatuur genoemd Uit diverse onderzoeken bleek dat de 
introductie van chinoloncn geassocieerd was met een toegenomen incidentie van bactenemie 
door vergroenende Streptococcen. Deze bacteriën zijn slechts matig gevoelig voor deze 
antibiomicrobiele middelen. Echter ook bij patiënten die profylactisch behandeld werden 
met co-tnmoxazol zag men de laatste jaren een toename van deze soort bactenemie. 
Daarnaast lijkt oromucositis als gevolg van cy tostatische behandeling bij bepaalde patiënten 
een predisponerende factor Cytostatische behandeling met cytarabine werd ook in verband 
gebracht worden met een verhoogde kans op bactenemie. 
In Hoofdstuk 2 werd de hypothese geformuleerd dat mogelijk selectie door 
antibactenele profylaxe tesamen met de aanwezigheid van oromucositis predisponeren voor 
het ontstaan van Streptococcen bactenemieen. Dit concept werd bestudeerd in een relatief 
homogene populatie, namelijk bij patiënten met een allogene beenmergtransplantatie. In 
Hoofdstuk 3 werd een opeenvolgende serie van 78 patiënten beschreven die profylactisch 
met Ciprofloxacine werden behandeld gedurende de neutropenische periode. Bactenemie 
met vergroenendc Streptococcen trad inderdaad vaker op dan bij soortgelijke patiënten, 
voorheen profylactisch met andere antibiotica behandeld Ciprofloxacine kon dus de 
Streptococcen bactenemie niet voorkomen. De meeste Streptococcen die uit bloed werden 
geïsoleerd bleken resistent tegen Ciprofloxacine 94% van deze patiënten waren behandeld 
met anthracyclines volgens de huidige, meer intensieve behandelingsschema's als onderdeel 
van hun conditionering en het gebruik hiervan resulteerde in ernstiger oromucositis dan 
voorheen. Slijmvlies schade bleek derhalve een belangenjke risicofactor, mogelijk van meer 
belang dan de aanwezigheid van resistente Streptococcen, die waarschijnlijk uitgeselecteerd 
waren onder invloed van Ciprofloxacine. 
De ernst van oromucositis werd vroeger gegradeerd aan de hand van de W H O 
classificatie die de nodige beperkingen kent. De alternative benadering hiervan in 
Hoofdstuk 4 bleek een eenvoudige en betrouwbare methode voor het dagelijks scoren van 
oromucositis door het kwantificeren van laesies, erythecm, oedeem, pijn en dysfagie op drie 
niveaus waarbij de som van de resultaten de dagelijkse mucositis score ofwel DMS levert. Op 
deze manier was het mogelijk om aan te tonen dat oromucositis m feite kort na de 
transplantatie begon en verergerde gedurende de daaropvolgende dagen, culminerend in 
koorts en bactenemie De oromucositis bleef ernstig tot het begin van het beenmergherstel 
maar verdween pas geheel nadat het aantal granulocyten in het perifere bloed boven de 
0 5 χ 109/L was gestegen. 
De rol van antibactenele profylaxe werd meer specifiek geanalyseerd in Hoofdstuk 5 
Ciprofloxacine had een duidelijke invloed op de orale flora in die zin dat er een verschuiving 
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plaats vond in de flora door eliminatie van gevoelige micro-organismen met selectie van 
vergroenende Streptococcen die resistent waren tegen Ciprofloxacine (minimum remmende 
concentratie >4 mg/l). Deze verschuiving met selectie trad zeer snel op, resistente Streptococcen 
waren reeds in de mond aanwezig bij 90% van de patiënten voordat de slijmvlies schade 
duidelijk werd. Kolonisatie en/of infectie met Gram-negatieve staven werd niet waargenomen. 
Ondanks de reeds permanente aanwezigheid van de resistente Streptococcen in de mucosa 
flora, trad bacteriëmie pas op nadat de oromucositis maximaal was geworden. 
De incidentie en het beloop van Gram-positieve bacteriëmieen, alsmede de betekenis 
ervan werd meer in detail bestudeerd in Hoofdstuk 6. In de bestudeerde patientenpopulatie 
had tenminste 90% van de patiënten een episode van bacteriëmie met staphylococcen, 
terwijl 62% een bacteriëmie met Streptococcen doormaakte. Een bacteriëmie met 
Streptococcen ontstond in het algemeen aan het eind van de eerste week na tranplantatie en 
werd alleen waargenomen tijdens progressieve oromucositis; bacteriëmie doorstafylococcen 
kon niet worden geassocieerd met het tijdstip van behandeling, granulocytopenic of 
slijmvlies schade. Het aantal Streptococcen in het bloed was meestal laag, slechts bij twee 
patiënten werden aantallen van meer dan 5 cfu/ml gevonden. Het aantal stafylococcen in 
het bloed was in het aigemcen groter. Overigens moet worden opgemerkt dat bacteriëmieen 
met Staphylococcus epidermidis alleen klinisch manifeste infectie veroorzaakten werden in 
die gevallen waarin het aantal stafylococcen > 10 cfu/ml was of indien er sprake was van een 
persisterende bacteriëmie. Op basis van deze gegevens kon worden geconcludeerd dat 
bacteriëmieen met coagulase negatieve staphylococcen slechts in 20% van de gevallen 
klinische betekenis hadden (relatie met kolonisatie c.q. infectie van intraveneuze catheters), 
terwijl slechts in 10% klinische tekenen van infectie aanwezig waren. Dit was in scherp 
contrast met de Streptococcen infecties, waarbij de bacteriëmie van voorbijgaande aard was 
en onveranderlijk geassocieerd met oromucositis. 
Indien Streptococcen een etiologische betekenis hebben bij het ontstaan van 
oromucositis en koorts zou behandeling met een actief antibacterieël middel een gunstige 
uitwerking moeten hebben. Behandeling met een hoge dosis clindamycine in combinatie 
met ceftazidime liet echter geen verandering in morbiditeit zien zoals waargenomen in 
Hoofdstuk 7. Integendeel, de koorts persisteerde tijdens de behandeling en de CRP 
spiegels stegen verder in meer van de helft der gevallen. Patiënten werden pas koortsvrij 
nadat de oromucositis was genezen en parallel daaraan normaliseerden de CRP spiegels. 
Oromucositis zelf en niet een bacteriëel agens leek derhalve de enige goede verklaring voor 
de aanhoudende ontstekingsreactie. 
Deze gegevens leidden tot de conclusie dat bij voldoende dekking tegen infectie door 
Gram-negatieve bacteriën, uitbreiding van empirische antibiotische therapie bij persisterende 
koorts met een antibioticum dat meer specifiek gericht is tegen Gram-positieve verwekkers, 
alleen noodzakelijk is als er daadwerkelijk een bron van infectie wordt gevonden of wanneer 
een bacteriëmie persisteert. 
Verdere analyse van de gegevens toonde aan dat er een duidelijke relatie was tussen 
koorts en oromucositis. In Hoofdstuk 8 werd beschreven dat er niet alleen sprake was van 
een significante relatie tussen de dagelijkse mucositis score en de eerdergenoemde parameters 
voor de ontstekingsreactie maar dat er ook een duidelijke relatie met de tijd bestond. De 
spiegels van zowel CRP als interleukine 6 stegen bij progressie van oromucositis en daalden 
pas na herstel van de slijmvlies beschadiging. Tussen de patiënten met en zonder bacteriëmie 
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bleek er geen verschil te zijn in de spiegels van CRP of interleukine. Evenmin werden er 
verschillen gevonden in de spiegels van patiënten met een infectie in vergelijking met hen 
die alleen een oromucositis hadden. Deze gegevens lijken te bevestigen dat een bactenemie 
met vergroenende Streptococcen een gevolg is van het oromucositis proces. Er zou meer 
aandacht besteed moeten worden aan het voorkomen en de symptomatische behandeling 
van oromucositis, omdat deze voor een groot deel verantwoordelijk is voor de morbiditeit 
tijdens neutropenic na beenmergtransplantatie. 
Hoewel bij het onderzoek in Hoofdstuk 7 was aangetoond dat toevoeging van 
clindamycinc aan ceftazidime, dat minder actief is tegen Gram- positieve bacteriën, de 
klinische resultaten niet verbeterde mag er van worden uit gegaan dat ceftazidime bij andere 
neutropenische patiënten met een Streptococcen bactenemie niet het optimale antibioticum 
is. Meropenem blijkt voor dit doel een goed alternatief te zijn. De in vitro activiteit tegen 
Gram-positieve coceen was sterker dan van die van andere ß-lactam antibiotica, waaronder 
cefepime en ceftazidime. De resultaten van dit onderzoek werden beschreven in Hoofdstuk 9 
volgens de Box-plot techniek en in Hoofdstuk 10 volgens de meer traditionele manier. De 
Box-plot techniek leent zich beter voor een snelle analyse en een beter te begrijpen 
presentatie van de gegevens maar het is nog niet duidelijk of deze techniek algemeen opgang 
zal vinden. 
Conclusie. Antibacteriele prophylaxe met Ciprofloxacine geeft aanleiding tot 
floraverschuiving en selecteert voor resistente vergroenende Streptococcen in de mondholte 
en vergroot daarmee het risico op bactenemie door resistente microorganismen. Oromucositis 
lijkt een hoofdrol te spelen, omdat bactenemie alleen optreedt als de slijmvhesschade 
ernstiger wordt. De morbiditeit die optreedt tijdens neutropenie wordt grotendeels bepaald 
d(Kir ontstek ingsprocessen als gevolg van oromucositis en niet veroorzaakt door vergroenende 
steptococcen. De aanwezigheid van deze bacteriën m de bloedbaan lijkt dan ook eerder een 
gevolg dan een oorzaak van een ernstige slijmvlies beschadiging. Deze Streptococcen 
bactenemicen geven zelden aanleiding tot sepsis of ARDS. De laatste zijn mogelijk uitingen 
van een ander infectieproces. Het is op dit moment onduidelijk welke factoren een rol spelen 
bij het ontstaan van de meer ernstige Streptococcen infecties. Alleen door middel van verder 
onderzoek kunnen factoren aan het licht gebracht worden die van belang kunnen zijn om 
onderscheid te maken tussen deze fenomenen. 
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1 Zoals de meeste bacteriën groeien Streptococcen in hun natuurlijke omgeving 
als een biofilm waardoor de cellen een soort gemeenschap ofwel een consortium 
vormen. 
Like most bacteria, streptococci grow as biofilm in tìieir normal environment in which celL· 
are associated one with anotlier to form a community or consortium. 
dit proefschrift 
2 Het blijft de vraag of vergroenende Streptococcen echte pathogeneri zijn. 
Whether viridans streptococci represent true pathogens remains an open question. 
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3 Prophylaxe (bij beenmergtransplantatie patiënten) met Ciprofloxacine leidt tot 
een vermindering van de orale commensale flora en snelle selectie van resistente 
vergroenende Streptococcen, maar bacteriëmie treedt niet op voordat de 
oromucositis een bepaald stadium heeft bereikt. 
Prophylaxis with ciprofloxacin (in bone marrow transplant reapienU) leads to the rapid 
selection of resistant oral viridans streptococci and a reduction in other commensal flora but 
bacteraemia only ensues after oromucositis has attained a certain degree of severity 
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4 Bij voldoende bescherming tegen een infectie door Gram-negatieve bacteriën is 
uitbreiding van de empirische antibiotische therapie bij persisterende koorts 
alleen noodzakelijk als er daadwerkelijk een bron van infectie is gevonden. 
Provided adequate coverage against Gram-negative infection is maintained, further 
modification of empirical therapy is only necessary when a focus of infection is actually 
documented. 
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5. Om de morbiditeit van beenmergtransplantatie te verminderen is een strategie 
voor het minimaliseren van de mucosaschade wellicht effectiever dan het 
gebruik van specifieke antibiotika ter voorkoming of behandeling van een 
bacteriëmie door vergroenende Streptococcen . 
Λ strategy designed to minimize mucosal injury may be more effective in reducing morbidity 
than the use of specific antimicrobial agents to either prevent or treat bacteraemia due to 
viridans streptococci 
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6. Koorts en stijgende concentraties van interleukine 6 en C-reactive protein 
blijken het gevolg te zijn van oromucositis en niet van bacteriëmie met 
vergroenende Streptococcen. 
Both fever and the elevated concentrations of interleukin-6 and CRP can be attributed to 
oromucositis rather than bacteraemia due to viridans streptococci. 
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7. De Box-plot is een techniek die de verwerking van informatie vereenvoudigt. 
Deze methode is een simpele en efficiente manier om informatie uit te wisselen. 
Box-plots are therefore one of those techniques which enhance the assimilation of 
information. They therefore deserve the attention of all who wish to communicate simply 
and efficiently. 
dit proefschrift 
8. Door het bredewerkings spectrum is meropenem mogelijk een aanwinst voor 
empirische therapie omdat hel als monotherapie kan worden toegepast. 
The broad-spectrum activity of meropenem is expected to translate into significantly 
improved efficacy of empiric therapy without the need for initial combination with other 
agents or later modification. 
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9 Het toeval is slechts de daarop voorbereide geest welgezind. 
Ije hasard ne favorise que les esprits préparés. 
Louis Pasteur 1822-1895 
10. Infection is essentially a conflict of interest between two entities who more often 
than not actually need each other to survive but nevertheless choose to risk each 
others total destruction rather than yield to this fact of life. 
11. Niets is moclijker dan het eenvoudige. 
Nothing is more difficult than simplirìly 
Ben De Pauw 
12. All antimicrobial therapy is empirical but would never be given by a true 
empiricist. 
13. Feiten houden niet op te bestaan door ze te negeren. 
Facts do not cease to exist just because, they are ignored. 
Aldous Huxley 1894-1963 
14. Antimicrobiële therapie wordt te vaak gebruikt voor andere doeleinden dan de 
behandeling van infectie. 
Antimicrobial therapy is too often used for every other reason than to treat infection. 
15. Much can be made of a Scot if he is caught early. 
Samuel Johnson 1709-1784 
16 Ik hoorde het van de postbode en dacht het is waarheidsgetrouw, 
Totdat het duidelijk werd dat het mij betrof en niet jou. 
I heard it from the postman and accepted it as true 
Until I realised that it was said of me and not of you. 
"The Gossip" 
17 "Madam, I am not prescribing valium for your nerves, but for mine" 
A surgeon's reply 
J Peter Donnelly 
June 21 1993 


